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Abstract 
RNA polymerases (RNAPs) are the ‘engines’ of cellular transcriptional machineries, 
which are essential to life and highly conserved from bacteria to eukaryotes. Though 
crystal structures of both eukaryotic and bacterial RNAPs have been intensively 
studied, the relationships between structures and appropriate functions of such 
enzymes in eukaryotes remain unknown since there has not yet been possible to 
constitute any active eukaryotic RNAPs from recombinant subunits. The successfully 
assembled archaeal counterparts have provided an alternative approach to study the 
eukaryotic system due to not only the structural similarities between these enzymes 
but also the structural and functional similarities of their basal transcriptional 
machineries.  
‘Bridge-helix’ is one of the most highly conserved structures near the catalytic site of 
RNAPs, which has been proposed to play an important role in coordinating the 
processing of nucleic acid substrates through the active center. 17 adjacent residues 
(mjA’-L814 to mjA’-R830) within the central portion of Methanocaldococcus 
jannaschii A’ ‘bridge-helix’ were chosen for a systematic high-throughput site-
directed mutagenesis approach using a novel robotic system. This robotic system is 
fully automated without any human interventions that may enormously reduce human 
errors and effectively increase the number of samples that could be processed in 
parallel. 
The results obtained from such high-throughput approach showed a wide spectrum of 
in vitro phenotypes ranging from complete loss of function to ‘superactivity’. 
According to the unexpected functional evidences obtained with the ‘superactive’ 
mutants, we propose a highly favorable kinked ‘bridge-helix’ conformation for the 
nucleotide addition cycle that has to be precisely localized in certain positions in order 
to increase the specific activity of RNAPs. The fact that no additive effects have been 
found so far in any of the ‘superactive’ double mutants suggests that various single 
amino-acid substitution ‘superactive’ mutants may affect the same process in a 
functionally overlapping and mutually independent manner. 
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Chapter 1 Introduction 
1.1 Gene Expression 
Deoxyribonucleic acid (DNA) had been demonstrated for the first time to take 
responsibility for the transmission of genetic information through generations in the 
1940s. However, the nature of that process had remained uncertain until the discovery 
of the double-helical structure of DNA in 1953 (Watson and Crick 1953). The term of 
genetic codes was referred to in 1954 by George Gamow who proposed that the 
genetic code was a triplet code, by which every triplet of nucleotides in a nucleic acid 
sequence specified a single amino acid. The fact that codons did consist of three DNA 
bases was first demonstrated in the Crick, Brenner et al. experiment (Crick, Barnett et 
al. 1961). The first elucidation of a codon (UUU) was done by Marshall Nirenberg 
and Heinrich J. Matthaei when the poly-U programmed synthesis of poly-
phenylalanine was demonstrated in an Escherichia coli-free protein-synthesizing 
system in 1961 (Nirenberg, Matthaei et al. 1962). Since then, the way in which 
genetic information is transcribed has been widely accepted by the modern biology.  
The genome of an organism is its whole inheritary information and is majorly made of 
DNA. This includes both genes and non-coding DNA sequences. The number of 
genes in different genomes varies from a few to hundreds of genes in bacteriophages 
and viruses, a few thousand genes in primitive micro-organisms (based on the 
availability of currently sequenced genomes) and 20,000-25,000 protein-encoding 
genes in humans (according to the figures published by the Human Genome Project, 
October 2004). There are an estimated 2,000 genes that encode transcription factors in 
the human genome (Tupler, Perini et al. 2001), which reflects the effort and expense 
that are applied to the regulation of gene expression in living cells. Abnormalities and 
mutations in many of the components involved in transcription lead to pathological 
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phenotypes or diseases, suggesting that the understanding of the transcription 
apparatus should have significant contribution to the benefit of the mankind.  
The central component of the transcriptional machinery is the RNA polymerase 
(RNAP), an enzyme that catalyzes the polymerization of nucleotide substrates (rNTPs) 
into RNA in a template DNA dependent manner. RNAPs from different domains of 
life vary considerably. However, the fundamental architecture of such enzymes is 
highly conserved among various species revealing its essential function and early 
origin in evolution (Cramer 2004). The interest of my project mainly focuses on a 
model organism (Methanocaldococcus jannaschii), which is a single-celled 
microorganism, but surprisingly with transcriptional machinery that is both 
functionally and structurally similar to ours. 
1.2 The third domain of life – Methanocaldococcus jannaschii 
Until the late 1970s, cellular organisms were classified into two separate domains, 
eukaryotes (with nucleus) and prokaryotes (before nucleus), which were based 
microscopically on the presence or absence of a cell nucleus. However, by 
comparison of the small ribosomal RNA (rRNA) sequences, a group of organisms 
were isolated from prokaryotes that were then identified as the third domain of life 
and called archaea (Woese, Kandler et al. 1990). Though the proposed three-domain 
system (dividing cellular life forms into archaea, bacteria and eukaryote) is still 
controversial, the differences between these domains have become ever more 
apparent with the increasing amount of sequenced genomes. Figure 1.1A illustrates a 
model of the evolution of cellular life forms from a common ancestor diverging into 
bacterial and archaeal/eukaryotic lineages, which later splits into two distinct domains:  
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Figure 1.1. The three domains of life and the universal phylogenetic tree of life.  
(A) The vertical line indicates the deepest known phylogenetic split between bacteria 
and archaea/eukarya. The horizontal line represents the division between prokaryotes 
and eukaryotes. The cenancestor is the last common ancestor of all living organisms 
and the progenote is a hypothetical ancestor in which basic information-handling 
processes (replication, transcription, and translation) were still undergoing rapid and 
fundamental evolutionary change (Edgell and Doolittle 1997). (B) Phylogenetic tree 
of life showing the three domains: bacteria, archaea and eukarya. Branches are based 
upon ribosomal RNA sequence comparisons and the branch lengths are proportional 
to their evolutionary divergence (Woese, Kandler et al. 1990).  
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archaea and eukarya. Figure 1.1B indicates the phylogenetic relationship between the 
three domains based on the comparisons of small ribosomal RNA sequences.  
Archaea were originally described in extreme environments, including extremes of 
temperature, pressure and salinity that are thought to be similar to the environment of 
the earth in the very early stages of life. Recently, several studies have shown that 
archaea may even have opportunities for contact with higher eukaryotes including 
humans (Stein and Simon 1996). 
Most of the well-studied species of archaea are members of two main kingdoms, the 
Euryarchaeota and Crenarchaeota. However, when Nanoarchaeum equitans was 
discovered in 2003, it has been given its own kingdom as the Nanoarchaeota (Figure 
1.2). The Euryarchaeota is highly diverse (Jones, Nagle et al. 1987) that includes 
methanogens and their phenotypically diverse relatives. The archaeon M. jannaschii 
(micrograph in Figure 1.3) belongs to the Euryarchaeota (Figure 1.2) that was 
discovered by Holger Jannasch at 21°N on the East Pacific Rise in 1982 (Figure 1.3; 
(Bult, White et al. 1996). M. jannaschii is a hyperthermophilic methanogen that 
survives at high temperature (48-94°C) and at high pressures (200atm). It metabolizes 
gaseous hydrogen/carbon-dioxide and produces methane – an important greenhouse 
gas that directly contributes to the current climate change and global warming 
(Callaghan, Bjorn et al. 2004). It was the first archaeal genome to be completely 
sequenced (approximately 1.7Mbp) containing 1,715 genes (Bult, White et al. 1996; 
Zhou, Kan et al. 2006).  
Since the archaeal RNAP is both functionally and structurally comparable to the 
eukaryotic RNA polymerase II (RNAPII), in addition of the availability of the M. 
jannaschii genome sequences and the hyperthermophilic property of the involved 
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proteins, M. jannaschii is considered to be an ideal model for in vitro assembly 
approach of the RNAP. 
 
 
 
 
 
Figure 1.2. Archaeal lineages. A phylogenetic tree of life is shown, where the 
domain of Archaea is highlighted. The domain of Archaea is divided into two 
kingdoms: Crenarchaeota and Euryarchaeota. Nanoarchaeum equitans is named as a 
separate kingdom – the Nanoarchaeota (Based on Allers and Mevarech 2005). 
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Figure 1.3. Methanocaldococcus jannaschii. (A) A micrograph of a cluster M. 
jannaschii cells (the bar corresponds to 0.5µm) (Pescovitz 2006). (B) A hydrothermal 
vent at the bottom of the Pacific Ocean where the M. jannaschii was discovered from 
the edge of a sea-floor chimney known as a ‘white smoker’ off the coast of Mexico in 
1982 (Image from www.ls.toyaku.ac.jp). 
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1.3 RNA polymerases 
RNA polymerases are essential to life and are encoded in all organisms (and viruses, 
bacteriophages and organelles), ranging from relatively small single subunit proteins 
(e.g. T7 RNAP, ~100kDa) to the large multisubunit eukaryotic/archaeal enzymes of 
varying degree of complexity (up to 17 subunits, total mass of 300-600kDa) 
(Geiduschek and Kassavetis 2001; Bushnell and Kornberg 2003; Russell and 
Zomerdijk 2005). Eukaryotic cells employ four different types of nuclear RNAPs 
(RNAPI, II, III and IV) (Young 1991; Herr, Jensen et al. 2005; Onodera, Haag et al. 
2005), characterized by the type of RNA they synthesize – RNAPI synthesizes a pre-
rRNA 45S, which matures into 28S, 18S and 5.8S rRNAs, which form the major 
RNA sections of the ribosome; RNAPII synthesizes precursors of mRNAs and most 
small nuclear RNA (snRNA) and microRNAs; RNAPIII synthesizes transfer RNAs 
(tRNAs), rRNA 5S and other small RNAs found in the nucleus and cytosol; and 
RNAPIV is only found in plants that directs silencing of endogenous DNA by making 
small-interfering RNA (siRNA) (Herr, Jensen et al. 2005; Onodera, Haag et al. 2005). 
Whereas archaea, similar to bacteria, only have a single type of RNAP that 
contributes to the transcription of all the genes encoded in their genome. Surprisingly, 
the subunit composition and primary sequences of the archaeal enzymes are highly 
reminiscent of the eukaryotic RNAPII. Many RNAPII-like subunits are found in 
archaea and many molecular components of the archaeal transcriptional machinery 
are structurally similar to the ones found in eukaryotic cells (Ouhammouch 2004). 
Table 1.1 shows the RNAP subunit composition across the three domains of life 
where functional and structural homologues across eukaryotes, archaea and bacteria 
are highlighted in blue. Appendix A contains the amino acid sequence alignments of 
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the full complement of M. jannaschii RNAP subunits and basal transcription factors 
with the M. thermoautotrophicum RNAP and the S. cerevisiae RNAPII counterparts.  
 
ScRNAPI ScRNAPII ScRNAPIII MjRNAP EcRNAP Class* 
A190 Rpb1 C160 A'/A'' β' Core 
A135 Rpb2 C128 B'/B'' β Core 
AC40 Rpb3 AC40 D α Core 
AC19 Rpb11 AC19 L α Core 
Rpb6 Rpb6 Rpb6 K ω Core/common 
Rpb5 Rpb5 Rpb5 H  Common 
Rpb8 Rpb8 Rpb8   Common 
Rpb10 Rpb10 Rpb10 N  Common 
Rpb12 Rpb12 Rpb12 P  Common 
A12.2 Rpb9 C11 X (TFS)   
A14 Rpb4 C17 F   
A43 Rpb7 C25 E   
+ 2 others  + 3 others    
*Core, sequence partially homologous in all RNAPs; common, shared by all 
eukaryotic RNAPs. 
 
Table 1.1. RNAP subunit composition in the three domains of life. Homologous 
RNAP subunits from S. cerevisiae (ScRNAPI, II and III), M. jannaschii (MjRNAP) and 
E. coli (EcRNAP) are listed in rows. Functionally and structurally conserved subunits 
are highlighted in blue.  
 
Although the RNAP subunit compositions vary from bacteria to human, the central 
paradigm of transcription is conserved through all domains of life. All RNAPs 
recognize a regulatory element that is upstream of the transcription start site (+1) 
called a promoter. In bacteria, the promoter is directly recognized by RNAP. However, 
the bacterial RNAP core enzyme (α2ββ’ω) cannot interact specifically with promoter 
DNA sequences; with binding of a sigma (σ) subunit to the core enzyme, RNAP 
holoenzyme (α2ββ’ωσ) recognizes σ-specific promoter sequences and is capable of 
initiating transcription (Vassylyev, Sekine et al. 2002). In contrast, the 
eukaryotic/archaeal RNAP requires pre-assembly of basal transcription factors on the 
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promoter template before it recognizes such nucleoprotein complex to initiate the 
transcription process. On most eukaryotic promoters, RNAPII requires at least seven 
general transcription factors (GTFs) for promoter directed transcription (Hampsey 
1998; Buratowski 2000; Gill 2001) whereas archaeal RNAP only requires two 
transcription factors – TBP (TATA-binding protein) and TFB (archaeal homologue of 
eukaryotic TFIIB)  (Hausner and Thomm 1993; Hethke, Geerling et al. 1996; Qureshi, 
Bell et al. 1997). However, in eukaryotic in vitro transcription systems, both of these 
basal transcription factors (TBP & TFIIB) and RNAPII may constitute a minimal 
configuration of transcription units that is sufficient for transcription on some RNAPII 
promoters.  
RNAPs catalyze the polymerization of rNTPs into RNA in a template DNA 
dependent manner. Upon transcription starts, RNAP engages in a phenomenon called 
abortive initiation (Carpousis and Gralla 1980), in which short RNA transcript of 5-11 
nucleotides in length are recurrently produced until the RNAP is able to leave the 
promoter site and transit to the elongation stage. Many pathways are thought to 
regulate transcription elongation, including binding of transcription elongation factors 
(Wind and Reines 2000), modification of RNAP subunits (Hartzog 2003) or 
packaging of DNA into chromatin in eukaryotes (Svejstrup 2002) or archaea (Reeve, 
Sandman et al. 1997). There are also various mechanisms of transcription termination 
proposed for both prokaryotes (Henkin 2000) and eukaryotes (Buratowski 2005); and 
it is obvious that RNAP has to be effectively liberated from template DNA in order to 
process another round of transcription.  
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1.4 Bacterial and eukaryotic RNAP architecture 
The three-dimensional structure of bacterial RNA polymerases has been intensively 
studied and well characterized using electron microscopy of negatively stained, two-
dimensional crystals (Escherichia coli) (Darst, Kubalek et al. 1989), nuclear magnetic 
resonance (NMR) spectroscopy (Escherichia coli)  (Polyakov, Severinova et al. 1995) 
and X-ray crystallography (Thermus aquaticus and Thermus thermophilus) (Zhang, 
Campbell et al. 1999; Vassylyev, Sekine et al. 2002; Murakami, Masuda et al. 2002a; 
Murakami, Masuda et al. 2002b). The crystal structures of eukaryotic RNAPII and the 
RNAPII elongation complex have also been determined at near atomic resolution (S. 
cerevisiae RNAPII at 2.8 Ångstrom and 3.3 Ångstrom resolution, respectively) 
(Cramer, Bushnell et al. 2001; Gnatt, Cramer et al. 2001). The availability of the cryo-
electron microscopy approach for the determination of the yeast RNAPIII structure (S. 
cerevisiae) has been recently described, which provides the first breakthrough to the 
structural analysis of such enzymes that donate great contributions to the synthesis of 
tRNA, 5S rRNA, U6 snRNA and other small RNAs (Fernandez-Tornero, Bottcher et 
al. 2007). Since a number of high resolution structures of S. cerevisiae RNAPII have 
become available, it provides valuable insights into the structure of eukaryotic RNAPs 
at a molecular level and many possible correlations between structure and function 
have also been proposed (Cramer, Bushnell et al. 2000; Cramer, Bushnell et al. 2001; 
Armache, Kettenberger et al. 2003; Bushnell and Kornberg 2003; Bushnell, Westover 
et al. 2004; Westover, Bushnell et al. 2004a; Westover, Bushnell et al. 2004b; 
Armache, Mitterweger et al. 2005; Vassylyev, Vassylyeva et al. 2007a; Vassylyev, 
Vassylyeva et al. 2007b). These comprehensive data of eukaryotic RNAPII structures 
are also of great value for the study of archaeal RNAPs due to the high degree of 
sequence conservation at the amino acid level (Appendix A).  
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1.4.1 Bacterial RNA polymerase – Escherichia coli 
The central component in transcriptional regulation in bacteria is the multi-subunit 
DNA-dependent RNAP, which consists of five subunits (core enzyme that describes 
as α2ββ’ω) and is responsible for all transcription. High-resolution structures on the 
core enzyme show that it adopts a similar structure to the yeast DNA-dependent 
RNAPII (Fu, Gnatt et al. 1999; Zhang, Campbell et al. 1999). The active site of the 
bacterial RNAP is formed by the large β and β’ subunits (1,342 and 1,407 residues, 
respectively, in E. coli core enzyme), which contains determinants for the binding of 
both template DNA and RNA transcripts during transcription (Korzheva, Mustaev et 
al. 2000). Each of the two identical α subunits (329 residues) consist of two distinct 
domains that are associated by an approximately 20-amino-acid flexible linker 
(Blatter, Ross et al. 1994). The larger amino-terminal domain (αNTD; residues 1-235) 
dimerizes and is responsible for assembly of the β and β’ subunits; and the smaller 
carboxy-terminal domain (αCTD; residues 250-329) is described as a DNA-binding 
domain that interacts with a DNA element upstream of the core promoter for 
promoter recognition (Gourse, Ross et al. 2000). The small omega (ω) subunit, which 
only contains 91 residues, has no direct role in transcription; however, it has been 
proposed to function as a chaperone that facilitates the folding of the β’ subunit 
(Hampsey 2001).  
As mentioned previously, the bacterial RNAP itself cannot specifically recognize a 
particular promoter; it must first interact with a sigma (σ) subunit to form the 
holoenzyme. There are generally three main functions of the σ subunit: to ensure the 
recognition of a specific promoter sequence; to localize the holoenzyme at a target 
promoter; and to facilitate unwinding of DNA duplex near the transcription start site 
(+1) (Gross, Chan et al. 1998; Wosten 1998). Many bacteria contain multiple sigma 
 
21 
factors that are distinguished by their characteristic molecular weights (e.g. the 
"housekeeping" sigma factor – σ70 refers to the sigma factor with a molecular weight 
of 70kDa); and different sigma factors are activated under different environmental 
conditions (e.g. σ54 is the nitrogen-limitation sigma factor and σ38 is the 
starvation/stationary phase sigma factor). 
During initiation, the holoenzyme specifically binds to two conserved hexamers on 
the promoter at position -35 (TTGACA) (35 base pairs upstream from the 
transcription start site that is recognized by the domain 4 of the RNAP σ subunit) and 
position -10 (TATAAT) (10 base pairs upstream from the transcription start site that 
is recognized by the domain 2 of the RNAP σ subunit) (Campbell, Muzzin et al. 2002; 
Murakami, Masuda et al. 2002) to form a closed complex. Two other important 
promoter elements – the extended -10 element (TGn) and the UP elements are 
recognized by the domain 3 (Murakami, Masuda et al. 2002; Sanderson, Mitchell et al. 
2003) and the αCTD dimer of the RNAP α subunits (Ross, Ernst et al. 2001), 
respectively. Figure 1.4 shows the bacterial RNAP architecture and its interactions at 
a target promoter. After initial binding of the RNAP, the DNA strands from 
approximately position -10 to position +2 are unwound, resulting in an open complex, 
and initiates transcription in the presence of nucleoside triphosphate substrates 
(Tomsic, Tsujikawa et al. 2001). 
After the synthesis of 9-12 nucleotides, the transcription complex passes from the 
initiation to the elongation stage. This transition is characterized by promoter escape 
(McClure 1985), the dissociation of σ from the core-enzyme (Mooney, Darst et al. 
2005), and the formation of a highly processive ternary elongation complex 
(Korzheva, Mustaev et al. 2000).  
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Figure 1.4. Bacterial RNAP architecture and its interactions at a target promoter. 
(A) A crystallographic model illustrates the bacterial RNAP holoenzyme architecture 
(Escherichia coli). The DNA strands are shown in green, with the -10 and -35 
elements highlighted in yellow and the TGn extended -10 and UP elements 
highlighted in red. The large β and β’ subunits of bacterial RNAP are shown in light 
blue and pink, respectively. Two identical α subunits are colored in grey whereas 
αCTD domains are represented as two grey spheres (I & II) that interact with the UP 
element of DNA template. Different domains of σ subunit are also labeled and shown 
in red color in this model. The active site of the bacterial RNAP is demonstrated by 
the Mg2+ ion (magenta). (B) A cartoon illustration of the model is shown in part A. 
Different interactions between promoter elements and RNAP are illustrated (modified 
from Browning and Busby 2004). 
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1.4.2 Eukaryotic RNA polymerase II – S. cerevisiae 
The eukaryotic RNAPII consists of 12 subunits, named as Rpb1-12 (Table 1.2). The 
total protein mass is approximately 450kDa. Initially, a backbone model of 10-subunit 
yeast RNAPII was derived from X-ray crystallography data (Cramer, Bushnell et al. 
2000). Until a dissociable heterodimer of subunits Rpb4 and Rpb7 was shortly 
determined afterwards (Bushnell and Kornberg 2003), the 12-subunit structure of 
RNAPII (Figure 1.5) has been completed and each discrete subunit/cluster was 
investigated intensively. Subunits Rpb1+2 are commonly known as ‘the largest 
subunits’ that contribute to most of the RNAPII functions including formation of the 
catalytic center of the enzyme, maintaining the template DNA binding sites, and 
defining the incoming rNTP substrate entry route (Cramer 2002; Trinh, Langelier et al. 
2006). Subunits Rpb3+10+11+12 are proposed to be a discrete cluster that acts as an 
assembly platform for the largest subunits; and subunits 4-9 are believed to be 
modulators of RNAP activity.  
1.4.2.1 The largest subunits Rpb1 & Rpb2 and their split archaeal 
homologues 
The two largest subunits Rpb1+2 account for approximately 3/4 of the total mass of 
the RNAPII. These subunits harbor most of the functional features of the enzyme 
including the template binding sites, the rNTP substrate entry pores, and the catalytic 
center (Cramer 2002). The large RNAP subunits (A’/A’’/B’/B’’ in archaeal RNAP; 
Rpb1/2 in RNAPII; β’/β in bacterial RNAP) show a high level of sequence homology 
across species from all three domains. The conserved regions are organized in blocks 
or segments named A to H in Rpb1/ β’ and A to I in Rpb2/ β subunits (Figure 1.6A). 
Highly variant linker regions are found between blocks that in some cases have been 
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shown to be dispensable for RNAP function in vitro (according to the study of 
bacterial Rpb1+2 homologues – β’+β subunits) (Severinov, Mustaev et al. 1995; 
Severinov, Mustaev et al. 1996). The large RNAP subunits in some archaeal species 
(e.g. M. jannaschii RNAP) are each split into two polypeptides in the linker regions 
and form two discrete subunits: A’/A’’ for Rpb1 (the split site between segments F & 
G) and B’/B’’ for Rpb2 (the split site between segments D & E) (Bell and Jackson 
1998; Geiduschek and Ouhammouch 2005; Goede, Naji et al. 2006). The M. 
jannaschii A’ represents the N-terminal 2/3 of Rpb1/β’ and A’’ represents the 
remaining C-terminal 1/3 whereas the B’’ corresponds to the N-terminal 1/3 of 
Rpb2/β and B’ is the C-terminal 2/3 (Figure 1.6A). Thus, the prime/double prime 
annotation is based on subunit sizes rather than the N- or C-terminal orientation.  
  
Subunit Gene tag Protein ID ORF (bp) Size (aa) Size (kDa) pI 
Rpb1 RPO21 NP_010141 5201 1733 191.6 5.42 
Rpb2 RPB2 NP_014794 3675 1224 138.8 6.10 
Rpb3 RPB3 NP_012243 957 318 35.3 4.52 
Rpb4 RPB4 NP_012395 666 221 25.4 4.82 
Rpb5 RPB5 NP_009712 648 215 25.1 9.18 
Rpb6 RPO26 NP_015513 468 171 17.9 4.53 
Rpb7 RPB7 NP_010692 516 155 19.1 7.83 
Rpb8 RPB8 NP_014867 441 146 16.5 4.53 
Rpb9 RPB9 NP_011445 369 122 14.3 7.72 
Rpb10 RPB10 NP_014853 213 70 8.3 7.85 
Rpb11 RPB11 NP_014638 363 120 13.6 5.40 
Rpb12 RPB12 AAB68994 213 70 7.7 9.84 
 
Table 1.2. The RNAPII subunits of S. cerevisiae. The size of open reading frames 
(ORF) is given in base pairs (bp). The size of each subunit is shown both in the 
number of amino-acids (aa) and in the molecular weight (kDa). The isoelectric point 
(pI) of the subunit is also given in this table (data from the Entrez protein database).  
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Figure 1.5. Three dimensional structure of the S. cerevisiae RNAPII derived from 
X-ray crystallography data. Individual subunits are painted in different colors and 
illustrated in the key below the view. Eight zinc-ions are depicted as cyan spheres and 
the active site is represented by the metal A Mg2+ ion (modified from Armache, 
Mitterweger et al. 2005). 
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Figure1.6. The large subunits Rpb1+2 and their split archaeal homologues. (A) A 
schematic diagram of the large subunits Rpb1 and Rpb2 shows the archaeal split sites. 
The sketch highlights the homologous blocks (A to H in Rpb1 & A to I in Rpb2) that 
are separated by highly variant linkers (dispensable regions). The two magnesium ion 
binding motifs A and B are also indicated. (B) Three dimensional structure of the S. 
cerevisiae RNAPII highlights the large subunits Rpb1 (black) and Rpb2 (Light brown) 
and the rest of the protein backbone is faded. The green arrow shows the ‘bridge-
helix’ of Rpb1 and the active site is indicated by the metal A Mg2+ ion (modified from 
Armache, Mitterweger et al. 2005). 
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High resolution X-ray crystallographic structures of RNAPs suggest that many 
domains of the large subunits are involved in the transcription process (Cramer, 
Bushnell et al. 2000; Gnatt, Cramer et al. 2001; Bushnell, Cramer et al. 2002; 
Westover, Bushnell et al. 2004b; Wang, Bushnell et al. 2006), including the ‘bridge-
helix’ (Figure 1.6B), ‘trigger-loop’ (Appendix A), ‘lid’, ‘zipper’, ‘rudder’, ‘forkloop 1 
and 2’, and several switch-domains. The relative positions of some of these domains 
have first been described by Bushnell, D. A. and his colleagues (Bushnell, Cramer et 
al. 2002); and recent high-resolution structures of bacterial RNAP (Thermus 
thermophilus) have suggested the involvement of homologous domains in prokaryotic 
transcription (Vassylyev, Vassylyeva et al. 2007a; Vassylyev, Vassylyeva et al. 
2007b).  
1.4.2.2 The “two-metal-mechanism” 
The catalytic residues constituted by the largest subunits A’ and B’ of M. jannaschii 
forms the active center of the archaeal RNAP. High-resolution structures of the T. 
aquaticus RNAP (Zhang, Campbell et al. 1999) and the S. cerevisiae RNAPII (Cramer, 
Bushnell et al. 2001) suggest a conserved domain structure with a single magnesium 
ion (metal A) in the active center. A highly conserved motif NADFDGD (Asn-Ala-
Asp-Phe-Asp-Gly-Asp) is involved in the segment D of Rpb1 (A’ of archaeal or β’ of 
bacteria) (Figure 1.6A and 1.7C) (Dieci, Hermann-Le Denmat et al. 1995), which is 
invariant in all multimeric RNAPs. Metal A is chelated by three aspartate residues in 
the invariant motif; and substitution of these aspartic acids with alanine creates a 
dominant lethal mutation in S. cerevisiae and E. coli, demonstrating the importance of 
each of the three aspartate residues in cell viability and their probable functions in the 
catalytic mechanism (Zaychikov, Martin et al. 1996). Furthermore, substitution of 
aspartate with glutamate also results in lethality, suggesting that the local geometry of 
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the active center is very sensitive to even minor distortions (Dieci, Hermann-Le 
Denmat et al. 1995). Refined RNAPII structural data indicates the presence of a 
second magnesium ion (Metal B) in the active center. Metal B has a much lower 
occupancy (<20%) than metal A (Cramer, Bushnell et al. 2001; Gnatt, Cramer et al. 
2001; Cramer 2002). Two invariant amino-acids (ED) in the conserved segment D of 
Rpb2 (B’ of archaea or β of bacteria) are involved in the chelation of the metal B 
(Figure 1.6A and 1.7C) in the active center. The symmetrical pair of Mg2+ ions (Metal 
A & B) switches its roles in RNA synthesis and degradation in the active center of 
DNA-dependent RNAPs that is believed to play essential roles in catalysis (Gnatt, 
Cramer et al. 2001; Sosunov, Sosunova et al. 2003; Westover, Bushnell et al. 2004a).  
Structural studies of crystallized single-subunit RNA and DNA polymerases propose 
a conserved mechanism for all polynucleotide polymerases involving two Mg2+ ions. 
The two-metal-mechanism is illustrated in Figure 1.7B. The catalytic reaction of 
nucleic acid polymerization consists of a nucleophilic attack of the 3’ hydroxyl group 
(-OH) of the polynucleic acid (RNA or DNA) on the α-phosphate of the incoming 
NTP. Metal A chelates both 3’ –OH of the RNA/DNA and the α-phosphate of the 
NTP; it lowers the pKa (acid dissociation constant) of the 3’ –OH group (increasing 
the acidity, i.e. weakening the O-H bond) and facilitates the 3’ O- attack on the α-
phosphate moiety. Metal A and B stabilize both the structure and charge of the 
transition state. Following the formation of a new covalent bond, metal B assists the 
exit of the pyrophosphate.  
The symmetrical pair of Mg2+ ions does not only play important roles in RNA 
synthesis but also in degradation. The mode of stabilization of metal B in the active 
center depends on the type of reaction: In polymerization, metal B is stabilized by the 
β,γ-phosphates of incoming rNTPs; whereas during hydrolysis, by the phosphates of  
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Figure 1.7. The two-metal-mechanism. (A) A stereoview of RNAPII active site from 
Rpb2 toward the clamp (modified from Cramer, Bushnell et al. 2001). The grey 
backbone trace represents Rpb1 and the olive green backbone trace is Rpb2. The two 
Mg2+ ions (light blue for metal A & green for metal B) and their chelating residues are 
indicated. Rpb1 D483/D485 correspond to M. jannaschii A’ D468/D470 and Rpb2 
E836/D837 correspond to B’ E224/D225. (B) A schematic diagram of the two-metal-
mechanism, adapted for the M. jannaschii RNAP active site. (C) A sequence 
alignment of metal A & B motifs from M. jannaschii, E. coli and S. cerevisiae. 
Chelating residues are highlighted in red. 
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a non-base-paired rNTP molecule. The model of RNAP active center built by 
Sosunov et al. (2003) shows that both synthesis and hydrolysis reactions are based on 
the bimolecular nucleophilic substitution (Sn2) mechanism (Yee, Armstrong et al. 
1979) operating in opposite directions. Moreover, recent studies revealed that metal B 
is absent at high Mg2+ concentration and is replaced by Mg2+ (Metal C) at a new 
location about 4 Å away. Since metals B and C are mutually exclusive and the 
alignment of metals A and B is likely to be essential for catalysis, the shift from B to 
C is suggested to lead to inhibition (Wang, Bushnell et al. 2006) 
1.4.2.3 The Rpb3+11+10+12 cluster – the assembly platform 
The Rpb3+11+10+12 are found in a discrete cluster at the back of the yeast RNAPII 
(Figure 1.8). Experimental evidences from bacterial and archaeal RNAP suggest that 
the homologues of these subunits may act as an assembly platform for the large 
subunits. The assembly of E. coli RNAP is initiated by the dimerization of two α 
subunits, which is followed by the incorporation of the β, β’ and ω subunits (Ishihama 
1981). The two α polypeptides are structurally distinct in the folded RNAP, where αI 
interacts with β and αII interacts with β’ subunit (Figure 1.4). The bacterial α subunit 
comprises two distinct domains: the N-terminal domain (αNTD) interacts with β and 
β’ subunits and the C-terminal domain (αCTD) interacts with upstream promoter 
DNA and transcriptional regulators (Figure 1.4) (Gaal, Ross et al. 1996; Rhodius and 
Busby 1998; Savery, Lloyd et al. 1998). Since the αI of a properly assembled bacterial 
RNAP is structurally homologous to the yeast Rpb3 and the αII corresponds to the 
Rpb11 (Ebright 2000), it is proposed that yeast Rpb3+11 and their M. jannaschii 
counterparts (D and L subunit) are directly involved in the assembly of the large 
subunits. Mutations disrupting the α dimerization motif in the αNTD and 
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eukaryotic/archaeal α-like-subunits are defective in activated transcription that 
suggests a conserved mechanism for activation in all three domains of life.  
The high-resolution structure of yeast RNAPII shows that the Rpb3+11 dimer forms a 
discrete cluster with Rpb10+12. Rpb10+12 are positioned between the large subunits 
and the Rpb3/11 dimer. Both Rpb10 and Rpb12 are shared among all three eukaryotic 
RNAPs (Table 1.1). The M. jannaschii Rpb10 homologue – subunit N interacts with 
subunit D (homologue of Rpb3) and forms a heterotrimeric complex with M. 
jannaschii D/L (homologues of Rpb3/11, respectively) dimer in vitro (Eloranta, Kato 
et al. 1998); and appear to form an extended assembly platform. Substitutions of any 
of the four cysteine residues in a putative zinc binding domain in Rpb10 lead to 
lethality, implicating that the integrity of the zinc-binding motif is essential for RNAP 
function (Gadal, Shpakovski et al. 1999). Even though, the yeast Rpb12 and its 
archaeal homologue (subunit P) also have a zinc-binding domain; and mutations of 
this motif do not have severe effects on cell viability (Rubbi, Labarre-Mariotte et al. 
1999). However, the C-terminus of the Rpb12 is highly positively charged and 
charge-reversal mutations result in a lethal phenotype, indicating a significance of 
electrostatic interactions for the function of Rpb12. The C-terminal domain of Rpb12 
is very close to an acidic patch of the Rpb2 (Cramer, Bushnell et al. 2001); and 
apparently the charge-reversal mutation could disrupt the Rpb2/12 interaction and 
leads to a defective phenotype. The possible Rpb10 and Rpb2 interaction has also 
been identified in a yeast two-hybrid screen (Flores, Briand et al. 1999), which 
suggests that Rpb10+12 may play a role in stabilizing the assembled RNAP structure. 
 
 
 
 
32 
 
 
 
 
Figure 1.8. A stereoview of the Rpb3+11+10+12 cluster in S. cerevisiae RNAPII. 
Each subunit is indicated in a different color. S. cerevisiae Rpb3, Rpb11, Rpb10 and 
Rpb12 correspond to the M. jannaschii RNAP subunits D, L, N and P, respectively. 
The interactions between the Rpb3+11+10+12 cluster and large subunits (Rpb1+2) 
suggest the structural role of the cluster in anchoring the large subunits and 
functioning as an assembly platform (modified from Armache, Mitterweger et al. 
2005). 
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1.4.2.4 The dissociable subunits Rpb4/7 (F/E) and Rpb6 (K/ω) 
Eukaryotic RNAPII was initially considered as a 10-subunit structure (Cramer, 
Bushnell et al. 2000) rather than a 12-subunit multimeric enzyme as the subunits 
Rpb4+7 easily dissociate during purification from large-scale cultures (e.g. 
dissociation from the remainder of the RNAP by 2M urea treatment) (Edwards, Kane 
et al. 1991). The S. cerevisiae Rpb4 and Rpb7 form a stable subcomplex that binds 
single stranded nucleic acids via a highly conserved S1 motif in the Rpb7 subunit 
(Orlicky, Tran et al. 2001). Experimental evidences show that yeast RNAPII lacking 
of Rpb4/7 dimer cannot initiate transcription from a range of promoters (e.g. CYC1, 
TEF1, AdML), suggesting that the Rpb4/7 dimer has been implicated in transcription 
initiation (Edwards, Kane et al. 1991; Orlicky, Tran et al. 2001). Both Rpb4 and Rpb7 
are essentially required for cell viability in Saccharomyces pombe (Sakurai, 
Mitsuzawa et al. 1999), whereas Rpb4 is dispensable in Saccharomyces cerevisiae 
(McKune, Richards et al. 1993). However, purified S. cerevisiae RNAPII lacking of 
Rpb4 also lacks Rpb7 (McKune, Richards et al. 1993), suggesting that Rpb4 may 
structurally support Rpb7 or facilitate its binding to the core RNAP. Structural studies 
of RNAPII have proposed that the function of the Rpb4/7 subcomplex is to modulate 
the clamp conformation: in the absence of the subcomplex, the RNAPII clamp is in the 
open conformation, whereas in the presence of Rpb4/Rpb7 subcomplex, the clamp is 
closed (Cramer, Bushnell et al. 2001; Armache, Kettenberger et al. 2003; Bushnell 
and Kornberg 2003). Another function of the archaeal E/F (homologues of 
Rpb7/Rpb4, respectively) subcomplex has been proposed from in vitro reconstitution 
studies of archaeal RNAP: the E/F heterodimer facilitates transcription bubble 
formation of the RNAP-promoter DNA complex under certain conditions 
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(Ouhammouch, Werner et al. 2004; Werner and Weinzierl 2005; Naji, Grunberg et al. 
2007). 
Rpb6 is shared by all three types of eukaryotic RNAPs (Table 1.1) and is functionally 
and structurally homologous to the bacterial ω subunit/ archaeal K subunit. Rpb6/ω 
contacts with the large subunit and latches two segments of Rpb1/β’ together 
(Minakhin, Bhagat et al. 2001). It appears to function as a molecular adapter for the 
Rpb4/7 heterodimer (Figure 1.5; Tan, Prysak et al. 2003) and can compensate for an 
assembly-impaired Rpb1 mutant when overexpressed in yeast (Minakhin, Bhagat et al. 
2001). Figure 1.9 and 1.10 represent the structures of Rpb4/7 subcomplex and Rpb6 
subunit, respectively; and their positions in S. cerevisiae RNAPII are also indicated.  
1.4.2.5 The peripheral subunits Rpb5+8+9 
Rpb5 is commonly shared by all three types of eukaryotic RNAPs and has an archaeal 
homologue – subunit H (Table 1.1). Rpb5 has a bipartite structure where the two 
domains appear to have distinct functions (Cramer, Bushnell et al. 2001; Todone, 
Brick et al. 2001). The N-terminal domain of Rpb5 is located in a position where it 
can physically and functionally interact with regulatory proteins, whereas the C-
terminus interacts with the RNAP and template DNA (Figure 1.11). Rpb5 has been 
demonstrated to have a strong interaction with the C-terminus of Rpb1 (also known as 
region H, Figure 1.6A). Experimental evidence shows that Rpb5 and the C-terminal 
domain of Rpb1 have overlapping roles in transcription activation (Miyao and 
Woychik 1998). Even though, Rpb8 is also shared by all three eukaryotic RNAPs, 
there is no archaeal homologue that has been identified. Since Rpb8 genetically 
interacts with Rpb6 that both of the small subunits are adjacent to the pore module in 
the core RNAP structure (Figure 1.5), it has been suggested that Rpb8 and Rpb6, 
together with the  
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Figure 1.9. A stereoview of the dissociable Rpb4/7 subcomplex in S. cerevisiae 
RNAPII. Rpb4 and Rpb7 subunits are colored in plum and blue, respectively. S. 
cerevisiae Rpb4 corresponds to the M. jannaschii RNAP subunit F, whereas Rpb7 
corresponds to subunit E (modified from Armache, Mitterweger et al. 2005). 
  
Figure 1.10. A stereoview of the Rpb6 subunit in S. cerevisiae RNAPII. Rpb6 
subunit is highlighted in pale blue. S. cerevisiae Rpb6 corresponds to the M. 
jannaschii RNAP subunit K. The structure also shows that Rpb6 latches two segments 
of Rpb1 (grey) together and functions as a molecular adapter for the Rpb4/7 
heterodimer (plum/blue) (modified from Armache, Mitterweger et al. 2005). 
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pore module, form a functional unit. However, the exact role of these small subunits 
remains unknown (Koonin, Makarova et al. 2007). 
Moreover, Rpb9 is homologous to the elongation factor TFIIS and its archaeal 
homologue TFS. It contacts with the transcription factor TFIIE (Van Mullem, Wery et 
al. 2002) and appears to be important for accurate selection of transcription start site 
in eukaryotes (Hull, McKune et al. 1995) and regulating transcription elongation 
(Hemming, Jansma et al. 2000). 
 
 
 
Figure 1.11. A stereoview shows the Rpb5 subunit in the context of S. cerevisiae 
RNAPII (modified from Armache, Mitterweger et al. 2005). The N-terminal 
domain of Rpb5 is part of the lower “jaw” of RNAPII and the C-terminus is involved 
in RNAP assembly.   
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1.5 Archaeal RNA polymerase – an alternative model for 
functional analysis  
High-resolution X-ray structures of bacterial RNAPs and yeast RNAPII have provided 
the first insights into the molecular organization of such enzymes (Boeger, Bushnell 
et al. 2005). However the correlation between most of the molecular structures and 
their functions remains uncertain. An experimental system is, therefore, required to 
link structural information with site-directed mutagenesis approaches and coupled 
with in vitro assays, to identify the functional consequences of the introduced changes. 
This aim has already been achieved with bacterial RNAPs; however, it is still less 
satisfactory for eukaryotic RNAPs since it has not yet been possible to reconstitute an 
active eukaryotic enzyme from recombinant subunits. 
Archaeal RNAP is a large multimeric enzyme consisting of 12 subunits (Table 1.1 & 
Figure 1.13A). Similar to bacteria, archaea only have a single type of RNAP that 
contributes to the transcription of all the genes encoded in their genome. Even though, 
archaeal RNAP displays a high degree of structural similarity to its eukaryotic 
counterparts, especially the RNAPII. Homologues of most RNAPII subunits are found 
in archaea (Table 1.1 & Figure1.12); many molecular components of the archaeal 
transcriptional machinery are also structurally similar to the ones found in eukaryotic 
cells, including the TATA-binding protein (TBP) and the eukaryotic TFIIB orthologue 
TFB (Ouhammouch 2004). In archaea, the largest subunits (Rpb1 in RNAPII) are split 
into two polypeptides, A’ and A’’, which are encoded by separate genes in an operon 
(Figure 1.6A) (Bell and Jackson 1998; Geiduschek and Ouhammouch 2005; Goede, 
Naji et al. 2006). Sequence alignments show that the archaeal A’ and A’’ represent 
the N-terminal two-thirds and the C-terminal one-third of the RNAPII Rpb1, 
respectively (Figure 1.6A). The eukaryotic Rpb2 is also split into two archaeal 
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subunits, B’ and B’’; and the B’ and B’’ correspond to the C-terminal 2/3 and the N-
terminal 1/3 of the Rpb2, respectively (Figure 1.6A).  
 
 
 
 
Figure 1.12. Structural similarities between archaeal and eukaryotic RNAPs. The 
schematic images represent subunits of the eukaryotic RNAPII (A) and the archaeal 
RNAP (B), in which protein-protein interactions are very similar to each other (Kosa, 
Ghosh et al. 1997). Subunits in the same color in both (A) eukaryotic RNAPII (S. 
cerevisiae) and (B) archaeal RNAP indicate the structural homology.  
 
Although the highly conserved largest subunits create the active site for enzymatic 
functions, their assembly is dependent on the presence of two other conserved 
subunits, D/L (homologues of eukaryotic Rpb3/Rpb11 or bacterial α homodimer, 
Table 1.1), which serve as a platform for assembly of the largest subunits. The crystal 
structure of the Sulfolobus solfataricus D/L subcomplex has been solved at 1.76Å 
resolution that suggests a three-domain structure of S. solfataricus D subunit, 
consisting of a 4Fe-4S cluster-binding domain, domain 2 and a dimerization domain 
(Figure 1.13B; Hirata, Klein et al. 2008). The folding of domain 2 in the subunit D is 
highly conserved in both Rpb3 and α. However, the 4Fe-4S cluster-binding domain is 
unique in S. solfataricus RNAP. Targeted mutagenesis studies suggests that the 4Fe-
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4S cluster-binding domain is not directly involved in the formation of D/L 
heterodimer but may play a role in supporting the structural integrity of the D subunit 
(Hirata, Klein et al. 2008). Furthermore, S. solfataricus is not the only archaeon 
possessing the Fe-S cluster in RNAP; such a motif has also been identified in the 
RNAP sequence of 16 out of 28 sequenced archaeal genomes, including almost all 
methanogens (except M. jannaschii and M. maripaludis). The archaeal K subunit is 
one of the small components of the RNAP core, which is an orthologue of eukaryotic 
Rpb6 and bacterial ω subunits. The folding of central regions of such subunits is 
highly conserved across three life domains. In archaea, subunit K, along with the E 
subunits tip loop, is determined to participate in protecting the C-terminal tail of the 
largest subunit (Figure 1.13C). The E/F subcomplex (homologues of dissociable 
eukaryotic Rpb7/Rpb4 subcomplex; Table 1.1) is also an important component of the 
archaeal RNAP that forms a protruding ‘stalk’. The relative positioning of the RNAP 
core enzyme and stalk is highly conserved between archaeal RNAP and the three 
types of eukaryotic counterparts (Fernandez-Tornero, Bottcher et al. 2007). Structural 
studies of RNAPII have proposed the function of the stalk as a modulator for the 
clamp conformation: in the absence of the subcomplex, the RNAPII clamp is in the 
open conformation, whereas in the presence of the subcomplex, the clamp is closed 
(Cramer, Bushnell et al. 2001; Armache, Kettenberger et al. 2003; Bushnell and 
Kornberg 2003). According to in vitro reconstitution studies of archaeal RNAP, the 
E/F subcomplex has also been proposed to facilitate transcription bubble formation of 
the RNAP-promoter DNA complex under certain conditions in archaea 
(Ouhammouch, Werner et al. 2004; Werner and Weinzierl 2005; Naji, Grunberg et al. 
2007).   
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Figure 1.13. Three-dimensional structure of the archaeal RNAP. (A) Crystal 
structure of the S. solfataricus RNAP at 3.4Å resolution. Each subunit is highlighted 
in a unique color. The disordered clamp head domain is indicated as a dotted line. (B) 
Crystal structure of the L/D subcomplex at 1.76Å resolution. Domain organization of 
the heterodimer is indicated. (C) Ribbon model of the archaeal RNAP. Various 
subunits are individually labeled. The contacts between K subunit, E tip loop and the 
largest subunits are also shown (modified from Hirata, Klein et al. 2008).  
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Unlike eukaryotic system, the entire archaeal transcriptional machinery from M. 
jannaschii has been successfully reconstituted in a recombinant form under defined in 
vitro conditions (see Chapter 2 for details). The constituted system is capable of both 
promoter-specific basal and activator-stimulated transcription, and faithfully 
reproduces all known properties of the in vitro transcription systems derived from 
archaeal cellular extracts. M. jannaschii thus acts as an ideal experimental model to 
investigate the fundamental mechanisms of the transcription cycle that is catalyzed by 
the archaeal RNAP; and may also work as an alternative approach for the further 
studies of its eukaryotic counterparts. 
1.6 DNA transcription 
DNA transcription is a process that converts the genetic information from DNA to 
RNA. This process is the first stage of protein biosynthesis that is enzymatically 
controlled by the RNAP. In transcription, the DNA strand opens and allows RNAP to 
transcribe only a single strand of DNA (proceeds in the 5' → 3' direction) into a single 
stranded RNA polymer called messenger RNA (mRNA), which is then translated by 
ribosomes into functional peptides or proteins in the cytoplasm. Since many 
transcription units and active RNA polymerases are observed within discrete sites in 
human nuclei (permeabilized HeLa cells), it suggests that transcription might occur 
within distinct clusters in the nucleus of an eukaryotic cell called ‘transcription 
factories’ (Iborra, Pombo et al. 1996). In comparison to this, transcription is usually 
coupled with translation in prokaryotic cells, as all required components for both 
processes co-exist in the cytosol.  
The general principles of transcription are conserved through all three domains of life 
that proceeds in three phases: initiation, elongation and termination. Each stage is 
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tightly regulated and only RNA polymerases are present in all three stages for the 
production of biologically relevant full-length RNA transcripts.  
The transcription initiation requires the interaction of RNAP with promoter DNA and 
formation of an initiation bubble, in which the duplex DNA around the transcript 
start-point is unwound so that the RNAP has access to the single stranded DNA 
template. In bacteria, the RNAP holoenzyme recognizes promoter sequences directly 
with the aid of a sigma factor (Browning and Busby 2004), whereas eukaryotic and 
archaeal enzymes require the preassembly of basal transcription factors on the core 
promoter to specifically initiate the transcription of a gene (Thomm 1996; Gill 2001).  
1.6.1 The basal transcription factors and transcription 
initiation in eukaryotes 
 In contrast to bacterial RNAP (holoenzyme), archaeal and eukaryotic RNAPs cannot 
recognize promoter DNA elements without additional basal transcription factors. In 
eukaryotes, the core promoter acts as a platform for the assembly of transcription 
preinitiation complex (PIC) that includes various general transcription factors (GTFs) 
and the RNAP. Each type of nuclear RNAPs requires a distinct set of basal 
transcription factors in order to initiate transcription accurately and specifically.  
Initiation of rRNA synthesis by RNAPI requires promoter selectivity factor 1 (SL1), 
which is a complex of the TATA-box-binding protein (TBP) and at least three TBP-
associated factors (TAFs) including TAFI110, TAFI63 and TAFI48 (Zomerdijk, 
Beckmann et al. 1994). For the assembly of the PIC, SL1 recruits RNAPI to the 
promoter via interaction of its TAFI110 and TAFI63 subunits with the RNAPI-
associated factor RRN3. Activated transcription requires the interaction of RNAPI 
PIC with the activator UBF (upstream binding factor) via the highly acidic C-terminus 
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of UBF and this might involve subunits TAFI48 and TBP of SL1 (Russell and 
Zomerdijk 2005).  
Transcription from a RNAPII promoter is initiated by sequential assembly of the basal 
transcription factors TFIID, TFIIB, TFIIA, TFIIF (bound to RNAPII), TFIIE and TFIIH 
on the promoter DNA (Thomas and Chiang 2006). TFIID first binds to the promoter 
region, followed by the entry of TFIIB and TFIIA that stabilize promoter-bound TFIID, 
and then the recruitment of RNAPII/TFIIF. After formation of a stable TFIID-TFIIB- 
TFIIA-RNAPII/TFIIF-promoter complex, TFIIE is then recruited, followed by a 
subsequent entry of TFIIH (Figure 1.14A). TFIID consists of TBP and several TAFs. 
The different TAFs interact with transcription activators, co-activators and promoter 
 
 
Figure 1.14. Pathways for the assembly of transcription preinitiation complex 
(PIC) (modified from Thomas and Chiang 2006). Panel A represents the stepwise 
recruitment of the general transcriptional machinery and the Panel B shows a two-
component pathway that resembles the prokaryotic RNAP holoenzyme system where 
a dissociable σ factor directs the entry of core enzyme (α2ββ’) to the promoter region.  
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sequence elements; and the binding of TBP to the TATA-box element nucleates the 
assembly of the PIC and is sufficient for basal levels of transcription in vitro (Albright 
and Tjian 2000). Early experiments indicated that the reversal of TATA-box 
orientation alone did not change the direction of transcription (Xu, Thali et al. 1991; 
Li, Kim et al. 1995). Affinity cleavage experiments have directly confirmed that yeast 
TBP alone can bind the TATA-box in either orientation (with only a 60:40 preference 
for the direction) (Cox, Hayward et al. 1997). Thus, additional factors are required to 
implement a unidirectional transcription. The general transcription factor TFIIB 
interacts with TBP and the TFIIB-responsive-element (BRE, locates adjacent to the 
TATA-box) (Lagrange, Kapanidis et al. 1998) that stabilizes the TBP-promoter 
interaction. Since the TFB/BRE interaction is shown to be the principal determinant 
of transcription polarity in archaea, it is likely that the TFIIB/BRE interaction 
contributes to the transcriptional polarity of RNAPII promoter as well (Bell, Kosa et al. 
1999; Littlefield, Korkhin et al. 1999). The association of TFIIA encourages the 
binding of TFIID to the TATA-box through direct contacts with both TBP and the 
DNA sequence immediately upstream of the TATA-box (Geiger, Hahn et al. 1996; 
Lagrange, Kim et al. 1996; Oelgeschlager, Chiang et al. 1996; Tan, Hunziker et al. 
1996).  
The next step of transcription initiation is the recruitment of RNAPII that is normally 
pre-associated with TFIIF. TFIIF interacts with the N-terminal domain of TFIIB (Ha, 
Roberts et al. 1993) that facilitates the recruitment of RNAPII to the promoter-bound 
TFIID-TFIIB complex (Flores, Lu et al. 1991). TFIIF serves as a stability factor to 
enhance the affinity of RNAPII for the TBP-TFIIB-promoter complex possibly by 
inducing changes in DNA topology that causes the promoter to wrap around RNAPII 
(Robert, Douziech et al. 1998). TFIIF is necessary for subsequent recruitment of TFIIE 
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and TFIIH (Orphanides, Lagrange et al. 1996) possibly via direct interactions with 
TFIIE (Maxon, Goodrich et al. 1994). TFIIE consists of two subunits, α and β, which 
form an α2β2 heterotetramer (Ohkuma, Sumimoto et al. 1991; Peterson, Inostroza et al. 
1991; Sumimoto, Ohkuma et al. 1991). The recruitment of TFIIE to the promoter may 
be through direct interaction with gene-specific transcriptional activators, such as 
Krüppel type zinc finger protein (Sauer, Fondell et al. 1995) and the Antennapedia 
and Abdominal-B homeodomain proteins (Zhu and Kuziora 1996). Once recruited, 
TFIIE directly interacts with TFIIF, TFIIB, RNAPII, and promoter DNA; and facilitates 
the recruitment of TFIIH (Flores, Maldonado et al. 1989; Maxon, Goodrich et al. 1994; 
Okamoto, Yamamoto et al. 1998; Yokomori, Verrijzer et al. 1998; Watanabe, Hayashi 
et al. 2003; Forget, Langelier et al. 2004). TFIIE can stimulate the ATPase, CTD 
kinase, and DNA helicase activity of TFIIH that facilitates the formation of an 
initiation-competent RNAPII complex (Ohkuma and Roeder 1994; Serizawa, 
Conaway et al. 1994; Ohkuma, Hashimoto et al. 1995; Lee and Young 2000). TFIIE 
and TFIIH are also essential for promoter melting and transition from initiation to 
elongation (Holstege, van der Vliet et al. 1996). 
In addition, an alternative pathway for PIC formation was uncovered when a 
preassembled RNAPII holoenzyme was purified, which contains RNAPII and SRBs 
(suppressors of RNA polymerase B mutations), with or without a subset of GTFs 
(Kim, Bjorklund et al. 1994; Koleske and Young 1994). It suggests that the RNAPII 
holoenzyme may be assembled prior to the interaction with promoter DNA and the 
entry of RNAPII holoenzyme to the promoter region is possibly facilitated by the GTF 
TFIID (similar to the prokaryotic RNAP system where a dissociable σ subunit recruits 
RNAP core enzyme to the promoter region; Figure 1.14B). 
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Moreover, the initiation of transcription by RNAPIII includes two protein complexes, 
TFIIIB and TFIIIC. The transcription of 5S rRNA also requires a third factor, TFIIIA. 
TBP is also an essential component of the TFIIIB complex.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
1.6.2 The basal transcription factors in archaea 
The archaeal transcription apparatus can be described as a simplified version of their 
eukaryotic RNAPII counterparts, however, with much smaller number of involved 
factors. Many archaeal genes contain TATA-box-like sequence elements in their 
promoter regions (Reiter, Palm et al. 1988; Reiter, Palm et al. 1989), which are 
specifically recognized by archaeal homologues of TBP (aTBP) (Rowlands, Baumann 
et al. 1994). aTBP recruits RNAP to the transcription start sites. Once aTBP is bound 
to the promoter region, it remains attached to the template DNA (reported from in 
vitro experiments with a minimal archaeal initiation system) (Xie and Reeve 2004) 
even after initiation. The binding of aTBP to the archaeal TATA box is stabilized by 
archaeal transcription factor B (aTFB; a functional homologue of TFIIB), which plays 
a functionally equivalent role to eukaryotic TFIIB (Wettach, Gohl et al. 1995). 
Corroborative crystallographic data (Bushnell, Westover et al. 2004) and biochemical 
analysis (Bartlett, Thomm et al. 2004; Renfrow, Naryshkin et al. 2004; Deng and 
Roberts 2006) suggest that the C-terminal region of TFB makes contacts with 
template DNA both upstream and downstream of the TATA-box element and the N-
terminus interacts with a region of template DNA that is close to the transcription start 
site. Photochemical cross-linking studies of aTFB in the archaeal PIC (Bartlett, 
Thomm et al. 2000; Bartlett, Thomm et al. 2004) are in agreement with similar studies 
of the eukaryotic PIC (Chen and Hahn 2004), which implies a common evolutionary 
origin of the transcription mechanisms. Recent studies have shown that a sub-domain 
of TFB – the B-finger – functionally participates in transcription initiation events by 
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stimulating an early transcription initiation event in a recruitment-independent 
function (Werner, Wiesler et al. 2006). The B-finger penetrates into the RNAP via the 
putative transcript exit channel and temporarily becomes an integral part of the active 
site during the transcription initiation process. Since the B-finger is an essential part 
of functional TFB, it is expected to display a high degree of sequence conservation. 
However, a systematic alignment of all available archaeal and eukaryotic TFB/ TFIIB 
sequences reveals that, contrary to expectation, the B-finger motifs are highly variable, 
especially near the tip of the loop that is close to the catalytic site of RNAP (Werner, 
Wiesler et al. 2006).  
With a few exceptions (e.g. the Sulfolobus shibatae TFB promoter), both TBP and 
TFB are necessary and sufficient for promoter directed transcription in archaea 
(Qureshi, Bell et al. 1997). There are no apparent homologues of TAFs in archaea. 
The assembly of archaeal PIC is in direct analogy to the eukaryotic RNAP class II 
system. The aTBP, aTFB and RNAP constitute a minimal basal in vitro transcription 
system that is both structurally and functionally directly comparable with the core 
components of the eukaryotic RNAPII transcriptional machinery (Bult, White et al. 
1996; Hausner, Wettach et al. 1996; Qureshi, Bell et al. 1997; Werner, Wiesler et al. 
2006).  
1.7 The ‘bridge-helix’ 
The downstream face of RNAP active center is formed by the ‘bridge-helix’ (also 
often referred to as ‘F-bridge’ in the bacterial system), which is a prominent α-helical 
structure spanning the active-center cleft and dividing the active-center cleft from the 
secondary channel (Cramer, Bushnell et al. 2001; Tuske, Sarafianos et al. 2005; 
Figure 1.15). The ‘bridge-helix’ is encoded by the largest RNAP subunit (β’ in 
bacteria, A’ in archaea and Rpa1/Rpb1/Rpc1 in eukaryotes), which is one of the most  
 
48 
 
 
Figure 1.15. A ribbon diagram shows the domains and domain-like regions of 
Rpb1 (S. cerevisiae). Diagram specifies discrete structures in a unique color, in which 
the α-helical structure (green) spanning the active-center cleft indicates the location of 
the ‘bridge-helix’. The supporting switch-1 (green) of the cleft is also shown 
(modified from Cramer, Bushnell et al. 2001).  
 
highly conserved structures near the catalytic site of RNAPs across the three domains 
of life. A short threonine-alanine (‘T-A’) motif represents the proposed bending 
position in the ‘bridge-helix’ structure, which is highly conserved in bacterial, 
archaeal and eukaryotic helix sequences; however, the alanine residue in the ‘T-A’ 
motif may be substituted by a serine residue (S) in some species (Figure 1.16). By 
comparing the crystal structures of bacterial RNAP and yeast RNAPII core enzyme, it 
has been proposed that an alternative straight-and-bent-bridge-helix conformational 
change exists and may play a key role in the transition between pre-translocation and 
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post-translocation states (Cramer, Bushnell et al. 2001; Gnatt, Cramer et al. 2001; 
Wang, Bushnell et al. 2006). The ‘swing-gate’ model suggests a possible mechanism 
by which ‘bridge-helix’ conformational cycling mediate both translocation of RNAP 
and incorporation of rNTPs (Epshtein, Mustaev et al. 2002): The ‘swing-gate’ is 
composed of the ‘F-bridge’ (‘bridge-helix’ in archaeal/eukaryotic RNAP) and the 
supporting ‘G-loop’ (‘switch-1’/ ‘trigger-loop’ in archaeal RNAP/eukaryotic RNAPII) 
in bacteria (T. aquaticus, Figure 1.15). The repetitive conformational change of ‘F-
bridge’ from straight to bent is controlled by the conformational change of the ‘G-
loop’. In the bent conformation of the ‘bridge’ (gate closed), residue K789 (ortholog 
of mjA’-R820) would block the entry of nucleotides into the active center, and 
residues T790 and A791 (orthologs of mjA’-T821 and mjA’-A822) would push out 
the template base from the i+1 site. In the straight conformation of the ‘bridge’ (gate 
open), K789 swings out of the i+1 site, leaving it available either for the incoming 
nucleotide, or for the 3’ terminus of RNA (Figure 1.17). 
Based on the yeast RNAPII structure, the likely extent of the M. jannaschii ‘bridge-
helix’ is a sequence of thirty-five amino acids (mjA’-T801 to mjA’-L835) in the 
largest A’ subunit (Figure 1.18). ‘T821-A822’ motif represents the bending point of 
the ‘bridge-helix’ in the M. jannaschii RNAP. Immediately C-terminal to the ‘T-A’ 
motif there are two amino-acids residues (mjA’-Q823 and mjA’-S824) in a ‘flipped-
out’ position (facing away the active site) that has been proposed to act as an 
intermediate between the straight and the bent ‘bridge-helix’ conformation (Zhang, 
Campbell et al. 1999; Cramer, Bushnell et al. 2001). Both of the positions directly 
contact with the supporting ‘G-loop’ that may allow the repetitive shift between 
straight and bent ‘bridge-helix’ following the conformational change of the ‘G-loop’ 
(Borukhov and Nudler 2008). An invariant arginine residue (R829 in M. jannaschii 
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that is in presence in all available ‘bridge-helix’ sequences; Figure 1.16) has been 
proposed to be involved in contacting the DNA template strand at position i and i+2, 
or in the stabilization of the ‘flipped-out’ mjA’-Q823 (Gnatt, Cramer et al. 2001; 
Vassylyev, Sekine et al. 2002). 
 
Figure 1.16. Multiple sequence alignment of a representative selection of ‘bridge-
helix’ from archaeal RNAPs (RPOA1_), and eukaryotic RNAPI (RPA1_), 
RNAPII (RPB1_) and RNAPIII (RPC1_). Highly conserved residues are highlighted 
in red near the central region of the sequences; similar and non-conserved residues are 
shown in blue and black, respectively. Amino-acid sequences are numbered as they 
are present in M. jannaschii ‘bridge-helix’. The blue arrow indicates the proposed 
bending point (T821/A822 in M. jannaschii ‘bridge-helix’); the green arrow points at 
the ‘bridge-helix’ ‘flipped-out’ positions (Q823 and S824 in M. jannaschii) and the 
red arrow shows the position of the invariant arginine residue (R829 in M. jannaschii). 
Data of amino acid sequences was obtained from Swiss-Prot and aligned using 
Multalin with following default settings: gap penalty at opening 10.0; gap penalty at 
extension 0.05; high consensus value 90%; low consensus value 50%.  
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Figure 1.17. ‘Swing-gate’ model (Modified from Epshtein, Mustaev et al. 2002) 
A) The transcription complex before formation of phosphodiester bond. ‘F-bridge’ 
(green) is relaxed. The ‘G-loops’ (yellow) and key bacterial ‘F-bridge’ residues 
(red and grey) are indicated. 
B) The pre-translocation stage. The phosphodiester bond is formed. 
C) Translocation: ‘F-bridge’ bends following the conformational change of ‘G-loops’, 
causing K789 (R820 in M. jannaschii, red) to enter the i+1 site. T790 and A791 
(T821 and A822 in M. jannaschii, grey) push DNA template base out from the 
i+1 position.  
D) Relaxation: ‘F-bridge’ returns to straight conformation, vacating the i+1 site for 
the next nucleotide, or for reverse translocation. 
 
 
Figure 1.18. Sequences of M. jannaschii ‘bridge-helix’ starting from T801 to 
L835. Blue circle indicates the ‘T-A’ motif (mjA’-T821/A822; the proposed bending 
point); Red circle shows the ‘flipped-out’ positions (mjA’-Q823 and mjA’-S824) and 
the invariant arginine (mjA’-R829) is specified by a light green circle. 
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1.8 Aims of this study 
The archaeal RNAP does not only display as a simplified version of the eukaryotic 
RNAPII in structure but also in the usage of basal transcription factors, which 
represents a minimal counterpart of the eukaryotic transcriptional machinery. A 
common evolutionary origin of both archaeal and eukaryotic transcription systems is 
implied by various studies of the basal transcription factors, including the function of 
aTFB/TFIIB in PIC (Bartlett, Thomm et al. 2000; Bartlett, Thomm et al. 2004; Chen 
and Hahn 2004) and the binding of both archaeal and eukaryotic TBP to archaeal 
promoters (Wettach, Gohl et al. 1995). Previous studies have provided a fully 
recombinant archaeal transcription system that is used as an experimental platform 
capable of making mutant variants in a reproducible manner under defined in vitro 
conditions (Werner and Weinzierl 2002; Ouhammouch, Werner et al. 2004; Werner 
and Weinzierl 2005). The recombinant M. jannaschii RNAP allows precise 
modification of its subunits and associated transcription factors in order to understand 
the transcription mechanisms at a molecular level. Here, I report a high-throughput 
site-directed mutagenesis approach for the study of hyperthermophilic archaeon M. 
jannaschii RNAP A’ ‘bridge-helix’, by which all 19 single amino-acid substitution 
variants were systematically produced in a series of ‘bridge-helix’ positions. Since the 
A’ ‘bridge-helix’ is in the position near the active site of the RNAP, the localized 
side-chain requirements at certain positions (e.g. sizes, charges, polarities) were 
evaluated by measuring the resulting catalytic activity of the mutants relative to the 
wild-type. Furthermore, this study may also be extended into a parallel mutagenesis 
approach of other neighboring functional domains or domain-like structures using a 
similar experimental strategy to investigate the critical intermolecular interactions that 
may have significant contributions to the process of transcription. 
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Chapter 2: Materials and Methods 
2.1 Bioinformatics 
Biological sequence alignment editor 
BioEdit (Hall, T. 2005) (http://www.mbio.ncsu.edu/BioEdit/bioedit.html) 
Biological sequence alignment editor, which is useful for daily DNA sequences 
alignment and manipulation. 
Molecular modeling and visualization tools 
Cn3D 4.1 (http://ncbi.nih.gov/Structure/CN3D/cn3d.shtml) 
A helper application that allows viewing 3-dimentional structures from NCBI’s 
Entrez retrieval service. 
 
PyMol (DeLano Scientific LLC, 2006) (http://pymol.sourceforge.net/) 
A molecular visualization system that is a capable molecular viewer with support for 
animations, high-quality rendering, crystallography, and other common molecular 
graphic activities. 
Multiple sequence alignements 
CLC Sequence Viewer 5 (http://www.clcbio.com/index.php?id=28) 
A free software workbench for basic bioinformatics, enabling users to make a large 
number of bioinformatics analyses including interactive restriction site analysis, 
creating and editing alignments, phylogenetics, integrated GenBank searches, and 
advanced DNA to protein translation. 
 
Multalin (Corpet 1988) (http://prodes.toulouse.inra.fr/multalin/multalin.html) 
Online sequence alignment tool that allow aligning multiple biological sequences 
simultaneously. 
Online Database 
NCBI (http://www.ncbi.nlm.nih.gov/) 
Used for obtaining DNA and protein sequence information and its PubMed database 
is useful for reference searches and citation. 
 
EBI Macromolecular Structure Database (http://www.ebi.ac.uk/msd/) 
Derived part from the Protein Data Bank (PDB) that is used to obtain protein 
structural data. 
 
Swiss-Prot (http://www.expasy.org/sprot/) 
Protein knowledge database for protein sequence information. 
Translation tool 
EXPASY Translate Tool (http://ca.expasy.org/tools/dna.html) 
Useful for nucleotide (DNA/RNA) to protein translation. 
 
 
54 
2.2 E. coli strains and growth conditions 
2.2.1 E. coli strains 
Strain Genotype Application Transformation 
efficiency 
Source 
DH5α F-, φ80dlacZΔM15, 
Δ(lacZYA-argF)U169, 
deoR, recA1, endA1, 
hsdR17(rk-, mk+), 
phoA, supE44, λ-, thi-1, 
gyrA96, relA1 
Cloning > 1x106 cfu µg-1 
DNA 
Invitrogen 
Acella 
(DE3) 
F-, ompT, hsdSB (rB-
mB-), gal, dcm, DendA, 
DrecA 
Cloning and 
Expression 
= 2x108 cfu µg-1 
pUC19 DNA 
(Bio-
Systems) 
Table 2.1. The list of E. coli strains used in this project. The genotype and 
applications of each strain are shown in the table. The transformation efficiency is 
also given in cfu (colony-forming unit) µg-1 DNA. 
2.2.2 E. coli growth conditions 
E. coli cells were either grown on Luria-Bertani (LB) plates in a 37°C incubator or in 
Terrific-broth (TB) medium on a temperature-controlled shaker (37°C). Selective 
growth of this project was generally achieved by 100µg ml-1 ampicillin. 
2.3 Cloning and mutagenesis strategy 
The open reading frames (ORFs) encoding M. jannaschii RNAP A’ mutants were 
constructed by site-directed mutagenesis. Complementary oligonucleotides carrying 
an unspecified genetic codon (NNN) were designed (based on the M. jannaschii 
RNAP A’ ‘bridge-helix’ master sequence, Figure 2.1) and commercially purchased 
(MWG Biotech). The oligonucleotide sequences harboring mutations at various M. 
jannaschii RNAP ‘bridge-helix’ positions are shown in Table 2.2. Oligos were diluted 
into 400pmol µl-1 with buffer TE [10mM tris-HCl (pH8.0) and 1mM 
Ethylenediaminetetra acetic acid (EDTA)] and incubated for 30 minutes at 37°C, 
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ensuring all the materials fully dissolved in the solutions. Equal volumes of 
complementary oligos (normally in a total volume of ~20µl) were combined and 
incubated for 1 minute at 100°C. Followed by incubation at room temperature for 16-
18 hours, the single oligonucleotide strands were annealed into double-stranded DNA 
(dsDNA). The resulting dsDNA was cloned into a cloning vector pUC57 (GenScript, 
Table 2.3) and verified by sequencing (Sequencing services, Cogenics). For the 
production of recombinant proteins, the insert was then subcloned into expression 
vector pET21a (+) (Novagen, Table 2.3). Table 2.3 shows the list of plasmids used in 
this project. All recombinant DNA techniques were performed according to standard 
procedures (Maniatis, Fritsch et al. 1982) or the manufacturer’s instructions (see 
2.3.1-2.3.6 for details). For long-term storage, the pET21a (+) vectors were 
transformed into Acella (DE3) chemically competent cells (Table2.1) and stored at     
-80°C with 5% dimethyl sulfoxide (DMSO).  
Figure 2.1. Master-sequence of M. jannaschii RNAP A’ ‘bridge-helix’ used in 
this project. The amino acid sequences of ‘bridge-helix’ are highlighted in green and 
its flanking sequences with multiple modified restriction sites (BstBI, StuI, NcoI, SfiI, 
SbfI, BsiWI, ClaI and BamHI) are shown in black. All restriction sites shown (DNA 
sequences, red) were designed to be unique within the plasmid construct that allow 
the replacement of part of the wild-type sequences with various mutant inserts 
following a double endonuclease treatment. 
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mjA’  T801→X (StuI – NcoI fragment) 
cctgagcccgNNNgaattcttcttccatgc 
catggcatggaagaagaattcNNNcgggctcagg 
mjA’  E802→X (StuI – NcoI fragment) 
cctgagcccgaccNNNttcttcttccatgc 
catggcatggaagaagaaNNNggtcgggctcagg 
mjA’  F803→X (StuI – NcoI fragment) 
cctgagcccgaccgaaNNNttcttccatgc 
catggcatggaagaaNNNttcggtcgggctcagg 
mjA’  F804→X (StuI – NcoI fragment) 
cctgagcccgaccgaattcNNNttccatgc 
catggcatggaaNNNgaattcggtcgggctcagg 
mjA’  F805→X (StuI – NcoI fragment) 
cctgagcccgaccgaattcttcNNNcatgc 
catggcatgNNNgaagaattcggtcgggctcagg 
mjA’  H806→X (StuI – SfiI fragment) 
cctgagcccgaccgaattcttcttcNNNgccatgggtggccgtga 
cggccacccatggcNNNgaagaagaattcggtcgggctcagg 
mjA’  A807→X (StuI – SfiI fragment) 
cctgagcccgaccgaattcttcttccatNNNatgggtggccgtga 
cggccacccatNNNatggaagaagaattcggtcgggctcagg 
mjA’  M808→X (StuI – SfiI fragment) 
cctgagcccgaccgaattcttcttccatgccNNNggtggccgtga 
cggccaccNNNggcatggaagaagaattcggtcgggctcagg 
mjA’  G809→X (StuI – SfiI fragment) 
cctgagcccgaccgaattcttcttccatgccatgNNNggccgtga 
cggccNNNcatggcatggaagaagaattcggtcgggctcagg 
mjA’  G810→X (NcoI – SbfI fragment) 
catgggtNNNcgtgagggcctggttgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattaa
cgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcggtacgcaccgcctggtcaaccaggccctcacgNNNa
cc 
mjA’  R811→X (NcoI – SbfI fragment) 
catgggtggcNNNgagggcctggttgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattaa
cgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcggtacgcaccgcctggtcaaccaggccctcNNNgcca
cc 
 
Table 2.2. Oligonucleotide sequences for the site-directed mutagenesis of the M. 
jannaschii RNA polymerase A’ ‘bridge-helix’ 
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mjA’  E812→X (NcoI – SbfI fragment) 
catgggtggccgtNNNggcctggttgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattaa
cgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcggtacgcaccgcctggtcaaccaggccNNNacggcca
cc 
mjA’  G813→X (NcoI – SbfI fragment) 
catgggtggccgtgagNNNctggttgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattaa
cgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcggtacgcaccgcctggtcaaccagNNNctcacggcca
cc 
mjA’  L814→X (SfiI – SbfI fragment) 
gggcNNNgttgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcggtacgcaccgcctggtcaacNNNgccctca 
mjA’  V815→X (SfiI – SbfI fragment) 
gggcctgNNNgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcggtacgcaccgcctggtcNNNcaggccctca 
mjA’  D816→X (SfiI– SbfI fragment) 
gggcctggttNNNcaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcggtacgcaccgcctgNNNaaccaggccctca 
mjA’  Q817→X (SfiI– SbfI fragment) 
gggcctggttgacNNNgcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcggtacgcaccgcNNNgtcaaccaggccctca 
mjA’  A818→X (SfiI– SbfI fragment) 
gggcctggttgaccagNNNgtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcggtacgcacNNNctggtcaaccaggccctca 
mjA’  V819→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcgNNNcgtaccgcgcagagcggttatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcggtacgNNNcgcctggtcaaccaggccctca 
mjA’  R820→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgNNNaccgcgcagagcggttatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcggtNNNcaccgcctggtcaaccaggccctca 
mjA’  T821→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtNNNgcgcagagcggttatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgcgcNNNacgcaccgcctggtcaaccaggccctca 
mjA’  A822→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccNNNcagagcggttatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctctgNNNggtacgcaccgcctggtcaaccaggccctca 
mjA’  Q823→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgNNNagcggttatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataaccgctNNNcgcggtacgcaccgcctggtcaaccaggccctca 
 
Table 2.2. Oligonucleotide sequences for the site-directed mutagenesis of the M. 
jannaschii RNA polymerase A’ ‘bridge-helix’ 
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mjA’  S824→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagNNNggttatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataaccNNNctgcgcggtacgcaccgcctggtcaaccaggccctca 
mjA’  G825→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagagcNNNtatatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatataNNNgctctgcgcggtacgcaccgcctggtcaaccaggccctca 
mjA’  Y826→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagagcggtNNNatgcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgcatNNNaccgctctgcgcggtacgcaccgcctggtcaaccaggccctca 
mjA’  M827→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagagcggttatNNNcagcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgctgNNNataaccgctctgcgcggtacgcaccgcctggtcaaccaggccctca 
mjA’  Q828→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagagcggttatatgNNNcgtcgcctgattaacgccctgca 
gggcgttaatcaggcgacgNNNcatataaccgctctgcgcggtacgcaccgcctggtcaaccaggccctca 
mjA’  R829→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagagcggttatatgcagNNNcgcctgattaacgccctgca 
gggcgttaatcaggcgNNNctgcatataaccgctctgcgcggtacgcaccgcctggtcaaccaggccctca 
mjA’  R830→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtNNNctgattaacgccctgca 
gggcgttaatcagNNNacgctgcatataaccgctctgcgcggtacgcaccgcctggtcaaccaggccctca 
mjA’  L831→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcNNNattaacgccctgca 
gggcgttaatNNNgcgacgctgcatataaccgctctgcgcggtacgcaccgcctggtcaaccaggccctca 
mjA’  I832→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgNNNaacgccctgca 
gggcgttNNNcaggcgacgctgcatataaccgctctgcgcggtacgcaccgcctggtcaaccaggccctca 
mjA’  N833→X (SfiI– SbfI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattNNNgccctgca 
gggcNNNaatcaggcgacgctgcatataaccgctctgcgcggtacgcaccgcctggtcaaccaggccctca 
mjA’  A834→X (SfiI– BsiWI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattaacNNNctgcaggatct
gaaaaaccgaattcgatggcacc 
gtacggtgccatcgaattcggtttttcagatcctgcagNNNgttaatcaggcgacgctgcatataaccgctctgcgcggta
cgcaccgcctggtcaaccaggccctca 
mjA’  L835→X (SfiI– BsiWI fragment) 
gggcctggttgaccaggcggtgcgtaccgcgcagagcggttatatgcagcgtcgcctgattaacgccNNNcaggatct
gaaaaaccgaattcgatggcacc 
gtacggtgccatcgaattcggtttttcagatcctgNNNggcgttaatcaggcgacgctgcatataaccgctctgcgcggta
cgcaccgcctggtcaaccaggccctca 
 
Table 2.2. Oligonucleotide sequences for the site-directed mutagenesis of the M. 
jannaschii RNA polymerase A’ ‘bridge-helix’ 
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2.3.1 Vectors 
Vectors used in this project are listed in Table 2.3. Both cloning (pUC57, derived 
from pUC19 vector, GenScript) and expression vectors (pET21a, Novagen) were re-
engineered to carry a full-length, PCR-generated ORF of M. jannaschii RNAP A’ 
(wild-type). For this study, the C-terminal portion (BstBI-BamHI) of the ORF was 
replaced with a gene fragment (GenScript) containing optimized codons and unique 
restriction sites flanking the ‘bridge-helix’ (Figure 2.1). The substitution of part of the 
wild-type DNA with mutant variants can be simply performed following an 
endonuclease double-digestion and re-ligation process (Figure 2.2). 
 
Figure 2.2. Cloning and mutagenesis strategy. Individual steps are numbered. Step 
1 and 2 represent the cloning of mutant oligos into cloning vector (pUC57), which are 
indicated by the solid arrows. Annealed dsDNAs with sticky ends were cloned into 
pre-cut plasmids by T4 DNA ligase. The dashed lines (Step 4-6) represent the 
subclone strategy of mutant inserts into expression plasmids (pET21a). Mutants were 
released from cloning vectors following endonuclease treatments and subcloned into 
pre-cut pET21a plasmids by T4 DNA ligase. The identities of mutants were verified 
by sequencing. Expression plasmids harboring various mutants were transformed into 
chemically competent cells (Acella) and stored at -80°C with 5% DMSO.   
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Plasmid Used for Selectable marker Copy number Source 
pUC57 Cloning ampicillin High GenScript 
pET21a (+) Expression ampicillin Low Novagen 
Table 2.3. Plasmids used in this project 
2.3.2 Release of mutant inserts from cloning vectors 
2.3.2.1 Restriction digestion of cloning plasmids 
DNA inserts were released from cloning plasmids (pUC57) followed by a double 
digestion reaction with endonuclease BamHI and BstBI (Figure 2.1). 5µl of plasmid 
was initially cut in a buffer containing 10µl of 10x Buffer 4 (New England Biolabs), 
82µl of H2O and 3µl of BamHI (20,000unit ml-1, New England Biolabs) and incubated 
for one hour at 37°C. 3µl of BstBI (20,000unit ml-1, New England Biolabs) was then 
added and the samples were incubated for another one hour at 65°C. DNA fragments 
were concentrated into 40µl by ethanol precipitation (see 2.3.6) and separated on 
1.5% agarose gels.  
2.3.2.2 Agarose gel electrophoresis 
Agarose gel electrophoresis allows separation of DNA fragments according to the 
sizes. Gels were made by appropriate amount of agarose with 0.5x Buffer TBE (5.4g 
L-1 tris-base, 2.75g L-1 boric acid and 0.5mM EDTA). Samples were loaded with 10x 
DNA loading buffer [0.125% (w/v) Xylene cyanol, 0.125% (w/v) Bromophenol blue, 
0.625% (w/v) SDS and 62.5% (v/v) glycerol] on a gel and separated in 0.5x Buffer 
TBE with ethidium bromide at 50-70V. DNA bands could be visualized by a UV 
detector and captured on a photograph. The sizes of DNA fragments were estimated 
by comparing with a DNA marker (HyperLadder I; Bioline). 
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2.3.2.3 Extraction of DNA from an agarose gel 
Digested DNA fragments were purified from an agarose gel by Qiagen QIAquick Gel 
Extraction Kit according to the supplier’s instruction (QIAquick Spin Handbook 
07/2002; p. 23-4). 
2.3.3 Ligation of DNA inserts into plasmids 
Ligation reaction of DNA inserts into plasmids in this project was performed by 
incubating 5µl of 2x ligation buffer (Promega), 1µl of dsDNA insert (3-5µg), 1µl of 
plasmid (0.5-2µg), 1µl of T4 DNA ligase (3unit µl-1, Promega) and 2µl of H2O for 
two hours at room temperature (Maniatis, Fritsch et al. 1982). 
2.3.4 DNA transformation of cells 
It is crucial to keep a sterile condition for transformation of DNA plasmids into 
competent cells. Any materials used at this stage were autoclaved to prevent 
contaminations. 1x recombinant plasmid DNA was transformed to 10x chemically 
competent E. coli cells (DH5α or Acella) by incubating for 20 minutes at 0°C. Cells 
were then incubated for 30 seconds at 37°C and 2 minutes at 0°C. The transformed 
cells were grown on LB plates with 100µg ml-1 ampicillin and incubated overnight at 
37°C. 
2.3.5 Extraction of recombinant plasmids from E. coli 
2.3.5.1 Mini preparation of plasmid 
Mini preparation of recombinant plasmid was performed using Qiagen QIAprep Spin 
Miniprep Kit and a micro-centrifuge according to the manufacture’s instructions 
(Qiagen QIAprep Miniprep Handbook 06/2005; p. 22-3). Plasmid DNA was eluted 
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with 50µl Buffer EB [10mM tris-Cl (pH8.5)]. 1µg of plasmid DNA was sequenced 
with appropriate primer to confirm its identity (Cogenics).  
2.3.5.2 Midi/Maxi preparation of plasmid from Escherichia coli 
Recombinant cloning plasmids (pUC57) were extracted by Qiagen HiSpeed Plasmid 
Midi Kit while recombinant pET21a (+) expression plasmids were isolated through 
Qiagen HiSpeed Plasmid Maxi Kit following the supplier’s instruction (Qiagen 
HiSpeed Plasmid Purification Handbook 12/2001; p. 15-8). Plasmid DNA was eluted 
with 1ml of Buffer TE and further concentrated into 100µl for either endonuclease 
digestion or cell transformation.  
2.3.6 Ethanol precipitation of DNA 
One-tenth volume of 3M sodium acetate [NaoAc (pH5.2)] and two volumes of 
ethanol (absolute, 99.8+%, Fisher Scientific) were added to one volume of plasmid 
DNA sample. The precipitation mixture was incubated on ice for at least 20 minutes. 
DNA was harvested by spinning down at 13k rpm (revolutions per minute) for 10-15 
minutes. All supernatant was fully removed and pellet was resuspended with Buffer 
TE (Szumanski, Toth et al. 1990). 
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2.4 Expression and purification of recombinant proteins 
The T7 promoter-based expression plasmids [pET21a (+), see table 2.3] were 
transformed into chemically competent E. coli cells (Acella, Biosystems). 
Transformations were carried out for 20 minutes at 0°C, followed by a heatshock for 
30 seconds at 37°C and 2 minutes at 0°C prior to plating on agar plates containing 
100µg ml-1 ampicillin. All bacterial cultures were grown in rich media (TB, Melford 
Laboratories Ltd). For expression, a single colony was resuspended in a starter culture 
of 15-20ml in a 50ml Falcon tube and incubated at 37°C overnight. The next day, the 
starter culture was then diluted into 500ml with the same medium in a baffled 
Erlenmeyer flask (2L) and expanded at 37°C. Vigorous shaking of the culture 
medium was used throughout to ensure good aeration. At A600= 0.6-0.8, the culture 
was induced with 1mM isopropyl-β-D-thiogalactopyranoside (IPTG, Sigma) and 
expression continued for another 3-5 hours at 37°C. Cells were harvested by 
centrifugation in a GS-3 rotorhead at 6,000 rpm for 10 minutes at 4°C and cell pellets 
were stored at -80°C. 
2.4.1 Glutathione fusion protein purification 
The cell pellets were resuspended in 20ml of Buffer T/G300 [tris-glycine (T/G0) buffer 
with 300mM potassium acetate (KoAc): 25mM tris base, 192mM glycine, 1mM 
EDTA, 10% (v/v) glycerol and 300mM KoAc] with 15mM β-mercaptoethanol and 
1mg ml-1 lysozyme (Sigma). Resuspended cells were incubated for 1 hour at room 
temperature (RT) and sonicated twice for 1 minute at 6µm amplitude by ultrasonic 
disintegrator (Sanyo MSE Soniprep 150). The extract was cleared by centrifugation 
for 20 minutes at 12,000 rpm at 4°C. The soluble extract was ‘batch’ bound to 5-10ml 
glutathione agarose (Sigma), loaded on a 25mm Ø glass column and the flow-through 
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fraction was collected. The column was subsequently washed with 100ml of T/G300 
buffer, 20ml of T/G100 buffer (identical to T/G300 buffer, but with 100mM KoAc) and 
eluted with T/G100 supplemented with 5mM glutathione (Sigma). The eluate fractions 
were collected in a BioRad fraction collector and protein-containing fractions were 
identified using BCA (bicinchoninic acid) protein assays. The GST fusion protein-
containing peak fractions were pooled and treated with thrombin (1unit ml-1) 
overnight at 4°C. 
2.4.2 TALON cobalt affinity purification 
Subunit KHis was purified on TALON resin in the presence of 6M urea (Werner and 
Weinzierl 2002). In brief, bacterial pellets were solublized in 50ml T/G300 buffer 
supplemented with 6M urea. Bacterial cells were lysed using sonication (twice for 1 
minute at 6µm amplitude). After the removal of insoluble cell components by 
centrifugation for 20 minutes at 12,000 rpm, the cleared extract was ‘batch’ bound to 
5-10ml TALON resin and loaded on a 25mm Ø glass column. Retained proteins were 
washed with T/G300 buffer (containing 6M urea) and eluted with the same buffer 
(containing 6M urea) plus 150mM imidazole.  
2.4.3 Purification of inclusion body 
The four large subunits A’, A’’, B’ and B’’ (small scale of A’ mutant subunits were 
prepared using automated techniques that is detailed in Chapter 3) were expressed in 
Acella cells (Biosystems) by inducing exponentially growing cultures with 1mM 
IPTG (Sigma) for 3-5 hours at 37°C. Cell pellets were resuspended in 20ml of Buffer 
T/G300 with 15mM β-mercaptoethanol and 1mg ml-1 lysozyme. After sonication, 
soluble extracts were fully removed and the inclusion bodies were washed intensively 
by a series of washing buffers (Table 2.4). Inclusion bodies were then solublized in 
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Buffer T/G0 [25mM tris base and 192mM glycine (pH 8.3)] with 15mM β-
mercaptoethanol and in the presence of saturating amount of urea (Werner and 
Weinzierl 2002).  
Washing Buffer 1 
15mM β-mercaptoethanol 
1mg ml-1 lysozyme 
1mg ml-1 deoxycholate (detergent) 
Incubated for 1 hour at 
room temperature 
Washing Buffer 2 15mM β-mercaptoethanol 1mg ml-1 deoxycholate (detergent) 
Incubated for 1 hour at 
room temperature 
Washing Buffer 3 15mM β-mercaptoethanol No incubation needed 
Table 2.4. Washing buffers for the purification of inclusion bodies 
 
2.4.4 Ion-Exchange Chromatography 
The thrombin cleaved GST fusion proteins were separated from the GST moiety by 
ion exchange or size exclusion chromatography. Manual ion exchange 
chromatography was performed by ‘batch’ binding the protein either to SP, Q or 
DEAE sepharose (Amersham Biosciences) in T/G0 buffer on a 25mm Ø glass column. 
Following the intensive washes with T/G100 buffer, the retained protein was eluted 
with T/G buffer containing increasing concentration of KoAc. Preparative scale 
chromatographic purification of the large RNAP subunits was performed in the 
presence of 6M urea on MonoS (for subunit A’) and MonoQ (for subunits A’’, B’ and 
B’’) columns (Amersham Biosciences) using linear salt gradients (0M to 1M KoAc) 
in T/G0 on the DuoFlow BioLogic HPLC device (BioRad). 
2.4.5 Size exclusion chromatography 
Preparative size exclusion chromatography for archaeal RNAP subunits was 
performed on Sephacryl S-100HR HiPrep 16/60 columns (Amersham Biosciences). 
All size exclusion experiments were performed on the DuoFlow BioLogic HPLC 
device (BioRad). 
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2.4.6 Summary of M. jannaschii RNAP recombinant subunit 
expression and purification 
All subunits used in this project were expressed in chemically competent E. coli cells 
(Acella, Biosystems) in either soluble or insoluble form. Subunits D/L and E/F were 
expressed as soluble heterodimeric complexes from a bacterial bicistronic expression 
system (Werner, Eloranta et al. 2000); subunits H (Thiru, Hodach et al. 1999), N and 
P (Werner, Eloranta et al. 2000) were expressed and purified under native conditions. 
Subunits A’, A’’, B’, B’’ and KHis were solublized and purified by ion-exchange 
chromatography in the presence of 6M urea (Werner and Weinzierl 2002). The 
overall purification schemes of various M. jannaschii RNAP subunits were 
summarized in Figure 2.3. 
2.4.7 Preparation of M. jannaschii TFB 
TB medium (10ml) containing 100µg ml-1 ampicillin was inoculated with 
recombinant E. coli cells (Acella, Biosystems) harboring wild-type M. jannaschii 
TFB (pET21a; with 6 his-tag). After overnight incubation, the bacterial culture was 
diluted into 1L with the same medium and grown at 37°C until A600= 0.6-0.8. Protein 
expression was induced by adding 1mM IPTG to the culture and incubated for 
another 3 hours with vigorous shaking. Cells were harvested by centrifugation in a 
GS-3 rotorhead at 6,000 rpm for 10 minutes at 4°C and cell pellets were stored at -
80°C. 
Recombinant TFB proteins were extracted by incubating bacterial pellets in the 
binding buffer (His-Buffer-Kit, GE Healthcare, Table 2.5) with 1mg ml-1 lysozyme 
(Sigma) and sonicated twice for 1 minute at 6µm amplitude by ultrasonic 
disintegrator (Sanyo MSE Soniprep 150). The supernatant was loaded on a pre-
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equilibrated column (with 10ml of binding buffer, Table 2.5) containing Ni Sepharose 
6 Fast Flow (GE Healthcare). The retained proteins were extensively washed with the 
binding buffer and eluted with 500mM imidazole (Table 2.5). The purity of protein 
was confirmed by SDS-PAGE. The protein-containing fractions were pooled and 
dialyzed against 25mM tris (pH 8.3), 192mM glycine, 10% (v/v) glycerol, 15mM β-
mercaptoethanol and 500mM sodium chloride (NaCl) for 1 hour and stored at -80°C. 
 
 
Imidazole 
concentration 
in buffer 
Phosphate 
buffer, 8x 
stock 
solution 
(pH 7.4) 
2M 
imidazole 
(pH 7.4) 
Glycerol 
 
β-
mercaptoethanol 
(reducing agent) 
Binding 
buffer 
(50ml) 
20mM 6.25ml 0.5ml 5ml 50µl 
Elution 
Buffer 
(8ml) 
500mM 1ml 2ml 800µl 8µl 
Table 2.5. Buffer used for TFB purification (His-Buffer-Kit, GE Healthcare) 
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Figure 2.3. Overall purification schemes of various M. jannaschii RNAP subunits 
(Werner and Weinzierl 2002) 
A) A schematic drawing of the expression, purification and assembly strategies for 
recombinant M. jannaschii RNAP subunits. 
B) The large subunits A’, A’’, B’ and B’’ and the small subunits L/D, F/E, N, P, H, K 
separated on 4-12% Bis-tris SDS PAGE and stained with Coomassie Blue.  
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2.5 In vitro assembly of recombinant RNAPs 
In vitro assembly of M. jannaschii RNAPs from recombinant subunits has been 
previously reported under a defined denaturation-renaturation condition (Werner and 
Weinzierl 2002). The four large subunits A’, A’’, B’ and B’’ were mixed in equimolar 
ratios with a four-fold excess of the small subunits L, D, N, P, K, H, F and E in S500 
buffer [25mM tris base, 192mM glycine, 1mM magnesium acetate (MgAc), 0.1mM 
zinc acetate (ZnAc), 10% (v/v) glycerol, 500mM NaCl and 15mM β-mercaptoethanol] 
in the presence of 6M urea (final protein concentration of approximately 0.1-0.5 mg 
ml-1). The mixture (typically 100µl) was then loaded on a Spectra/Por 96-well 
MicroDialyzer (MWCO 3500, Spectrum Laboratories; Figure 2.4) and samples were 
dialyzed against 170ml of S500 buffer plus 6M urea. Renaturation was achieved by 
constantly pumping 1L of dilution buffer (S500 buffer without urea) into the 
MicroDialyzer chamber in 16 hours (Flow-rate= 1ml min-1; Watson-Marlow Bredel 
Pump 400 series), resulting in a controlled reduction of the urea concentration from 
6M to approximately 0M in S500 buffer. 
 
Figure 2.4. Spectra/Por 96-Well MicroDialyzer 
Panel A is an image of the Spectra/Por 96-well MicroDialyzer that is assembled with 
a molecularporous membrane (MWCO 3500, Spectrum Laboratories). Panel B is a 
schematic representation of the MicroDialyzer: Samples (dark blue) were dialyzed 
against gradually diluted urea-containing buffer on the dialysis membrane (red dot 
lines). 1L of S500 buffer (without urea) was pumped into the MicroDialyzer chamber 
(light blue) in a constant rate (1ml min-1). Stirrer ensured an instant mix of the buffer. 
Recombinant M. jannaschii RNAPs were generally assembled after 16 hours. 
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2.6 Non-specific (promoter-independent) in vitro transcription 
assays – TCA precipitation assays 
Non-specific (promoter-independent) transcription assay on nicked dsDNA templates 
is one of the simplest functional assays, which is used to compare the overall specific 
catalytic activity of various RNAP mutants relative to the wild-type. Non-specific 
transcription activity was measured by the incorporation of [α-32P]-UTP into TCA 
insoluble material (15% TCA). Standard reactions were performed in 1x transcription 
buffer [120mM KoAc, 10mM MgAc and 2mM tris-acetate (tris-Ac)] in a total volume 
of 50µl containing 1µl of recombinant M. jannaschii RNAP (0.5-1.0µg), 10mM 
dithiothreitol (DTT), 500µM CTP, 500µM ATP, 500µM GTP, 1µM UTP and 27nM 
[α-32P]-UTP (3000Ci/mmol, Perkin Elmer) using 1.5µg nuclease activated calf 
thymus DNA (0.3µg µl-1, Sigma) as template. Reactions were performed in 1.5ml 
Eppendorf tubes for 30 minutes at 65°C and stopped by the addition of 500µl of 15% 
(w/v) TCA. After incubation at 0°C for 20 minutes, the insoluble precipitates (RNA 
transcripts) were collected on the 25mm filter-discs, extensively washed with 10% 
(w/v) TCA (in order to remove unincorporated [α-32P]-UTP substrate) and quantified 
in Beckman LS 6000SC Liquid Scintillation Counter with 50µl of scintillation fluid 
(MicroScint 40, Perkin Elmer).  
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2.7 Abortive initiation transcription assays  
The abortive initiation transcription assay was performed by following the production 
of α-32P-radiolabeled RNA formed from the initiating nucleotide GpU and UTP. 
Standard reactions were performed in 1x transcription buffer in a total volume of 10µl 
containing 1µl of recombinant M. jannaschii RNAP (0.5-1.0µg), 1µl of recombinant 
M. jannaschii TFB (0.5-1.0µg), 10mM DTT, 12.5µM UTP, 0.5mM dinucleotide 
primer GpU and 27nM [α-32P]-UTP (3000Ci/mmol, Perkin Elmer) using 1.5µg 
nuclease activated calf thymus DNA (0.3µg µl-1, Sigma) as template. Reactions were 
incubated for 30 minutes at 65°C and stopped by adding 10µl of formamide loading 
dye [98% (v/v) formamide, 10mM EDTA, 0.026% (w/v) bromophenol blue and 
0.026% (w/v) xylene cyanol]. The samples (typically 11 nucleotides long) were 
incubated for 1 minute at 95°C and loaded directly on to a polyacrylamide/urea gel 
[4ml of 40% acrylamide/bis solution (19:1, BioRad), 10ml of RapidGel 8% Liquid 
Acrylamide (7.6% acrylamide, 0.4% bis-acrylamide, 7M urea, 89mM tris, 89mM 
boric acid and 2mM EDTA, USB Corporation), 0.7ml of glycerol, 14µl of TEMED 
and 140µl of 10% (w/v) ammonium persulphate (APS)]. The gel was run at 225V for 
90 minutes in 1x TBE buffer (100mM tris, 90mM boric acid and 1mM EDTA) and 
quantified using a PhosphorImager (Fuji FLA-5000). 
2.8 Elongation transcription assays  
The RNA-DNA template strand hybrid (Figure 2.5) mimicking an elongation 
complex was assembled by heating 10µM RNA and 5µM DNA template strand in a 
total volume of 100µl for 1 minute at 95°C and cooled down slowly overnight to 
room temperature. 1µl of such mixture was used as template in the elongation 
transcription assay. Reactions were performed in 10µl of 1x transcription buffer 
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containing 1µl of RNA-DNA hybrid, 1µl of recombinant M. jannaschii RNAP (0.5-
1.0µg) and 10mM DTT. The reaction mixtures were pre-incubated for 20 minutes at 
60°C allowing the assembly of elongation complexes. rNTPs [500µM CTP, 500µM 
ATP, 500µM GTP, 1µM UTP and 27nM [α-32P]-UTP (3000Ci/mmol, Perkin Elmer)] 
were then added and the reactions were further incubated for 30 minutes at 60°C. By 
addition of 10µl of formamide loading dye, reactions were stopped. The samples were 
incubated for 1 minute at 95°C and loaded directly on to a polyacrylamide/urea gel. 
The gel was run at 225V for 90 minutes in 1x TBE buffer (100mM tris, 90mM boric 
acid and 1mM EDTA) and quantified using a PhosphorImager device (Fuji FLA-
5000). 
 
 
Figure 2.5. Experimental strategy and templates of the elongation transcription 
assays. The DNA template (long strand) was hybridized with a 14nt RNA primer 
(short strand) that mimicked as an elongation complex with mj-RNAP. The RNAP 
activity was measured by the incorporation of [α-32P]-UTP into elongating RNA 
products at 60°C and subsequently visualized by a Fuji BAS PhosphorImager device 
(Fuji FLA-5000). 
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Chapter 3: The ‘RNA polymerase factory’ 
3.1 Introduction 
Many of the enzymes involved in molecular information processing are large and 
complex molecular machines that are assembled from a variety of subunits. Recent 
technical advances in X-ray crystallography have provided first insights into the 
molecular organizations of such protein complexes, including bacterial and eukaryotic 
RNAPs (Zhang, Campbell et al. 1999; Cramer, Bushnell et al. 2000; Cramer, 
Bushnell et al. 2001; Gnatt, Cramer et al. 2001; Vassylyev, Sekine et al. 2002; 
Murakami, Masuda et al. 2002a; Murakami, Masuda et al. 2002b; Boeger, Bushnell et 
al. 2005). RNAPs are the core components of cellular transcriptional machineries. The 
availability of high-resolution structures of such enzymes has inspired numerous 
structural models attempting to explain key RNAP functions in mechanistic terms 
(Kettenberger, Armache et al. 2004; Westover, Bushnell et al. 2004b; Wang, Bushnell 
et al. 2006). However, all those currently existing models are based on a small 
number of individual ‘snap-shots’ of relatively stable molecular events that likely 
involves significant conformational changes and/or ‘short-lived’ intermediates. 
Predictions based on such static models must therefore be analyzed extensively by 
targeted mutagenesis of essential domains to investigate their functional contributions 
(Trinh, Langelier et al. 2006). Since technical obstacles prevent the in vitro assembly 
of catalytically active eukaryotic RNAPs, an alternative archaeal transcription system 
was considered and successfully reconstituted from all recombinant subunits (Werner 
and Weinzierl 2002). The fully recombinant system (derived from the 
hyperthermophilic euryarchaeon M. jannaschii) faithfully produces all known aspects 
of the archaeal in vitro transcription systems, including promoter-directed 
transcription and activator-stimulated transcription that provides an ideal experimental 
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ground to obtain comprehensive insights into their structure-function relationships 
(Werner and Weinzierl 2002; Ouhammouch, Werner et al. 2004; Werner and 
Weinzierl 2005; Naji, Grunberg et al. 2007).  
A site-directed mutagenesis approach was performed to study the functional aspects 
of the ‘bridge-helix’ mechanism in this project. Individual critical positions relative to 
the active site were systematically mutated with all 19 possible mutant variants for in 
vitro studies. A highly automated protein purification/in vitro assembly-and-activity 
assay process (the ‘RNA polymerase factory’) was constructed as a high-throughput 
working bench in order to effectively reduce human labor and to avoid experimental 
errors resulting from manual handling (Nottebaum, Tan et al. 2008). All previously 
developed protein purification and in vitro assembly methods were converted into a 
streamlined and simplified automated procedure that is capable of producing and 
assaying hundreds of individually assembled enzyme variants every week. 
3.2 Re-engineered bacterial expression vectors for site-
directed mutagenesis 
The original expression vectors harboring the archaeal RNAP A’ subunits (mjA’) 
from the hyperthermophilic euryarchaeon M. jannaschii were constructed by 
subcloning the full-length, PCR-generated ORFs into pET21a (+) plasmids. For this 
project, the pET21a-mjA’ vector was modified by replacing the C-terminus of the 
ORF (BstBI-BamHI) with a synthetic gene fragment (GenScript) encoding the 
identical amino-acid sequence, but containing codons optimized for E. coli expression 
and with unique restriction enzyme targets flanking the ‘bridge-helix’ encoding 
sequence. A list of sequences of modified constructs and the description of the 
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cloning and mutagenesis strategy are presented previously in Chapter 2 (2.3 Cloning 
and mutagenesis strategy).  
3.3 Robotic platforms 
All robotic manipulations were performed on either of the two Theonyx Liquid 
Performers (Aviso Trade GmbH) that equipped with an 8-tip pipetting arm, separate 
gripper arm, 2D barcode reader, vacuum manifold, microplate shaker, thermocycler, 
microplate reader, 96-well MicroDialyzer and an integrated microplate centrifuge. 
Figure 3.1 shows the layout of one of the platforms where key robot-integrated 
devices are indicated. 
 
       
Figure 3.1. The image of Theonyx Liquid Performer, in which black arrows 
indicate the main devices integrated on the platform. The use of this robot permits 
rapid processing of a large number of samples in a highly reproducible manner. 
Reagent addition, compound addition, incubation, and vacuum wash were all 
performed automatically by the robot. Other additional devices, including 96-well 
MicroDialyzer and E-Page facility (Invitrogen), were also used with the platform, by 
which a highly automated protein purification/in vitro assembly-and-activity assay 
process (the ‘RNAP factory’) was developed.  
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3.4 Bacterial growth and harvest 
The expression plasmids were stored in 2D-barcoded tubes at -80°C in the presence of 
5% DMSO as anti-freezing agent. 1.5ml of autoinduction growth medium (Novagen) 
with 100µg ml-1 ampicillin were inoculated with single Acella colonies containing 
wild-type or mutant pET21a (+) expression constructs in a 24-deepwell plate. For 
each mutagenized amino-acid position, all substitutions were arranged in a 
standardized pattern (Appendix B) in the presence of positive (wild-type) and 
negative (mjA’ T821-ter) controls.  The plates were covered with a ‘BugStopper’ 
venting capmat (Whatman) and incubated for 18 hours at 37°C. The expression 
cultures were then transferred onto the robotic platform and 10µl of each culture were 
sampled to a 96-well plate for an automatic measurement of the cell density at 600nm 
(A600) after a 1/10 dilution step (a step that documents the quality of cell expression 
cultures).  
3.5 Recombinant protein purification 
900µl of each bacterial expression culture was transferred from the 24-well plates to a 
defined position in a 2.2ml 96-deepwell plate and then lysed directly by the addition 
of 100µl FastBreak reagent (Promega) and 2µl Lysonase (Novagen). The lysates were 
mixed extensively by repeated up-and-down pipetting and occasional vortexing on the 
platform-integrated microplate shaker at 5-minute intervals for a total of 30 minutes at 
room temperature. The ‘bridge-helix’ A’ inclusion bodies were then separated from 
the lysates using the robotic centrifuge (10 minutes at 4700rpm). The protein pellets 
were washed once with 950µl T/G0 buffer [25mM tris base and 192mM glycine (pH 
8.3)] by vigorous robotic pipetting and plate shaking. After a further centrifugation 
and supernatant-decanting step, the inclusion bodies were solublized by the addition 
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of 500µl of T/G0 buffer containing near-saturating urea (~8.3M) by robotic pipetting 
and plate shaking. The protein concentrations of the solublized inclusion bodies were 
quantitated by the Bicinchonic acid (BCA) assay. 10µl of purified A’ subunits were 
mixed with 190µl of BCA protein assay reagent [98% BCA reagent A containing 
BCA, sodium carbonate, sodium tartrate and sodium bicarbonate in 0.1N NaOH, final 
pH 11.25; and 2% BCA reagent B containing 4% (w/v) copper (II) sulfate 
pentahydrate; Sigma] in a clear microplate and measuring the absorption at 562nm 
after 2-hour incubation at 37°C. The read-outs of resulting inclusion bodies were then 
compared with a previously established bovine serum albumin (BSA) standard curve; 
and several purification tests showed that the typical yield of recombinant A’ subunits 
using this automated system was 250µg (from 900µl expression culture) with a 
standard deviation in the concentrations of individual subunit preparations of less than 
±10% (Nottebaum, Tan et al. 2008). 
15mM β-mercaptoethanol was previously used in all of the subunit purification 
buffers (see Chapter 2/2.4), but this chemical compound interferes with the BCA 
assay and was therefore omitted without any identified loss of activity of the 
recombinant subunits after in vitro assembly.   
3.6 Automatic assembly of recombinant M. jannaschii RNAPs 
The previously described 96-well MicroDialyzer (see Chapter 2 /2.5) was installed on 
top of a Hi300N magnetic stirrer (Hanna Instruments) positioned on the robotic 
platform. The dialyzer position is fully accessible by the pipetting and gripper arms; 
and the cover lid was also customized for automatic handling by the gripper arm. A 
peristaltic pump (Watson Marlow Sci400) was calibrated to deliver a flow-rate of 1ml 
min-1 and automatically power-controlled by the robot. The in vitro assemblies were 
performed in a total volume of 100µl per dialysis well and a molecularporous 
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membrane was used for all assemblies (MWCO 3500, preventing the smallest 
subunits from leaking into the buffer chamber under denaturing conditions; Spectrum 
Laboratories). The ratios of various M. jannaschii RNAP subunits in the assembly 
mix were previously described in Chapter 2 (2.5 In vitro assembly of recombinant 
RNAPs); and after the 16-hour-in vitro-assembly, the refolded recombinant proteins 
were collected in a fresh 96-well plate and subjected to various transcription assays. 
3.7 High-throughput transcription assays 
The non-specific transcription assay is the only functional analysis approach that has 
been fully automatically performed on the robotic platform so far without any human 
interventions. 50µl of reactions were set up in a 96-well thin wall plate using reaction 
conditions previously described (see Chapter 2/2.6). After incubation for 30 minutes 
at 65°C (using the integrated thermocycler with heated lid), the plate was transferred 
to the cooling platform where the temperature was maintained at 1°C. The 
precipitation of radiolabeled transcripts was initiated by the addition of 150µl of 15% 
(w/v) TCA. After incubation at 1°C for 20 minutes, the insoluble precipitates (RNA 
transcripts) were collected on the GF/F filter of a 96-well microplate (Whatman) 
using a robotic vacuum platform. The precipitates immobilized on the filter surface 
were washed eight times with 200µl of 10% (w/v) TCA to remove unincorporated [α-
32P]-UTP substrate, twice with 200µl of 95% ethanol and then dried thoroughly by a 
final application of vacuum. The incorporated [α-32P]-UTP levels were quantified 
using Beckman LS 6000SC Liquid Scintillation Counter with 50µl of scintillation 
fluid (MicroScint 40, Perkin Elmer). The results obtained with the fully automated 
‘RNAP factory’ were found to be identical to the results acquired from previously 
described manual techniques (L.T. & R.O.J.W. unpublished data).  
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Chapter 4 Activity assays of recombinant mj-RNAP 
mutant variants 
Structural studies of RNAPs have revealed that only a relatively small proportion of 
amino-acid residues may take direct responsibility in transcription mechanisms. These 
residues are typically arranged within structurally distinct domains (such as ‘bridge-
helix’, ‘trigger-loop’, ‘lid’, ‘zipper’) that directly contact with substrates (DNA, RNA, 
nucleotides) and/or interact with other protein domains within the active site (Zhang, 
Campbell et al. 1999; Cramer, Bushnell et al. 2000; Cramer, Bushnell et al. 2001; 
Gnatt, Cramer et al. 2001; Westover, Bushnell et al. 2004b; Wang, Bushnell et al. 
2006). In order to understand the correlations between discrete structures of RNAP 
and their appropriate functions, residues located within such domains thus tend to be 
the primary targets for site-directed mutagenesis.  
The ‘bridge-helix’ is a highly conserved structure spanning the cleft near the active 
site of multi-subunit RNAPs across all three domains of life. It is believed to play an 
important role (though still controversial) during the RNAP transcription cycle by 
defining the position of the DNA template strand and of the DNA/RNA hybrid in the 
catalytic site. Since the ‘bridge-helix’ is a flexible α-helical structure so that single 
amino-acid substitutions are very unlikely to interfere with subunit assembly or 
overall stability of the enzyme.  
17 adjacent residues within the central portion of the α-helical structure (mjA’-L814 
to mjA’-R830) have been chosen for the high-throughput mutagenesis approach, 
which represent the most critically important region of the ‘bridge-helix’ spanning the 
active site cleft. A mutant library was initially constructed for each of these residues 
by creating targeted single amino-acid substitutions encoding all 19 possible mutant 
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variants. The constructs encoding a complete set of M. jannaschii RNAP A’ variants 
(all 19 possible substitutions and the wild-type) were expressed as recombinant 
subunits in bacterial competent cells, purified and assembled in quadruplicate under 
identical conditions using a fully automated ‘RNAP factory’ approach (see Chapter 3). 
The robot-controlled automation system provided a remarkable degree of consistency 
in the reaction conditions throughout every single experimental stage (including 
bacterial growth, subunit purification, in vitro assembly of recombinant enzymes and 
transcription assays of assembled proteins) that allow the phenotypic effect of each 
mutation to be quantified vigorously under clearly defined in vitro conditions 
(Nottebaum, Tan et al. 2008). All resulting recombinant M. jannaschii RNAP variants 
(323 site-directed mutants along with the wild-type) were initially screened using a 
high-throughput TCA-precipitation assay that measured the incorporation of [α-32P]-
UTP into RNA transcript with nuclease activated calf thymus DNA (0.3µg µl-1, 
Sigma) as template (see Chapter 2/2.6). Since the ‘bridge-helix’ is an essential part of 
the RNAP active site, such activity assays were considered to be an ideal testing 
platform for the studies of all these mutants and practically provided a reliable and 
informative readout. A subset of mutants (mjA’-T821 to mjA’-G825) was also tested 
in separate elongation and dinucleotide extension assays (see Chapter 2/2.7 & 2.8). 
These assays specifically mimic the transcription elongation and measure the abortive 
transcription initiation events, respectively. Results obtained with these assays 
showed that the effects of various mutants on either transcription elongation or 
abortive initiation are comparable to the results collected from the non-specific 
transcription assays (Figure 4.1A-E).  
In Figure 4.1, All 19 possible mutant variants and the wild-type were screened with 
both positive (wild-type) and negative (mjA’-T821-ter) controls using high-
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throughput TCA-precipitation assays, elongation assays and dinucleotide extension 
assays. The results are shown relative to the wild-type activity (100% activity). 
Mutant activities are plotted in blue bars with the corresponding substituted residues 
shown along the X-axis positions. Error bars shown represent standard deviations (n = 
4) based on independently expressed, assembled and assayed mutants carried out in 
parallel. The images represent both the captured elongation assay and abortive assay 
gels. The general chemical properties of amino-acid side-chains are also indicated and 
shown in different color codes. Grey arrows show the wild-type products, whereas the 
‘superactive mutants’ (mutants exhibit catalytic activities exceeding the normal wild-
type level; >120% wild-type activity) are indicated by red arrows. mjA’-T821 (Figure 
4.1A) and mjA’-G825 (Figure 4.1E) are shown to be very sensitive to mutagenesis 
that only the wild-type gives full activity (most of the mutant variant displays <40% 
activity). mjA’-Q823 (Figure 4.1C) and mjA’-S824 (Figure 4.1D) can be mutated to 
‘superactivity’ that are structurally localized in a ‘flipped-out’ position in previously 
published bacterial RNAP structures. The interactions between these two residues and 
adjacent ‘trigger-loop’ are proposed to play an important role in controlling the 
conformational change of the ‘bridge-helix’ during translocation of RNAPs (more 
details shown later in this chapter). 
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Figure 4.1A. Activity assays of M. jannaschii RNAP A’ T821→X mutants. 
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Figure 4.1B. Activity assays of M. jannaschii RNAP A’ A822→X mutants. 
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Figure 4.1C. Activity assays of M. jannaschii RNAP A’ Q823→X mutants. 
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Figure 4.1D. Activity assays of M. jannaschii RNAP A’ S824→X mutants. 
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Figure 4.1E. Activity assays of M. jannaschii RNAP A’ G825→X mutants. 
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4.1 ‘Bridge-helix’ mutants reveal a broad spectrum of changes 
in RNAP catalytic activities 
The non-specific transcription assays of all the 323 targeted mutants in the central 
portion of the ‘bridge-helix’ show a broad spectrum of RNAP catalytic activity 
phenotypes, varying from complete loss of enzymatic function to the activities 
exceeding the normal wild-type level (‘superactive mutants’). The observed 
phenotypes are due to the local changes of amino-acid side chain chemistry (e.g. gain 
or loss of electrostatic/ hydrophobic interactions) that either change the interactions 
with neighboring molecules and/or influence intrinsic structural properties of the 
‘bridge-helix’. 
Many of the residues (including T821, G825, Y826 and R829), which were proposed 
to occupy critical positions in the previously published X-ray structures, also appeared 
to be sensitive to mutagenesis in this study that cannot be substituted with any other 
amino acids (Figure 4.2). These residues are located near the active site of the RNAP 
that interact either with the rNTPs in the catalytic site (T821), or the DNA template 
strand entering the active site (T821, G825, Y826 and R829). The results obtained 
with activity assays have provided the preliminary ideas about the precise 
requirements for side-chain chemistry of several amino-acid positions, especially for 
the residues where most substitutions substantially result in loss of catalytic function. 
The targeted mutagenesis of mjA’-G825 suggest that the physical size of the side-
chain at this position play a critical role for the overall enzymatic activity. The 
activities of recombinant RNAPs containing the 19 possible mutant variants in the 
position 825 reach at the most 40% of the wild-type catalytic activity and many of the 
more bulky amino acid substitutions (F, Y, W, K, R, H) display <5% activity in non-
specific transcription assays (Figure 4.2). This is possibly because any additional 
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atoms (other than the single hydrogen) may create a physical obstacle that prevents 
the DNA template entering the active site. The phenotypes of T821 substitutions also 
show a high degree of sensitivity to variation (only the wild-type gives full activity). 
Due to the unique position of mjA’-T821 within the active site, its side-chain is placed 
in a position where the residue either interacts with the 3’-OH end of the nascent 
transcript or the base-paired rNTP in the active site (depending on the translocation 
state). The loss-of-function mutants obtained by substituting T821 with alternative 
residues containing long, charged and/or bulky side-chains may be caused by steric 
clashes and unfavorable intermolecular interactions.  
A critical requirement of a positively charged side-chain at the position 829 of M. 
jannaschii A’ has also been observed from this study, where only R829-K provides an 
active alternative (Figure 4.2). However, even this rather conservative mutant still 
displays a substantial loss-of-function. The residue R829 is placed adjacent to the 
DNA template strand that confirms the observation that a positively charged amino-
acid may play an essential role in this position. However, since there is also evidence 
suggesting that this position may be involved in stabilizing an alternative 
conformation of the ‘bridge-helix’ (Vassylyev, Sekine et al. 2002), I will present 
further evidence to show that R829 can be replaced with a negatively charged residue 
[aspartic acid (D)] in particular double-mutants and still provide a reasonable level of 
catalytic activity (see later part of this chapter for further details). 
Surprisingly, other residues that appear to be in spatially constrained positions in the 
previously published X-ray structures can be substituted with a broad range of 
chemically diverse set of side-chains without substantial loss of function. Previous 
studies of the crystals of the RNAP elongation complexes suggest that the position 
A822 would be unable to accommodate large side-chains due to steric clashes with 
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the DNA template strand (Cramer, Bushnell et al. 2001; Gnatt, Cramer et al. 2001). 
However, results obtained with this project have shown an unexpected high degree of 
tolerance at this position where substitutions of alanine with large/bulky/hydrophobic 
side chains (N, Q, F, Y) may only cause a moderate decrease of activity relative to the 
wild-type level (Figure 4.2). There is also another unexpected tolerance to proline 
substitutions at certain ‘bridge-helix’ positions observed in this project. As an α-
helical structure disruptor, the imino acid proline (P) is fundamentally incapable of 
participating in the middle portion of the ‘bridge-helix’ conformations. As expected, 
the proline substitutions in many ‘bridge-helix’ positions cause a substantial loss of 
activity. However, there remains a detectable activity for some of the positions (e.g. 
T821 & A822); and the position 824 displays an unanticipated increase of activity 
(>160% wild-type activity in non-specific transcription assays) when the serine (S) is 
replaced with proline (Figure 4.2). We can therefore conclude that there is no absolute 
requirement for the ‘bridge-helix’ to maintain a continuous α-helical conformation 
that has been previously observed consistently in the structural studies of elongation 
complexes (Gnatt, Cramer et al. 2001; Wang, Bushnell et al. 2006; Vassylyev, 
Vassylyeva et al. 2007a). 
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Figure 4.2. Graphic overview of the mutant activities from high-throughput non-
specific transcription assays. The vertical axis shows the identity of the amino-acid 
residues located along the M. jannaschii ‘bridge-helix’ (from L814 to R830). The 
horizontal axis marks the amino-acid substitutions for each of these positions. The 
specific transcriptional activities of each mutant (relative to the wild-type activity, 
100%) are color coded according to the color scale on the right-hand side, ranging 
from inactive (dark blue 0%) to ‘superactive’ (dark red, 200%). Every single mutant 
was assayed in a quadruplicated manner. 
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4.2 ‘Bridge-helix’ favors a kinked conformation at certain 
positions to be ‘superactive’ 
A class of mutants with unexpected increased activities (25 out of 323 single 
substitution mutations) was uncovered by the high-throughput screen. This 
phenomenon, which exceeds the normal wild-type level, will be referred to as 
‘superactivity’ in this study. The mutations causing the catalytic enhancement are 
predominantly clustered in the D816, Q817, V819, Q823 and S824 positions. 
However, certain substitutions resulting in moderately increased catalytic activities 
were also observed in the position R820, A822 and M827 (Figure 4.2). Since the side 
chains of residue D816, Q817, V819, Q813, S824 and M827 all point away from the 
RNAP active site, it is very unlikely that the ‘superactivity’ may be induced by any 
mutation-stimulating events in the catalytic center. Taking the localized positions of 
the ‘superactive’ mutations into consideration, it becomes clear that such observed 
phenotypes must be caused due to conformational changes of the ‘bridge-helix’ 
structure itself and/or due to an altered intermolecular interaction pattern (e.g. 
interactions with adjacent ‘trigger-loop’ domain).  
The residues Q823 and S824 (both can be mutated to ‘superactivity’) are orthologs of 
Thermus thermophilus β’ (tthβ’-) D1090 and S1091, which have been shown to cause 
the kink in the bacterial ‘F-bridge’. These two residues are in a ‘flipped-out’ position 
in certain bacterial RNAP structures that disrupt the local hydrogen-bonding pattern 
of the α-helical structure (Zhang, Campbell et al. 1999; Vassylyev, Sekine et al. 2002; 
Tuske, Sarafianos et al. 2005). Previous studies of the bacterial RNAP structures have 
shown that tthβ’-D1090 (Q823 in M. jannaschii) stabilizes the kinked conformation 
of the ‘bridge-helix’ through specific hydrogen bonds with a nearby invariant residue, 
tthβ’-R1096 (ortholog of mjA’-R829, Figure 4.3). Such aspartate-arginine interactions 
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are known to be of unusual strength, highly directional and thus particularly suitable 
to stabilize intermolecular interactions. The mjA’-Q823-D mutant therefore appears to 
mimic the aspartate-arginine stabilization pattern that is previously observed in the 
kinked conformation of the bacterial ‘F-bridge’. Taking the ‘superactive’ phenotype 
of the mjA’-Q823-D mutant (>140% wild-type activity in non-specific transcription 
assays) and the previously proposed ‘bridge-helix’ mechanism into consideration, it 
seems that the kinked ‘bridge-helix’ is a highly favorable conformation for the 
nucleotide addition cycle.  
 
 
Figure 4.3. The functional interaction between tthβ’-D1090 (mj-A’-Q823) and 
tthβ’-R1096 (mjA’-R829) positions. Panel A represents the ‘bridge-helix’ 
conformations as seen in different X-ray structures. The α-helix is shown as a green 
cartoon structure with the species and PDB access numbers displayed below. 
Residues tthβ’-D1090 and tthβ’-R1096 are shown as stick structures in red and blue, 
respectively. Panel B is the model of T. thermophilus ‘F-bridge’ kink (PDB # 1IW7). 
The interaction between tthβ’-D1090 and tthβ’-R1096 is indicated as space-filling 
models and the surrounding helical structure is shown in green. The ‘flipped-out’ 
D1090 residue juxtaposes its side-chain opposite R1096 and the resulting contact 
stabilizes the kinked conformation.  
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Another ‘superactive’ mutant, mjA’-S824-P, is also likely to mimic a kinked ‘bridge-
helix’ conformation in an unexpected accurate manner. As described previously, 
when present in the middle portion of an α-helix, proline residues distort the helical 
structure by consistently introducing a highly localized and permanent kink of ~26° 
(Barlow and Thornton 1988). Results obtained from this study show that the location 
of proline residues within the ‘bridge-helix’ has to be very precise to give a 
‘superactive’ effect since proline substitutions at most positions lead to substantial, or 
even complete loss of activity (Figure 4.2). 
Since the increased level of catalytic activity could be the result of a decreased 
abortive transcription rate favoring promoter clearance (Guillerez, Lopez et al. 2005), 
it is possible that the ‘superactivity’ observed in the Q823 and S824 mutants could be 
the result of a shift in equilibrium between the abortive initiated and fully synthesized 
transcripts. However, the dinucleotide extension assays confirmed that these 
‘superactive’ mutants also displayed comparable increases in the abortive 
transcription (RNAPs harboring Q823-D and S824-P show ~125% and 165% wild-
type activity in abortive initiation assays; Figure 4.1 C & D). The results, therefore, 
show that the kinked structure of the ‘bridge-helix’, which is predicted to be induced 
by ‘superactive’ Q823-D and S824-P, does not appear to interfere with the proposed 
‘scrunching’ mechanism (in which RNAP remains fixed on promoter DNA and pulls 
downstream DNA into itself and past its active site during abortive initiation; 
Kapanidis, Margeat et al. 2006; Revyakin, Liu et al. 2006). In addition, a parallel 
assay mimicking an elongation complex was used to investigate how these 
‘superactive’ mutants affect the elongation properties. Since the results obtained are 
reasonably consistent to the activities shown in the abortive assays (Figure 4.1 C & D), 
it is clear that the increased production of transcript is solely a consequence of the 
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enhanced catalytic activity of the RNAP active site. Moreover, the wild-type enzyme 
and the ‘superactive’ ‘bridge-helix’ mutants were preliminarily tested for mis-
incorporation of dTTP in non-specific, abortive and elongation assays and the results 
showed no detectable loss of selectivity in rNTP incorporations (R.O.J.W. 
unpublished data). 
According to the experimental evidences shown above, we thus conclude that the 
‘superactive’ mutants (Q823-D and S824-P) are capable of creating and/or stabilizing 
a localized kink in a precisely defined position of the ‘bridge-helix’. Since these 
mutations appear to cause a similar effect on the overall ‘bridge-helix’ conformation 
but with different structural principles, double mutant combinations were investigated 
to see whether further gain-of-function is achievable. Constructs containing Q823 and 
S824 ‘superactive’ substitutions in combinatorial configurations were used to create 
double mutants, Q823-D/S824-P and Q823-E/S824-P. However, the double mutants 
showed similar levels of elevated activity as Q823-D and S824-P on their own, 
demonstrating that the ‘superactive’ mutations in the ‘bridge-helix’ modulate the 
catalytic center in a rate-limiting manner and no further gain-of-function is possible 
(Figure 4.4).  
A final piece of evidence in support of an interaction between Q823 and R829 is 
based on another set of double mutants. Since the interactions between tthβ’-D1090 
and tthβ’-R1096 stabilize the kinked conformation of the α-helical structure (Figure 
4.3), we re-created this interaction by switching the positions of these residues to see 
whether similar ‘superactivity’ would be achievable. Although Q823-R/R829-D was 
inactive, another mutant Q823-H/R829-D revealed ~50% of wild-type activity (Figure 
4.5). Taking into account the fact that R829-D is completely inactive in the single 
substitution screen (Figure 4.2), it is a remarkable observation that the presence of 
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histidine at position 823 could rescue the mutant R829-D phenotype, which further 
proves the predicted local interaction between these two positions during ‘bridge-
helix’ kinking.     
The structural evidences for a kinked conformation of ‘bridge-helix’ were only 
previously observed in bacterial RNAPs (Zhang, Campbell et al. 1999; Vassylyev, 
Sekine et al. 2002; Tuske, Sarafianos et al. 2005), the data obtained with this project 
therefore provides the first evidence for the existence of a common link between the 
distinct ‘bridge-helix’ conformations in bacterial and archaeal RNAPs. Since the 
archaeal ‘bridge-helix’ is more similar to its eukaryotic counterpart, we can thus make 
an argument that localized ‘bridge-helix’ kinked conformation may participate in part 
of the normal RNAP catalytic cycle across the entire evolutionary range. 
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Figure 4.4. Activity assays of Q823 & S824 double mutants. (A) The abortive 
transcription assays showing the incorporation of [α-32P]-UTP into abortive 
dinucleotide extension products on activated calf thymus DNA template. (B) 
Elongation assays on a DNA-RNA scaffold. The identity of each mutant is marked. 
The double mutants do not show any further gain-of-function in comparison with the 
single ‘superactive’ mutants. 
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Figure 4.5. Activity assays of Q823 & R829 double mutants. Images show the 
results of both abortive and elongation transcription assays of Q823 & R829 double 
mutants. Q823-R/R829-D is completely inactive. However, the histidine residue at 
position 823 could rescue the R829-D null mutant phenotype where the double mutant 
Q823-H/R829-D displays 49% (abortive assays) and 52% (elongation assays) of wild-
type activity.  
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Chapter 5 Discussion 
5.1 Protein purification 
The subunits of M. jannaschii RNAP and the corresponding transcription factors TBP 
and TFB were produced recombinantly in typical E. coli system and purified through 
various chromatographic methods. Soluble and thermo-stable subunits from M. 
jannaschii were easily purified, as heat-inactivation of the whole-cell lysates results in 
denaturation of most E. coli proteins. Insoluble subunits, such as the large subunits 
A’/A’’ and B’/B’’, were also easily purified as inclusion bodies. The large subunit 
pellets could be separated from soluble E. coli proteins and denatured with near-
saturating urea (~8.3M) before ion-exchange chromatography. Surprisingly, large 
subunits usually exhibited the presence of extra protein bands after purification, which 
were normally co-purified with the full-length products and were extremely difficult 
to separate from each other. The stability of banding patterns of these subunits over 
time suggests that these unexpected bands are truly partial products but not the results 
of degradation (Figure 5.1). These partial products are most likely to be produced due 
to premature termination of RNA transcripts, which generally happens to genes longer 
than 1kb. As the archaeal genes are not native in E. coli cells, premature termination 
of the transcripts may also occur due to poor codon usage. 
Since the mjA’ subunits form insoluble inclusion bodies, they were purified from the 
lysates by robotic centrifugation and automatic supernatant decanting. The retained 
inclusion bodies were recovered by solubilizing them directly in a low ionic-strength 
buffer containing saturated urea. The mjA’ subunits were detected to be >95% pure 
and were ready for assembly into recombinant mjRNAPs (Nottebaum, Tan et al. 
2008). The protein concentrations of the purified subunits were automatically 
determined on the robotic platform using BCA protein assays; and as an optional step, 
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the proteins were characterized further by high-throughput electrophoresis (L.T. & 
R.O.J.W. unpublished data). The simplicity of the automated procedure ensures an 
exceptionally high degree of consistence in the quality and quantity of the 
recombinant subunits prepared in this manner, thus contributing greatly to the ability 
to compare the activities of the recombinant RNAPs assembled at the next stage. 
 
 
Figure 5.1. A 10% polyacrylamide gel of recombinant M. jannaschii RNAP A’ 
mutants (the alanine substitutions of mjA’-D816 to mjA’-G825, excluding mjA’-
A818 & mjA’-A822).  The full-length large A’ subunits were normally purified with 
extra bands (labeled as the ‘partial products’) through MonoS column (BioRad). 
These co-purified proteins are believed to be partial products rather than the results of 
degradation due to the stabilized chromatographic patterns. The molecular weight of 
proteins is given in kDa.   
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5.2 In vitro assembly of recombinant Archaeal RNAP  
So far, three types of archaeal RNAPs were successfully reconstituted in our 
laboratory, those from Methanocaldococcus jannaschii, Pyrococcus furiosus and 
Nanoarchaeum equitans. There were two other failed attempts to the in vitro 
assembly of the mesophilic RNAP from Methanosarcina mazei and the thermophilic 
RNAP from Methanobacterium thermoautotrophicum. Since all the successfully 
assembled RNAPs are from the hyperthermophilic archaeal species, there is certainly 
one question to ask: why do only hyperthermophilic RNAPs refold correctly in vitro? 
Although there appears to be a high degree of sequence conservation between 
mesophilic and hyperthermophilic enzymes, a number of factors have been identified, 
which are considered to contribute to an increased stability of hyperthermophilic 
proteins (Jaenicke and Bohm 1998; Kumar, Tsai et al. 2000; Vieille and Zeikus 2001). 
These factors were initially thought to increase the number of interactive forces 
between amino acids, including additional electrostatic interactions within proteins in 
the form of salt-bridges (Perutz 1978), and thus conferred more stable secondary, 
tertiary and quaternary structures. However, the organization of these structures is 
governed by the primary amino acid sequences that does not significantly differ in 
mesophilic and hyperthermophilic proteins (Kumar, Tsai et al. 2000). Advances in 
structural biology have provided an experimental platform to directly compare the 
structures of orthologous proteins from mesophiles and hyperthermophiles at the 
molecular level. These structural studies further suggest a number of additional 
factors that may also play a role in an increased level of protein stability at high 
temperature, including increased number of charge-charge interactions (Elcock 1998), 
increased network of hydrogen bonds (Bougault, Eidsness et al. 2003), increased 
number of polar interactions (Zhou 2002), improved hydrophobic interactions 
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(Spassov, Karshikoff et al. 1995), improved hydrophobic packing (Maes, Zeelen et al. 
1999), optimized protein-solvent interactions (Spassov, Karshikoff et al. 1995), 
cofactors such as metal ions to increase structural integrity (Fujii, Hata et al. 1997), 
slightly higher α-helical content (Kumar, Tsai et al. 2000), truncation of solvent-
exposed protein loops (Wahl, Bourenkov et al. 2000) and association of oligomers 
(Byun, Rhee et al. 2007). Thus, even a number of small and subtle changes may cause 
a concerted effect that makes proteins to be resistant to unfolding at high temperature.  
Moreover, sequence analysis of subunit D revealed that a conserved series of cysteine 
residues is present in some RNAPs that could make up an iron-sulfur cluster (Fe-S) 
binding site (Hirata, Klein et al. 2008). This motif is also present in the eukaryotic 
AC40 subunit of RNAPI and RNAPIII. However, such an Fe-S cluster is not found in 
the D subunits of M. jannaschii, P. furiosus and N. equitans. Since subunit D is 
believed to be part of the assembly platform for the large RNAP subunits, it possibly 
suggests that the refolding of this Fe-S cluster is a rate-limiting stage in the overall 
assembly process of some archaeal RNAPs and may need to draw special attention in 
future refolding attempts.  
5.3 Validation of automated transcription assays 
The manual TCA-precipitation assay has been well established to measure the non-
specific transcription activity of recombinant RNAPs and yield satisfactory results. 
Since human errors may commonly arise during experimental stages that could 
possibly affect the consistency of corresponding samples, an automation system was 
considered in order to minimize human interventions and also increase the number of 
samples that could be processed in parallel. The technical obstacles for such prospects 
were overcome by the acquisition of a Theonyx robotic platform. Many possible 
sources of errors were eliminated by a stringent process of validation. A 96-well filter 
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microplate was investigated to test its ability to retain TCA-precipitated 
polynucleotide molecules. The filter microplate offered a significantly reduced 
surface area and the overall retention potential in comparison with the traditional 
25mm filter-discs. However, the reaction size (50µl) was not reduced using such filter 
plates and the efficiency of retaining insoluble 32P-labelled RNA molecules was 
proved by strong signals in the scintillation counter.  
There was another question to consider: How can we trust the scintillation counter 
that we were using? On average, the reproducibility of a series of experiments was 
within an error margin of 12%. Every individual sample in this project was repeated 
in quadruplicate at the same time and the resulting standard error was generally less 
than 5% of the average signal strength. The reliability of the scintillation counter was 
further challenged by reading the same 96-well microplates several times. There was 
an approximately 5% deviation between the values from different readouts. 
Furthermore, various amounts of scintillant were also investigated and none appeared 
to distort the relative relationships of signals towards each other.  
5.4 Functional analysis of recombinant mj-RNAP mutants 
RNAPs are powerful macromolecular devices that drive the cellular transcription 
process at a considerable speed (~1.2-1.6 kb min-1; Edwards, Kane et al. 1991). 
Although the chemical aspects of polymerase catalytic functions have been uncovered 
(Steitz 1998), there is still uncertainty concerning the mechanical aspects that link the 
catalytic steps to the movement of nucleic acid substrates through the active center. It, 
therefore, becomes very important to understand the transcription mechanisms of the 
enzymes that are capable of reaching such a high level of performance at the 
molecular level. 
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In this project, a new experimental approach is designed to systematically sample a 
substantial area of structure/function space of the M. jannaschii RNAP A’ ‘bridge-
helix’ using either of the two robotic platforms. We refer to this fully automated 
system as the ‘RNA polymerase factory’ (see Chapter 3). After extensive efforts in 
installation and adjustments, the robotic system has been trusted to provide reliable 
assistance in most of our experimental stages, including all previously developed 
protein purification and in vitro assembly methods; and allows assaying hundreds of 
mutant variants in a completely automated manner in one week without any human 
interventions (so far, the non-specific transcription assay is the only availability for 
automation). The results obtained with the ‘RNAP factory’ were found to be identical 
to the results acquired from previously described manual techniques (this conclusion 
was made according to the observations from numerous test-runs on either of the two 
robotic platforms; R.O.J.W. unpublished data).  
Many of the most informative mutants discovered in this study show remarkable new 
insights at certain ‘bridge-helix’ positions, as the experimental results collected are 
usually unexpected using prior knowledge (e.g. S824-P). A large number of complete 
or partial loss-of-function phenotypes has also been detected and considered to be 
very useful either to show the precise requirement of the side-chain chemistry at such 
positions (e.g. T821, G825 and R829) or to demonstrate the predicted intermolecular 
interactions (e.g. the local interaction between position 823 and 829). The 
extraordinary rescue effect of Q823-H/R829-D is well documented due to the unusual 
sensitivity of the R829 position (only R829-K provide ~60% of wild-type activity). 
Since a local interaction between position 823 and 829 is proposed according to the 
‘superactive’ phenotype of Q823-D mutant, the double mutant Q823-H/R829-D has 
provided further evidences for such predictions (see Chapter 4/4.2).  
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The site-directed mutagenesis strategy thus has considerable hypothesis-generating 
scope because it provides a number of data that can be interpreted, in conjugation 
with previously published structural information, to gain new insights into the 
enzymatic mechanisms. One particular noteworthy conclusion from the data presented 
in this work is the ‘all-or-nothing’ nature of many of these events. This is most clearly 
illustrated by the fact that the level of ‘superactivity’ observed with some of the most 
distinct mutants (e.g. S824-P) cannot be increased in the presence of other 
‘superactive’ mutants (e.g. Q823 & S824 double mutants; Figure 4.4). These non-
additive effects suggest that the ‘superactive’ mutations at such positions appear to 
affect the same process. According to the unexpected functional evidence shown 
previously (see Chapter 4/4.2), we can propose a highly favorable kinked ‘bridge-
helix’ conformation for the nucleotide addition cycle that has to be precisely localized 
in order to give the ‘superactive’ effects. Since the kinked ‘bridge-helix’ was only 
previously observed in a relatively small subset of RNAP crystals, it has often been 
interpreted as ‘off-pathway’ conformations. However, results obtained with this study 
prove decisively that kinked ‘bridge-helix’ conformations are in fact fully compatible 
with catalytic function and even capable of supporting catalytic rates that exceed the 
wild-type activity. We, therefore, suggest that the kinked ‘bridge-helix’ is possibly a 
‘short-lived’ intermediate conformational state of RNAP and that the enhanced 
catalytic rates observed from the ‘superactive’ mutants are the result of a bias towards 
this state.  
However, not all the observed ‘superactive’ phenotypes are exclusively caused by 
conformational changes within the ‘bridge-helix’. It may be due to the participation of 
other neighboring functional domains (e.g. the ‘trigger-loop’; Tan, Wiesler et al. 
2008). Surprisingly, the ‘bridge-helix’ residues that can be mutated to ‘superactivity’ 
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are predominantly facing away from the RNAP catalytic site. The structures of 
bacterial, archaeal and yeast elongation complexes show that the mjA’-Q823 and 
mjA’-S824 orthologs are located close to the adjacent mjA’’ ‘trigger-loop’. In order to 
investigate the possible consequences of such contacts in more details, the interactions 
between carefully selected ‘bridge-helix’ and ‘trigger-loop’ residues were also 
extensively studied in parallel using the same experimental strategy in our laboratory. 
The intermolecular contacts between ‘bridge-helix’ and ‘trigger-loop’ are achieved 
only via two successive residues: mjA’-Q823 touches a specific residue in the C-
terminus of the ‘trigger-loop’ base helix (mjA’’-I98; ‘TLC’) and mjA’-S824 interacts 
with a specific residue in the N-terminal ‘trigger-loop’ base helix (mjA’’-G72; ‘TLN’). 
Similar single amino-acid substitutions were performed on these two ‘trigger-loop’ 
positions. The results reveal an extremely unexpected pattern that none of the 19 
alternative substitutions in either ‘trigger-loop’ base helix gives any substantial drop 
of catalytic activity in the high-throughput transcription assays. In fact, most of the 
mutants cause ‘superactivity’ (only with a few exceptions) that reaches the level 
indistinguishable to the effects seen in some substitutions of the adjacent ‘bridge-
helix’ residues (Tan, Wiesler et al. 2008). Since similar activities were observed from 
substitutions with radically different chemical properties (i.e. substitutions with A, G, 
S, T, C, F, Y and R in position mjA’’-I98 display similar catalytic activity; Tan, 
Wiesler et al. 2008), it suggests that the side chain identity may play only a minor role 
for these positions but the major factors influencing the function of the ‘trigger-loop’ 
base helices may be the local stability (e.g. the local hydrophobicity/net charge 
density). Taking this evidence into consideration, we thus propose that some of the 
mutations in mjA’-Q823 and mjA’-S824 destabilize the TLC and TLN by kinking this 
part of the ‘bridge-helix’ away from the ‘trigger-loop’ base helices, therefore causing 
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conformational changes in the ‘trigger-loop’ that increase the catalytic activity. 
Similar events may also occur in other ‘superactive’ mutations located in more N-
terminal region of the ‘bridge-helix’, such as D816, Q817 and V819. However, the 
precise contact points between ‘bridge-helix’ and ‘trigger-loop’ in such positions still 
remain unclear because various ‘trigger-loop’ orientations have been shown in 
different RNAP crystal structures. Similarly, no additive effects were observed in any 
of the ‘bridge-helix’/‘trigger-loop’ ‘superactive’ double mutants, suggesting that each 
mutant affects the same process in a functionally overlapping and mutually 
independent manner. 
5.5 Future dissection of RNAP function 
The fully automated ‘RNA polymerase factory’ is believed to be a mature 
experimental approach for the characterization of a large number of RNAP variants. 
The next task is likely to extend such high-throughput site-directed mutagenesis 
approach to more terminal regions of the ‘bridge-helix’ and also include 
comprehensive analysis of the ‘trigger-loop’ residues and the active site residues that 
are predicted to contact nucleotide substrates. So far, only mutants in regions that 
have a direct influence on the catalytic activity of RNAP (e.g. the ‘bridge-helix’ 
mutants generated in this project) can be studied intensively by automation (through 
directly comparing the activities of targeted substitution variants with the wild-type 
enzyme by measuring the overall nucleotide incorporation rate; see Chapter 3.7). For 
the full characterization of the functional properties of mutants in other domains, the 
development of additional high-throughput assays (i.e. assays are able to directly 
measure the RNAP elongation rate and substrate selection) has become one of the 
major challenges that will need to be addressed in the foreseeable future.  Since most 
of the currently available manual in vitro transcription assays are gel- and 
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autoradiography based, and thus not suitable for implementation on robotic platforms. 
The development of new fluorescence-based methodologies appears to be likely to 
change this situation, but it may still need to pass through a few technical barriers 
before such assays can be fully compatible with robotic platforms.  
The site-directed mutagenesis strategy has been considered as a hypothesis-generating 
scope that information obtained from such approach can be used, in conjugation with 
previously published structural data, to gain new insights into the RNAP mechanism. 
Information on such a wide spectrum of mutants will benefit single-molecule studies 
in which RNAP variants with specific defects can be used to probe models of the 
transcription mechanism. Biophysical studies may also be included to directly probe 
and characterize RNAP active site dynamics, such as ‘bridge-helix’ and ‘trigger-loop’ 
movement, and how such movement is impacted by substrate binding and 
perturbation of RNAP structure at the near-atomic level. ‘Superactive’ mutants 
identified in this project can promote their catalytic rate more efficiently during the 
nucleotide addition cycle in vitro. However, the fact that such high levels of catalytic 
activities have been eventually eliminated during evolution, suggests a probable 
defect in their ability to regulate transcription in an accurate manner in vivo. More 
traditional assays will be required to test how transcription regulation may be affected 
in such ‘superactive’ mutants.  
Finally, this project can be further moved up to substitute a number of archaeal 
subunits and/or functional domains with their eukaryotic counterparts (e.g. those from 
RNAPII) in order to directly study the mechanism of eukaryotic RNAPs in an 
alternative way.  
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Appendix A 
Amino acid sequence alignment of Methanocaldococcus jannaschii (mj-), 
Methanobacterium thermoautotrophicum (mt-) and Saccharomyces cerevisiae (sc-) 
RNAP subunits and basal transcription factors (TBP and TFB). Archaeal subunit F is 
aligned with the Schizosaccharomyces pombe (sp-) Rpb4. 
The data are obtained from NCBI protein database and calculated with CLC Sequence 
Viewer software using following default settings: open gap penalty 10.0; extended 
gap penalty 1.0. Individual residues are shown with default color codes and the 
conservation is indicated underneath in a range from 0% to 100%. 
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Appendix B 
The standardized pattern of 24-deepwell plate layouts for mutagenized amino-acid 
positions of the M. jannaschii A’ ‘bridge-helix’. The color key is used to represent the 
chemical properties of individual amino-acid side-chains: non-polar amino-acids are 
highlighted in brown; polar/uncharged residues are shown in blue; the green color 
represents the amino-acids with aromatic cyclic rings; whereas, the positively and 
negatively charged amino-acid residues are indicated in purple and orange, 
respectively. The ‘medium-only well’ locating in different positions is used for the 
recognition of individual plate. For this project, each mutant variant is plated in a 
quadruplicated manner and the positive (wild-type) and negative (mjA’-T821-ter) 
controls are also included in each plate. 
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ABSTRACT
The in-depth structure/function analysis of large
protein complexes, such as RNA polymerases
(RNAPs), requires an experimental platform capable
of assembling variants of such enzymes in large
numbers in a reproducible manner under defined
in vitro conditions. Here we describe a streamlined
and integrated protocol for assembling recombinant
archaeal RNAPs in a high-throughput 96-well
format. All aspects of the procedure including
construction of redesigned expression plasmids,
development of automated protein extraction/
in vitro assembly methods and activity assays
were specifically adapted for implementation on
robotic platforms. The optimized strategy allows the
parallel assembly and activity assay of 96 recombi-
nant RNAPs (including wild-type and mutant
variants) with little or no human intervention within
24h. We demonstrate the high-throughput potential
of this system by evaluating the side-chain require-
ments of a single amino acid position of the RNAP
Bridge Helix using saturation mutagenesis.
INTRODUCTION
Many of the enzymes involved in molecular information
processing are large and complex molecular machines that
are assembled from a variety of subunits. Recent technical
advances in X-ray crystallography have started to yield
insights into the structure of protein complexes, such as
bacterial and eukaryotic RNA polymerases (RNAPs;
1–6). RNAPs are key components of the cellular
transcriptional machineries. The availability of high-
resolution structures of such enzymes has inspired
numerous structural models attempting to explain key
RNAP functions in mechanistic terms. Some of these
models are based on features of individual structures
[e.g. separation of the transcript from the DNA template
strand (7)], whereas other mechanisms have been pro-
posed by comparing the conformations of protein
domains in diﬀerent crystals or by co-crystallizing poly-
merases in the presence of various substrates or cofactors
(e.g. 8,9). It is important to recognize that X-ray structures
can only provide individual ‘snap-shots’ of molecular
events likely to involve considerable conformational
changes and/or short-lived intermediates. Predictions
based on such static models must therefore be tested
extensively by targeted mutagenesis of key domains (and
individual residues therein) to assess their functional
contributions (10). We believe that archaeal transcription
systems, and speciﬁcally archaeal RNAPs, provide an
ideal testing ground for the development of high-
throughput experimental strategies to obtain comprehen-
sive insights into their structure/function space. Archaea
contain a single RNAP and a reduced set of basal
transcription factors that closely resemble the eukaryotic
core RNAPII transcriptional machinery (11). Technical
obstacles preventing the in vitro assembly of catalytically
active eukaryotic RNAPs were a key factor that originally
motivated us to develop a method for the assembly of
archaeal RNAPs from recombinant subunits (12). The
fully recombinant system resulting from these eﬀorts
reproduces faithfully all known aspects of archaeal in vitro
transcription systems, including promoter-directed trans-
cription and activator-stimulated transcription (12–15).
The availability of such recombinant in vitro trans-
cription systems sets the scene for the introduction of any
desired mutation into any position within an archaeal
RNAP by incorporating a suitably mutated subunit into
the in vitro assembly reactions. Here we describe an
integrated experimental strategy that takes full advantage
of these features of the recombinant archaeal RNAP
system and allows the formulation of a high-throughput
approach by combining eﬃcient mutagenesis with a highly
automated protein puriﬁcation/in vitro assembly process.
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We scrutinized every aspect of the previously developed
in vitro assembly method to convert a long and complex
manual method into a streamlined and simpliﬁed auto-
mated procedure that is capable of producing and
assaying hundreds of individually assembled enzyme
variants per week.
MATERIALS AND METHODS
Re-engineered bacterial expression vectors for targeted
mutagenesis
The original expression vectors for the RNA polymerase
subunits A0 and B00 from the euryarchaeal hyperthermo-
phile Methanocaldococcus jannaschii (mjA0 and mjB00,
respectively) were generated by subcloning the full-
length, PCR-generated open reading frames into pET21a
(12). For this study, the pET21a-mjA0 vector was modiﬁed
by replacing the N-terminal portion of the reading frame
(NdeI-AleI) with a synthetic gene fragment (GenScript)
encoding the identical amino acid sequence, but contain-
ing codons optimized for Escherichia coli expression and
with unique restriction enzyme targets ﬂanking the Zipper
and Lid encoding sequences. The C-terminal portion
(BstBI-BamHI) of pET21a-mjA0 was also replaced with a
synthetic gene fragment (GenScript) containing optimized
codons and unique restriction enzyme targets ﬂanking the
Bridge Helix. A similar modiﬁcation (replacement of the
BseYI-EcoRI fragment with a synthetic gene construct)
was carried out on pET21a-mjB00 to allow mutagenesis of
the Fork Loop domains. Further details/full sequences/
samples of the modiﬁed constructs are available from the
corresponding author on request.
Robotic platforms
All robotic manipulations described here were carried
out on either of the two Theonyx Liquid Performers
(Aviso Trade GmbH), equipped with an 8-tip pipetting
arm, separate gripper arm, barcode reader, vacuum
manifold, microplate shaker, thermocycler, microplate
reader, 96-well microdialyzer and E-Page facility
(Invitrogen) and an integrated microplate centrifuge.
Detailed descriptions of all robotic procedures, platform
layouts and specialized hardware modiﬁcations are avail-
able from the corresponding author upon request.
Bacterial growth and harvest
Single E. coli ‘Acella’ (EdgeBio) colonies containing
wildtype or mutant pET expression constructs were
inoculated into 1.5ml of autoinduction growth medium
(16; Novagen ‘Overnight Express’) containing 100 mg/ml
ampicillin in a 24-deepwell plate. The plates were covered
with a ‘BugStopper’ venting capmat (Whatman), bar-
coded and incubated in a shaking incubator for 18 h at
378C at 250 r.p.m. The plates were then transferred to the
robotic platform (1–4 plates per run). After reading the
barcode, each plate was transferred to the robotic shaker
for 10 s (to ensure an even cell suspension) before 10 ml of
each culture were transferred to a 96-well plate for
automatically measuring the cell density at 600 nm (A600)
after a 1/10 dilution step. This step documents cultures
that either did not grow or failed to reach the expected
cell density.
Recombinant protein extraction
All procedures described subsequently were carried out on
the robotic platforms at room temperature. Nine hundred
microlitres of each bacterial expression culture were
transferred from the 24-well growth plates to a deﬁned
position in a 2.2ml 96-deepwell block and then lysed
directly, without prior centrifugation, by the addition of a
mixture of 100 ml FastBreak reagent (Promega) and 2 ml
Lysonase (Novagen). The lysates were mixed extensively
by repeated up- and down-pipetting and occasional
vortexing on the robotic microplate shaker at 5min
intervals for a total of 30min at room temperature.
Inclusion bodies were then separated from the lysate using
the robotic centrifuge (10min at 4700 r.p.m; 2300 g),
washed once with 950 ml TG100 buﬀer (25mM Tris base;
192mM glycine; pH 8.9) by vigorous robotic pipetting
and plate shaking. To ensure complete automation of the
entire procedure we developed a custom-built microplate
decanter that automatically decants the supernatants
without disturbing the inclusion body pellets (R.O.J.W.,
unpublished data). After a further centrifugation/auto-
matic decanting step the washed inclusion bodies were
solubilized by the addition of 500 ml of TG100 buﬀer
containing near-saturating urea (8.3M) by robotic pipet-
ting and plate shaking. We chose the TG buﬀer system to
provide a vast excess of free amino groups which would
compete for the carbamylation reactions that might occur
in the urea-containing in vitro assembly reactions (see
subsequently). The protein concentrations of the resulting
solubilized inclusion body preparations were measured by
mixing 10 ml with 190 ml Bicinchonic Acid (BCA) protein
assay reagent (Sigma) in a clear microplate and measuring
the absorption at 562 nm after incubation at 378C for 2 h.
Diﬀerent concentrations of bovine serum albumin (BSA)
dissolved in TG100/8.3M urea were set up at the same
time to establish a standard curve. Out of several other
assays tested, we found that the BCA assay performed
best in the presence of the high urea concentrations used
and gave an essentially linear read-out in the 0.1–10mg/ml
range. We previously used b-mercaptoethanol (15mM) in
all of our subunit puriﬁcation buﬀers (12), but this
compound interferes with the BCA assay and was
therefore omitted without any apparent loss of activity
of the recombinant subunits after in vitro assembly
(R.O.J.W., unpublished observations). Based on compar-
isons with the BSA standards and on the staining of the
puriﬁed subunits on gels we typically obtained 250 mg of
puriﬁed recombinant subunits from 900 ml expression
culture with a standard deviation in the concentrations
of individual subunit preparations of less than 10%.
Automaticassemblyof recombinantRNAPs in96-well format
A commercially available 96-well microdialysis device
(Spectrum Laboratories) was installed on top of a Hi300N
magnetic stirrer (Hanna Instruments) positioned on the
robotic platform. The dialyzer position is fully accessible
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to the pipetting and gripper arms of the robots. The
perspex lid was customized for handling by the gripper
(details available from the corresponding author). A
peristaltic pump (Watson Marlow Sci400) was calibrated
to deliver a ﬂow-rate of 1ml/min and switched on and oﬀ
under robotic control. In vitro assembly reactions were set
up in a total volume of 100 ml per dialysis well and a
dialysis membrane with a 3K cut-oﬀ point was used for all
assemblies (Spectrum Laboratories; a narrow pore mem-
brane is required to prevent the smallest subunits from
leaking into the buﬀer chamber under denaturing condi-
tions). The concentrations of the various RNAP subunits
and subunit ratios were empirically determined to yield
recombinant RNAPs displaying the same speciﬁc activities
in non-speciﬁc and factor-dependent transcription assays
as previously described for the wild-type enzyme (12). For
the example shown here (mjA0 G825-X mutagenesis set),
90 ml of a ‘Master Mix’ containing 3.2mg A00, 4.2mg B0,
6 mg B00, 7.2mg D, 8.7mg L, 6.5 mg H, 5 mg N and 3 mg P
were mixed with 10 ml of the robotically puriﬁed mjA0
mutant subunit (12 mg). The stoichiometric ratios of the
subunits required for optimal in vitro assembly most likely
reﬂect diﬀerences in the relative refolding eﬃciencies.
Under these conditions the subunits present in the
Master Mix (-A0) are rate-limiting in the assembly
reactions, thus ensuring that the added mutant mjA0
subunits are present in >2 molar excess. Any minor
variation in the concentrations of various mjA0 samples
is thus compensated for and does not aﬀect the amount
of assembled polymerase (the presence of excess mjA0 has
no detectable negative eﬀect on the eﬃciency of the
assembly reaction).
High-throughput transcription assays
The following procedures were carried out automatically
without human intervention. Non-speciﬁc transcription
assays (measuring the incorporation of a-32P-rUTP into
acid insoluble transcripts) were set up as 50 ml reactions in
a 96-well thin wall plate using reaction conditions
previously described (12,14). After incubation for 45min
at 708C (using the integrated thermocycler with heated lid)
the plate was transferred to a temperature-regulated block
maintained at 18C. The precipitation of the radiolabelled
transcripts was initiated by the addition of 150 ml 15% ice-
cold trichloroacetic acid (TCA), followed by incubation
for 30min at 18C. The precipitation reactions were then
transferred by pipetting onto a 96- GF/F glass ﬁber ﬁlter
plate (Whatman) positioned on the robotic vacuum
platform. The soluble portion of the reactions was ﬁltered
to waste. The precipitates immobilized on the ﬁlter surface
were washed eight times with 200 ml ice-cold 10% TCA to
remove traces of unincorporated nucleotides, twice with
200 ml ice-cold 95% ethanol and then dried by a ﬁnal
application of vacuum. The incorporated a-32P-rUTP
levels were measured after addition of 50 ml of scintillant
(Optiﬂuor-O) on a microplate counter (TopCount NXT,
Packard) and were found to be identical to the results
obtained with the previously described manual technique
(12,14).
RESULTS
Expression vector redesign
Structural studies of RNAPs have revealed that only a
relatively small proportion of amino acid residues are
likely to play any direct functional role in transcription
mechanisms. These residues are typically arranged within
structurally distinct domains [such as Fork Loops, Bridge
Helix, Lid, Zipper, Rudder (2,3)] that contact substrates
(DNA, RNA, nucleotides) directly and/or interact with
other protein domains within the active site (1–4,7,8).
Residues located within such domains are thus prime
targets for site-directed mutagenesis projects. Moreover,
these functional domains tend to be either inherently
unstructured [e.g. Fork and Trigger Loops (2–4)] or are
part of ﬂexible a-helical structures [e.g. Bridge Helix (1,2)
and Trigger Loop (8)] so that single amino acid substitu-
tions are unlikely to interfere with subunit assembly or
overall stability of the enzyme.
The RNAP from the archaeonM. jannaschii (mjRNAP)
contains 12 diﬀerent subunits that are structurally and
functionally highly similar to their counterparts in
eukaryotic RNAPII (11,12). A high-throughput func-
tional analysis of a particular functional domain, such as
the Bridge Helix located in the archaeal A0 subunit,
requires an eﬃcient method for creating the desired
mutants, followed by a robust method for purifying the
mutated subunits in a highly reproducible manner. The
resulting puriﬁed mutant protein preparations then need
to be combined with a ‘master mix’ of all other essential
subunits and assembled into separate recombinant
RNAPs. Finally, the enzymes containing the mutated
subunits need to be assayed and compared to the wild-
type polymerase to assess the phenotypic consequence of
the introduced mutations.
We started the design of the high-throughput assembly
strategy by redesigning the previously used bacterial
expression vectors encoding the mjA0 and mjB00 subunits
(12). These two subunits include many of the identiﬁed
functional motifs surrounding the active site (mjA0:
Zipper, Lid, Rudder, Switch-2, Bridge Helix; mjB00: Fork
Loop 1, Fork Loop 2; Figure 1a). The redesigned
sequences were codon-optimized for optimal translation
eﬃciency in E. coli, and also contain unique 6- and 8-bp
target sites for restriction enzymes that ﬂank the nucleo-
tide sequences encoding the various functional motifs
(Figure 1b). The introduced restriction enzyme sites are
silent, i.e. encode the ‘wild-type’ primary amino acid
sequence of the encoded proteins. Cutting these modiﬁed
expression vectors with two restriction enzymes ﬂanking a
particular functional domain releases a short piece of
double-stranded DNA and allows this sequence to be
replaced by a double-stranded synthetic oligonucleotide
encoding the desired codon replacement(s) (Figure 1c).
Using this method, we have up to now successfully created
systematic substitution mutants in several RNAP motifs,
including Fork Loop 1 and 2, Lid, Zipper and the Bridge
Helix (L.T., D.T., H.C. and R.O.J.W., unpublished
results). Apart from the ease of creating a variety of
mutations, one of the main advantages of this method of
creating mutants is that it allows the saturation
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mutagenesis of a short region (typically 30–80 nt, depend-
ing on the length of the chosen motif) without aﬀecting
any of the other regions outside the targeted area. This
mutagenesis strategy therefore oﬀers many advantages
over frequently used ‘shotgun’ mutagenesis methods, such
as error-prone PCR (17), by limiting the mutagenic
changes to distinct regions of an open reading frame.
High-throughput expression and purification of RNAP
subunit variants
The previous section described an approach capable of
creating a broad range of mutations restricted to ‘func-
tional’ residues. The resulting bacterial expression vectors
encode recombinant RNAP subunits (mjA0 or mjB00) that
contain a variety of predetermined mutations in one or
more residues. This is, however, only the ﬁrst step of a
more complex procedure since the mutant subunits need
to be assembled in the presence of all other essential
subunits into an intact recombinant RNAP before the
functional consequences of a particular mutation can be
assessed. These robotically implemented procedures take
place in parallel (up to 96 independent puriﬁcation/
assemblies per run) to maximize consistency and to
create optimal conditions for functional comparisons.
In addition, the technical solutions outlined below take
full advantage of eﬀorts to miniaturize protein expression/
puriﬁcation methods and the extensive use of automation/
robotic capabilities. A ﬂowchart that summarizes the
entire sequence of expression/puriﬁcation procedures is
shown in Figure 2.
The need for processing a large number of expression
constructs resulting from the mutagenesis strategy
described above preclude the previously described meth-
ods of growth of bacterial cultures on a ‘preparative’ scale
(typically 0.5–2.0 l), followed by sonication and chromato-
graphic puriﬁcation of the recombinant subunits (12).
Instead, by growing the constructs in 24-deepwell plates
containing autoinduction medium (16) we were routinely
able to obtain 250 mg of recombinant wild-type or
mutant mjA0 and mjB00 subunits from 900 ml overnight
cultures at a satisfactory level of purity using robotic
procedures. Brieﬂy, after transfer to a 96-deepwell culture
plate, 900 ml of each bacterial expression culture were lysed
directly (i.e. without centrifugation) by the addition of a
detergent/lysozyme/nuclease mixture. Since the mjA0 and
mjB00 subunits form insoluble inclusion bodies they can be
puriﬁed from the lysate by robotic centrifugation and
automatic supernatant decanting. The retained inclusion
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Figure 1. Redesign of the bacterial expression vectors. (a) Schematic diagram of the redesigned coding regions of the mjA0 and mjB0 0 bacterial
expression vectors. The full-length open reading frames are shown with the codon-optimized sequences in light blue. The position of the sequences
encoding key functional RNAP domains are shown in color (Zipper, Lid, Rudder, Switch-2 in red, Bridge Helix in dark green and Fork Loops in
blue). The numbers refer to nucleotide positions. (b) Original and redesigned sequence encoding the Bridge Helix domain and surroundings (positions
2281-2550 in the mjA0 open reading frame). The original nucleotide sequence (as found in the M. jannaschii genome; 23) is shown on the top line with
the redesigned sequence (starting at the BstBI site) beneath. The silently introduced restriction sites ﬂanking various portions of the Bridge Helix-
encoding sequence are in red, whereas other sequence alterations that improve codon usage in E. coli are shown in light blue. The amino acid
sequence encoded is shown in single-letter code in black and the Bridge Helix primary sequence is highlighted in green. (c) Example of mutagenic
oligonucleotides for creating targeted substitutions in Bridge Helix residues mjA0-G825. The two strands are designed to hybridize to each other to
create a double-stranded ‘cassette’ bearing single-stranded extensions (shown in red) suitable for ligating into cloning vectors cleaved with suitable
restriction enzymes. The cassettes shown have been used to replace the wild-type Bridge Helix sequence between the SﬁI and SbfI sites (as shown in
panel B) with a sequence containing a single randomized codon (shown in purple; 18).
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bodies are recovered by solubilizing them directly in a low
ionic-strength buﬀer containing saturated urea. At this
stage, the mjA0 or mjB00 subunit preparations are >95%
pure and are ready for assembly into recombinant
RNAPs. The protein concentrations of the puriﬁed
subunits are automatically determined on the robot
using a colorimetric assay and, as an optional step the
proteins can be characterized further by high-throughput
electrophoresis (Supplementary Figure S1). The simplicity
of the automated procedure ensures an exceptionally high
degree of consistence in the quality and quantity of the
recombinant subunits prepared in this manner, thus
contributing greatly to the ability to compare the activities
of the recombinant RNAPs produced at the next stage.
High-throughput in vitro assembly of recombinant RNAP
variants
Active archaeal RNAP can be reconstituted by mixing the
various subunits in appropriate ratios under denaturing
conditions (6M urea), followed by the time-controlled
removal of urea by dialysis against buﬀers containing
decreasing urea concentrations (12,15). The originally
described methods were time-consuming (because the
buﬀers were changed manually according to a strictly
deﬁned timetable) and low-throughput (parallel assembly
of only a few recombinant RNAP preparations per
experiment). In addition, variations in the assembly
conditions (e.g. due to diﬀerences in protein/buﬀer
preparations) contributed to poor quality control in such
procedures. We therefore introduced two signiﬁcant
technical changes aimed at increasing throughput and
reproducibility. First, we changed the dialysis set-up by
using a microdialyzer device on the robotic platform that
allows the in vitro assembly of up to 96 recombinant
RNAPs in parallel (Figure 3a). The dialysis wells on the
microdialyzer are arranged in the standardized 96-well
format that facilitates the robotic transfer of liquids in and
out of the dialysis block. Each well typically holds 100 ml
of dialyzate that is separated from a lower communal
buﬀer chamber by a dialysis membrane. The communal
buﬀer chamber contains inlet and outlet ports that allow
dialysis buﬀer from an external supply to be pumped
through the chamber (Figure 3a). This is an important
consideration in light of the other modiﬁcation we made in
the procedure: instead of manual changes of dialysis buﬀer
to lower the urea concentration during the assembly
reaction we decided that the reproducibility of the
procedure could be improved substantially if the buﬀer
changes were carried out automatically (similar to an
independently developed method; 18). We therefore
modiﬁed the renaturation protocol by initially ﬁlling the
chamber with 200ml of buﬀer containing 6M urea. The
RNAP subunit mixtures are then robotically pipetted into
the wells and dialyzed against the 6M urea buﬀer. After
1 h a pump is switched on under robotic control to pump
urea-free buﬀer into the chamber at a low rate (typically
1ml/minute). The urea-free buﬀer is immediately mixed
with the 6M urea buﬀer in the chamber by a magnetic
stirrer and excess liquid is allowed to drain through the
outlet port. This simple set-up therefore leads to a slow
and continuous dilution of the urea concentration in the
dialysis buﬀer in the lower chamber, resulting in a
corresponding drop of the urea concentration in the
RNAP subunit mixtures located across the dialysis
membrane. Over a period of around 16–17 h the urea
concentration in the dialysis chamber approaches zero and
the assembly reaction is complete (Figure 3b). The
assembled recombinant RNAPs are robotically pipetted
out of the dialysis wells and transferred to 96-well
microplates for immediate use in various functional
assays. The robotic systems carrying out these procedures
thus constitute a genuine ‘RNA polymerase factory’
capable of purifying and assembling up to 96 recombinant
archaeal multi-subunit complexes with little or no human
intervention.
Case study: saturation mutagenesis ofmjA’-G825
We demonstrate the eﬀectiveness, reproducibility and
high-throughput potential of the RNA polymerase factory
strategy by showing examples of results obtained by
saturation mutagenesis of a single residue of the Bridge
Helix of archaeal RNAP. Brieﬂy, the Bridge Helix is a
highly conserved structure (Figure 4a) spanning the cleft
near the active site in bacterial, archaeal and eukaryotic
multi-subunit RNAPs (1–4). It is thought to play an
important (though still controversial) role during the
RNAP transcription cycle by deﬁning the position of
the template strand and of the DNA/RNA hybrid in the
Functional Assays
α-32P-rUTP incorporation
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96-well In Vitro Assembly
High-Throughput Dialysis
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Figure 2. Flow diagram of the automated subunit puriﬁcation and
assembly process. See text for further details.
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catalytic site (Figure 4b). Inspection of the yeast RNAPII
X-ray structure of an elongation complex (7; PDB #1SFO)
suggests that an evolutionary invariant residue (scRPB1-
G835 in yeast RNAPII, orthologous to mjA0-G825 in
M. jannaschi; Figure 4a) may have been speciﬁcally
selected for the small size of its side chain to allow an
unimpeded passage of the DNA template strand into the
active site. The available structural data predicts that any
other amino acid substitutions in this particular location
would result in decreased catalytic activity due to steric
clashes between the larger side chains and the phospho-
diester backbone of the DNA template strand. To test this
hypothesis we created a set of mjA0 mutants containing all
19 possible amino acid substitutions (the ‘mjA0 G825-X’
set) by substituting the SﬁI-SbfI fragment of the rede-
signed mjA0 expression vector with a double-stranded
synthetic oligonucleotide containing a randomized codon
(19) in the position encoding G825 (Figure 1c). A
complete set of amino acid substitutions in G825 was
selected from 60 randomly picked clones and by cloning
double-stranded oligonucleotides designed to contain any
missing substitutions. Plasmids encoding the mjA0 G825-X
subunit variants were grown in expression strains and
processed by the RNA polymerase factory. The results
obtained conﬁrm that the size of the side chain does
indeed appear to play a key role for the residue at position
825 (Figure 4c). The activities of recombinant RNAPs
containing the other 19 possible residues in this position
reach at the most 40% of the wild-type catalytic activity
and many of the more bulky amino acid substitutions
(F, Y, W, K, R, H) result in <5% activity in non-speciﬁc
transcription assays. The wide dynamic range of repro-
ducible activity measurements demonstrated by the mjA0
G825-X mutant set show that the RNA polymerase
factory is a robust experimental tool capable of providing
functional data at an unprecedented speed and accuracy.
DISCUSSION
The ability to routinely produce and assay up to 96
recombinant RNAPs within 24 h in a highly automated
manner has many advantages. The most obvious advan-
tage is that this system is capable of testing sample
numbers that exceed the capability of most human
laboratory workers, especially if carried out on a
continuous basis over longer periods. The increased
throughput translates into an ability to screen a larger
number of mutants (e.g. a library of random mutants
spread over a large segment of a subunit) for particular
functional properties using a variety of automated assays.
Alternatively, the ability to process a substantial number
of samples can be used to measure the activity of a smaller
number of mutants with a high degree of accuracy by
increasing the amount of information available for
statistical analysis. In the examples shown here, it is
clear that a comparison of various mutant and wild-type
activities can be achieved with a high degree of accuracy
due to the optimized and robust design of the procedure.
A slightly less obvious (but in our view equally
important) key feature of the RNA polymerase factory
is that the robotic work ﬂow does not merely speed up a
particular subset of steps within a long protocol, but
actually encompasses the entire procedure. We have even
gone as far as eliminating a rather trivial human
intervention (decanting of supernatants from deep-well
plate after centrifugation) by constructing a custom-built
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Figure 3. Robotic microdialysis set-up for assembly of recombinant RNAPs. (a) The photograph shows the placement of the 96-well microdialysis
device on the robotic platform. A magnetic stirrer is sunk into the platform with full manual access to the stir speed control dial. The lid of the
microdialysis device is held by the gripper arm of the robot during the loading and removal of the assembly reactions. On the left hand side, the
peristaltic pump controlling the ﬂow/dilution rate of the dialysis buﬀer can be seen. (b) Calculated urea concentration of the dilution of 200ml 6M
urea-containing buﬀer with urea-free buﬀer at a ﬂow of 1ml/min. After 17 h, the urea concentration in the dialysis buﬀer has eﬀectively fallen to
zero. The change of urea concentration (dc) over time (dt) can be expressed as a diﬀerential function (dc/dt) that is equal to the dilution (-D) of the
initial concentration (c0) of urea according to the following equation ct= c0 e Dxt [D, Dilution (i.e. ﬂowrate/volume); ct, urea concentration at time
t; e, Euler’s constant].
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device speciﬁcally for the purpose of removing a possible
source of human error (R.O.J.W., unpublished data).
Using the procedure as currently implemented it is
therefore possible to start with a bacterial expression
strain (containing a plasmid with an easily veriﬁable DNA
sequence) and to end up with a fully assembled RNAP
and an activity result within 24 h. All the intermediate
steps are carried out on robotic platforms, thus essentially
eliminating the possibility of error and/or sample mix-ups.
In the worst case scenario, any unexpected or questionable
result can be easily checked by repeating the process and,
ultimately by checking the DNA sequence of the expres-
sion clone(s) used. The high degree of reproducibility and
comparability observed and documented is also due to the
fact that variants located within a single subunit (such as
the Bridge Helix mutants shown in Figure 4) are
assembled with a constant cocktail of all the other
subunits, which ensures a consistency not only within a
single experiment, but also between independent robotic
runs.
In summary, the robotic platform for the automated
puriﬁcation of mutant RNAP subunit variants, combined
with reproducible methods for assembling them into
recombinant RNAPs, provides a powerful new tool for
carrying out a detailed analysis of various functional
domains. The time-consuming nature of studying the
eﬀects of mutations in the context of multi-protein
complexes means that conventional mutagenesis studies
are typically restricted to deleting whole domains, ‘alanine
scanning’ (20), or the replacement of a small number of
key residues with a few selected substitutions. The robotic
RNA polymerase factory approach eliminates all the
bottlenecks typically encountered in the manual procedure
and thus increases experimental throughput by at least
one order of magnitude. This enhanced capacity has
encouraged us to initiate high-throughput mutagenesis
studies based on hundreds of site-speciﬁc and random
mutations in various functional domains of archaeal
RNAPs. In preliminary work, we have already obtained
several unexpected results that would probably have gone
undetected with the conventional manual approaches
(R.O.J.W. et al., unpublished observations). This shows
that this experimental strategy, although initially driven
by an assumption-free systematic mutagenesis process, has
a high degree of ‘hypothesis-generating’ potential, similar
to other current structural genomics endeavors (21).
One of the major challenges that will need to be
addressed in the foreseeable future is the development of
new types of high-throughput assays capable of analyzing
the functional properties of the large number of mutants
that can be generated by the RNAP factory approach. For
studying mutants in regions that have a direct inﬂuence on
the catalytic activity of the polymerase (such as the Bridge
Helix example described here), relatively simple assays
capable of measuring overall nucleotide incorporation can
be used to compare the activities of targeted substitutions
directly with the wild-type enzyme (Figure 4 and R.O.J.W.
et al., unpublished observations). It is, however, likely that
the full characterization of the functional properties of
mutants in other domains will depend on the development
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Figure 4. Saturation mutagenesis of mjA0-G825. (a) The sequence alignment shows part of the central and C-terminal region of the Bridge Helix
[Hs, Homo sapiens RPB1 (positions 845–863); Sc, Saccharomyces cerevisae RPB1 (positions 822–840); Mj, M. jannaschii A0 (positions 812–830)]. Bold
residues are identical in all three species and the residues orthologous to mjA0-G825 are marked by an yellow box. (b) The position of the glycine
residue in yeast RNAPII corresponding to mjA0-G825 is shown in yellow. The Bridge Helix (including the residues aligned in a) is in gray and the
backbone of the DNA template strand is shown in light blue. Note the close spatial proximity between the G825 side chain and the phosphodiester
backbone of the DNA [data from PDB #1SFO (5) visualized with Cn3D; www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml]. (c) Transcription
activity assays of RNAP variants containing all 19 possible substitutions of mjA0-G825 carried by the RNA polymerase factory. The two columns on
the right represent the positive (WT; wild-type) and negative (RNAP containing a mjA0-T821 termination codon substitution) control reactions.
Error bars shown represent standard deviations (n=4) based on independently expressed, assembled and assayed mutants carried out in parallel.
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of additional high-throughput assays designed to test
speciﬁc subfunctions of the enzymes (e.g. elongation rate).
Most of the currently available manual in vitro transcrip-
tion assays are gel- and autoradiography based (and thus
not suitable for implementation on robotic platforms), but
the development of new ﬂuorescence-based methodologies
(e.g.22) is likely to change this situation in the foreseeable
future. The capacity for producing large volumes of
functional data generated by such high-throughput
robotic approaches will supplement available structural
insights and may eventually need to be systematically
stored in standardized electronic formats similar to the
current literature, sequence and structural databases.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR online.
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Abstract
Background: Cellular RNA polymerases are highly conserved enzymes that undergo complex
conformational changes to coordinate the processing of nucleic acid substrates through the
active site. Two domains in particular, the bridge helix and the trigger loop, play a key role in
this mechanism by adopting different conformations at various stages of the nucleotide
addition cycle. The functional relevance of these structural changes has been difficult to assess
from the relatively small number of static crystal structures currently available.
Results: Using a novel robotic approach we characterized the functional properties of 367
site-directed mutants of the Methanocaldococcus jannaschii RNA polymerase A′ subunit,
revealing a wide spectrum of in vitro phenotypes. We show that a surprisingly large number
of single amino acid substitutions in the bridge helix, including a kink-inducing proline
substitution, increase the specific activity of RNA polymerase. Other ‘superactivating’
substitutions are located in the adjacent base helices of the trigger loop.
Conclusions: The results support the hypothesis that the nucleotide addition cycle involves a
kinked bridge helix conformation. The active center of RNA polymerase seems to be
constrained by a network of functional interactions between the bridge helix and trigger loop
that controls fundamental parameters of RNA synthesis.
Background
RNA polymerases (RNAPs) are central components of the
cellular transcriptional machineries that are targeted by
numerous regulatory proteins to fine-tune the expression of
genomes in a highly controlled manner. It is therefore
important to study the functional properties of RNAPs in
order to understand how these are modulated during the
various stages of the transcription cycle.
Combined insights from biochemical, genetic and structural
studies have led to the unambiguous identification of several
structural motifs that participate in the key enzymatic
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processes of RNAPs (reviewed in [1-4]). Among these, the
bridge helix, which is approximately 35 amino acids long, is
one of the most prominent features of the active site of all
cellular RNAPs (Figure 1a,c). Its primary sequence is highly
conserved across the entire evolutionary range, including
bacteria, archaea and eukaryotes (Figure 1b and Additional
data files 1b-17b). Structural studies suggest that the bridge
helix guides the template DNA strand into the active center
and positions the DNA-RNA hybrid relative to the catalytic
site. In many RNAP structures the bridge helix is a
continuous and gently curved α helix (see, for example,
[5-9]). In contrast, in some bacterial RNAP structures the
bridge helix is distinctly kinked in the vicinity of the
catalytic site [10-12], and recent yeast RNAPII structures
have also revealed helical irregularities in more amino-
terminal locations [7,13] (Figure 1d). Periodic conversions
from the straight to the various kinked bridge helix confor-
mations during each ribonucleotide addition step could, in
principle, provide a mechanical basis for translocating the
nucleic acid substrates through the active site in single
nucleotide steps [5,6,14,15] (Figure 1a,c). Structural changes
in an adjacent domain, the trigger loop, are thought to be
responsible for influencing the bridge helix conformations
[16,17]. Recent models thus emphasize a direct role for the
trigger loop in controlling the catalytic functions of RNAPs
through conformation-specific contacts with the NTP in the
nucleotide insertion site [7,8,18]. The crucial role of the
combined bridge helix/trigger loop mechanism in RNAP
function is most clearly demonstrated by the inhibitory
action of bacterial antibiotics and eukaryotic toxins that
block bridge helix and trigger loop movements [12,13,
19-21] (Figure 1b).
Although the key domains involved in the translocation of
the substrates through the RNAP catalytic site are thus
unambiguously identified, there is still a lot of uncertainty
concerning the detailed molecular events occurring in the
active site during RNA synthesis. This lack of understanding
is mostly due to the fact that the current models are based
on a small number of ‘snapshots’ of relatively stable struc-
tures that can be studied after crystallization. RNAPs are,
however, complex macromolecular machines that undergo
multiple conformational changes during the nucleotide
addition cycle, which may be too unstable and short-lived
to be captured in a rigid crystal structure. We therefore
decided to learn more about the functional aspects of the
bridge helix/trigger loop mechanism by systematically
mutating residues located in critical positions relative to the
active site. We employed an archaeal RNAP model system,
derived from the hyperthermophilic euryarchaeon Methano-
caldococcus jannaschii, to reconstitute an active enzyme from
separate recombinant subunits in vitro [22,23]. Archaeal
RNAPs are structurally and functionally very closely related
to bacterial and eukaryotic RNAPIIs and thus provide an
ideal experimental platform for a structure-function
approach that can exploit the large body of data obtained
in these mainstream experimental systems [9,24]. The
ability to reconstitute recombinant RNAPs in vitro allows
targeted mutation(s) to be introduced at predetermined
locations using efficient DNA cloning and protein
expression technologies. This approach, in combination
with recently developed robotic methods for assembling
recombinant RNAPs in high-throughput format [25],
provides the necessary tools for dissecting the functional
properties of key RNAP domains at unprecedented
resolution. The results obtained shed new light on the role
of individual residues and provide evidence for the
functional relevance of conformational changes in the
active site of RNAPs that are not evident from the
previously available structural and genetic data.
Results
Bridge helix mutants display a broad spectrum of catalytic
activity phenotypes
The bridge helix of M. jannaschii RNAP is located near the
carboxyl terminus of the mjA′ subunit and is clearly
identifiable by its colinearity and high degree of sequence
identity and/or similarity to bacterial and eukaryotic ortho-
logs [25] (Figure 1b). The region chosen for the high-
throughput mutagenesis approach is a stretch of 17 contigu-
ous residues (mjA′ L814 to mjA′ R830 inclusive) that spans
the active site (Figure 1a). We produced a library for each of
these residues by creating targeted point mutations
encoding all 19 possible single substitutions. The constructs
encoding the mutants were expressed as recombinant
subunits in Escherichia coli, purified and assembled in quad-
ruplicate under identical conditions using the recently
developed ‘RNAP Factory’ approach [25]. The parallel
conditions for the growth, purification and in vitro assembly
of a large number of mutant subunits (typically 96) provide
a remarkable degree of consistency that allows the pheno-
typic effect of each mutation to be quantified robustly
under defined in vitro conditions [25]. The resulting RNAP
variants were initially screened using a high-throughput
trichloroacetic acid (TCA) precipitation assay that measures
the incorporation of [32P]rUTP into transcripts using
nuclease-activated DNA as template. The bridge helix is part
of the catalytic site of RNAPs, and these assays therefore
provide a reliable and informative readout. We also tested a
subset of mutants in separate dinucleotide extension assays
that specifically measure abortive transcription events. These
assays show that the effects of the various mutants on
abortive transcription are comparable to the results obtained
with the TCA-precipitation assays ([23] and LT and ROJW,
unpublished results; see also Figures 2c,d and 3b).
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Figure 1
Structure, evolutionary conservation and conformational isomers of the bridge helix. (a) Structure of the active site of Saccharomyces cerevisiae
RNAPII [7] (based on PDB code 2E2H). All structures, except the trigger loop (dark blue) and the rNTP in the insertion site (salmon pink) are shown
in the space-filling representation. The bridge helix is green and the region that has been mutagenized for this study is highlighted in yellow. The DNA
template strand is in light blue and the nascent transcript red. The Mg2+ ion (metal ‘A’, magenta) is part of the catalytic site. (b) Sequence alignment of
representative bacterial [Escherichia coli K12 (UniProt/Swiss-Prot accession number P0A8T7), Thermus aquaticus (Q9KWU6), Thermus
thermophilus HB27 (Q72HM6)], archaeal [Methanocaldococcus jannaschii (A64430) and Sulfolobus solfataricus (NP_341776)] and eukaryotic [S.
cerevisiae (CAA65619), Homo sapiens (NP_000928); RNAPII only] bridge helix sequences. Except for H. sapiens and M. jannaschii, all other
sequences have been selected solely on the basis of the availability of X-ray structures. The numbers on the left and right side of the sequences refer
to the amino- and carboxy-terminal amino acid positions of the sequence shown relative to the full-length open reading frame. The numbering of the
residues in the M. jannaschii sequence is based on the intein-free final product. Amino acid residues identical to the corresponding M. jannaschii
position are shown in red, the ‘hinge’ region [11,12] in gray and binding sites of α-amanitin [13,19] and streptolydigin [12,20] are boxed in blue. Note
that the location of the hinge region in archaeal and eukaryotic RNAPs is inferred from the position of the kink in bacterial bridge helices. The
residues in the M. jannaschii sequence that were mutagenized in this study are highlighted with a yellow box. (c) Top view (from the amino terminus
of the bridge helix) of structure shown in (a). Note the position of the bridge helix relative to the DNA-RNA hybrid. (d) Bridge helix conformations
as seen in three different X-ray structures. The bridge helix is shown in green in ribbon representation. The species and PDB codes are shown below.
Two orthologous residues in each structure, corresponding to D1090 and R1096 in the T. thermophilus β′ subunit, are shown in stick representation
in red and blue, respectively (see text for further discussion of the possible significance of these residues in stabilizing the kinked conformation).
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Figure 2
Activity assays of bridge helix mutants. (a) Graphical overview (‘heat map’) of the mutant activities from high-throughput non-specific transcription
assays. The vertical axis shows the identity of the residues located along the M. jannaschii bridge helix, spanning the interval from L814 to R830
(inclusive). On the horizontal axis the amino acid substitutions for each of these positions is indicated. The specific transcriptional activities of the
mutants are color-coded according to the scale shown lower right, ranging from inactive (dark blue, 0%) to superactive (dark red, 200%) relative to
the wild-type activity (defined as 100%). The activity values for each substitution are based on a minimum of four independent assemblies and
transcription assays (see Additional data files 1c-17c for further details). Data for the mjA′ G825 substitutions have been published previously [25]
but are included here for completeness. (b) Polar plot (‘helical wheel’) of mutant activities reflecting the spatial arrangement of the residues relative
to each other in the α-helical bridge helix. The activities of substitutions in individual residues (as labeled on the periphery) are plotted along the
radius. Activities below the wild-type level (100%) are in black, whereas activities above that level are coded by their color and radial position. The
figures along the 90°, 180°, 270° and 0/360° axes refer to percentage of wild-type activity. (c) Abortive transcription assays showing the
incorporation of [α-32P]rUTP into abortive dinucleotide extension products on activated DNA during a 20-minute incubation period. (d) Multiple-
round elongation transcription assays on a DNA-RNA scaffold. The position of the extension product is marked FL.
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The results of the transcription assays of 323 targeted
mutants in the bridge helix reveal a broad spectrum of
changes in the catalytic activities, varying from total loss of
polymerase function to activities substantially exceeding the
normal wild-type level (Figure 2a; Additional data files
1c-17c). The large variety of phenotypes observed is due to
local alterations of side-chain chemistry (for example, gain
or loss of charge and hydrophobic interactions) that either
change the interactions with nearby molecular partners
and/or affect intrinsic structural properties of the bridge
helix. The site-directed mutations described here are targeted
towards independently folded domains and are therefore
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Figure 3
A functional interaction between the Q823 and R829 positions. (a) Model of the T. thermophilus bridge helix kink (PDB 1IW7). The interacting
residues (β′ D1090 and R1096) are shown as space-filling models and the surrounding helix in green in ribbon representation. Note that the flipped-
out D1090 residue juxtaposes its side chain opposite R1096. The resulting contact stabilizes the kinked α helix. (b) High-throughput transcription
assay results of mjA′ R829X substitutions. The results are shown relative to wild-type activity (100%; dashed line). Single substitution mutant results
are shown in dark blue with the substituted residues shown along the x-axis positions; note that all substitutions, except K, result in a substantial
drop of catalytic activity. The results of two double mutant constructs, Q823R/R829D (R-D) and Q823H/R829D (H-D), are shown on the same
scale as a separate graph with green bars. Error bars indicate standard deviation (n = 4). (c) Abortive and elongation transcription assay results of the
double mutants. Q823R/R829D is inactive; Q823H/R829D has 49% (abortive assay) and 52% (elongation assay) of wild-type activity.
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unlikely to affect the conformation or stability of the overall
RNAP structure (Additional data files 18 and 19; ROJW,
unpublished observations).
As expected, many residues that seem to occupy critical
positions in the previously published X-ray structures are
particularly sensitive to change and cannot be substituted
with any other amino acid without noticeable loss of
activity. These include residues that interact with the rNTPs
in the catalytic site (T821 in the single-letter amino acid
code), or the DNA template strand entering the active site
(T821, G825, Y826 and R829), thus confirming their
essential roles. It is possible to deduce, for several positions
in the bridge helix, the precise requirement for side-chain
chemistry. This is easiest with residues for which most sub-
stitutions result in substantial loss of function. We have
previously commented on the fact that for G825 the
physical size of the side chain seems to be crucial because
any additional atoms (other than the single hydrogen side
chain of glycine) create a physical obstacle for the passing of
the DNA template strand into the active site [25]. The
phenotypes of T821 substitutions also reveal a high degree
of sensitivity to alteration. Because of its location in the
active site, the T821 side chain is placed in a unique
position where, depending on the translocation state, the
residue interacts either with the 3′ OH end of the nascent
transcript, or with the rNTP at the insertion site. Substitu-
tions of T821 with alternative residues containing long,
charged and/or bulky side chains lead to dramatic loss of
function that is almost certainly caused by steric clashes and
unfavorable intermolecular interactions.
It is similarly noticeable that the presence of a positively
charged side chain in the R829 position seems to be
absolutely critical (Figure 3b). Only R829K provides an
active alternative, but even this rather conservative mutation
incurs a substantial loss of function. At first glance, the
location of R829 adjacent to the DNA template strand
supports the idea that a positively charged residue may have
a key role in this position, but there is evidence that this
residue is also required for stabilizing an alternative
conformation of the bridge helix [11] (see below for further
details). In fact, we present evidence below that shows that,
in particular double-mutant combinations, R829 can be
replaced with a negatively charged residue (glutamic acid)
and still support a reasonable level of catalytic activity.
Surprisingly, other residues that seem to be in spatially
constrained positions in published X-ray structures can be
replaced with a chemically diverse set of side chains without
substantial loss of function. Inspection of X-ray structures of
elongating RNAP complexes suggests that the A822 position
would be unable to accommodate large side chains owing
to steric clashes with the DNA template strand (see, for
example, [5,6,11]). Substitutions of A822 with residues
containing large, bulky and/or hydrophobic side chains (for
example N, Q, F or Y) cause only a modest decrease of
activity as compared with the wild-type enzyme. There is
also a similarly unexpected tolerance to proline substitu-
tions in certain bridge helix positions. The imino acid
proline is fundamentally incapable of participating in α-
helical conformations, restricts the conformational space of
the residue at its amino-terminal side and disrupts the local
hydrogen bonding pattern that stabilizes the secondary
structure (see, for example, [26]). In many positions of the
bridge helix, proline substitutions cause, as expected, a large
loss of activity (summarized in Additional data file 20). In
other positions (for example, T821P and A822P), a clearly
detectable activity remains, and in one case (S824P) we
found an astonishing increase of activity of the mutant in
comparison with the wild type (Figure 2a; a more extensive
interpretation of this phenotype is provided below). We
deduce from the proline substitution phenotypes that there
is no absolute requirement, at any stage of the nucleotide
addition cycle, for the bridge helix to maintain the
continuous α-helical conformation that has previously been
observed very consistently in structural studies of elongating
RNAPs (see, for example, [6-8]).
Localized kinks in the bridge helix cause superactive catalysis
A third class of phenotype uncovered in the high-through-
put screen is an unexpected large number of mutations
(about 7% of the entire set) showing increased activity. We
will refer to this phenomenon as ‘superactivity’ because it
exceeds the normal wild-type level. The substitutions
causing the catalytic enhancement are predominantly
clustered in the D816, Q817, V819, Q823 and S824
positions. In addition, certain substitutions of R820, A822
and M827 result in more moderately increased levels of
activity. A helical wheel projection shows that the side
chains of D816, Q817, V819, Q823, S824 and M827 point
away from the RNAP catalytic center (Figure 2b). This leads
us to conclude that superactivity is not caused by the
mutated side chains stimulating events in the active site
directly; the observed phenotypes must instead be due to
conformational changes in the structure of the bridge helix
itself, and/or to an altered interaction pattern of the bridge
helix with the adjacent trigger loop domain.
Two of the residues that can be mutated to superactivity
(Q823 and S824) are orthologs of Thermus thermophilus
(tth) subunit β′ residues D1090 and S1091. In certain
bacterial RNAP structures the two residues are present in a
flipped-out configuration that disrupts the local hydrogen-
bonding pattern of the α-helical structure [10-12]. These
studies [10-12] have shown that tthβ′ D1090 (the ortholog
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of mjA′ Q823) stabilizes the kinked conformation of the
bridge helix through specific hydrogen bonding with a
nearby invariant residue, tthβ′ R1096 [11] (Figures 1d and
3a). Such arginine-aspartate contacts are known to be of
unusual strength, highly directional and, thus, particularly
suitable for stabilizing intramolecular interactions [27];
there is also evidence that they can act as switches to
stabilize alternative protein conformations (‘ionic locks’;
see, for example, [28]). It therefore seems that the mjA′
Q823D substitution is capable of mimicking the aspartate-
arginine stabilization pattern that is responsible for the
kinked conformation of bacterial bridge helices. The
enzyme containing Q823D is substantially more active than
the wild type, suggesting that the kinked bridge helix
represents a conformation that is highly favorable for the
nucleotide addition cycle.
This interpretation of the Q823D phenotype receives further
support from the most unusual mutant revealed in our
screen. The superactive S824P substitution is also predicted
to cause a kinked bridge helix conformation. When present
in an α helix, proline residues distort the helical structure by
consistently introducing a highly localized and permanent
kink of about 26° [29]. Our results show that the placement
of proline residues in the bridge helix sequence needs to be
very precise to achieve this effect because proline substitu-
tions in most other positions cause substantial, or even
total, loss of activity (Figure 2a; Additional data file 20).
Increased levels of transcription can be the result of
decreased abortive transcription rates favoring promoter
clearance [30]. Dinucleotide extension assays confirmed,
however, that the increased catalytic activities of the super-
active mutants were reflected by comparable increases in
abortive transcription. Under these conditions the RNAPs
harboring Q823D and S824P have activities of about 135%
and about 210%, respectively, relative to the wild-type
enzyme (Figure 2c). The results show that the extent of
kinking of the bridge helix predicted to be induced by
Q823D and S824P does not seem to interfere in any way
with the proposed template scrunching mechanism [31,32].
In addition, we investigated the elongation properties of the
mutant RNAPs using factor-independent nucleic acid
scaffolds under conditions allowing repeated initiation
[23,33]. The results are directly comparable to the activities
shown in the abortive transcription assays (Figure 2d). It is
therefore clear that the superactive phenotypes are
consistently observed in a variety of transcription assays. In
comparison with the wild-type enzyme, superactive mutants
assemble with equal efficiency, show identical chromato-
graphic elution patterns and the same degree of thermo-
stability (Additional data files 18 and 19; ROJW, unpublished
data). The increased production of transcripts is thus solely
a consequence of the enhanced catalytic activity, and it
demonstrates that mutations in the bridge helix modulate
the active site in a direct and rate-determining manner. In
preliminary studies we tested the wild-type enzyme and
RNAPs containing the superactive bridge helix substitutions
for misincorporation of dTTP in non-specific, abortive and
elongation assays and have so far found no detectable loss
of selectivity in rNTP incorporation (data not shown).
The conclusions from two independently acquired pieces of
evidence thus converge on the same explanation: the super-
active mutations Q823D and S824P are capable of creating
and/or stabilizing a localized kink in a precisely defined
region of the bridge helix. Because these mutations seem to
achieve a similar result using different structural principles,
we investigated the effects of double mutant combinations.
Constructs containing Q823 and S824 substitutions in
combinatorial configurations were used to create Q823D/
S824M, Q823D/S824P, Q823E/S824M and Q823E/S824P
double mutants. The double mutants showed similar levels
of elevated activity as Q823D and S824P on their own,
demonstrating that no further gain of function is achievable
(Figure 2c,d; Additional data file 19).
A final piece of evidence in support of an interaction
between Q823 and R829 comes from a stringent test using
another set of double mutants. Taking into account the
stabilizing interactions between tthβ′ D1090 and tthβ′
R1096 [8] (Figure 3a), we wondered whether it would be
feasible to recreate this interaction by switching the
positions of these residues. Although a Q823R/R829D
double substitution was inactive, another, Q823H/R829D,
had 47-50% of wild-type activity (Figure 3b,c). We consider
this result to be remarkable, taking into account the fact that
R829D is completely inactive (like any other substitution in
that position except, to a certain extent, lysine; Figure 3b).
The presence of a histidine residue in position 823 thus
rescues, to a significant extent, the R829D phenotype in a
manner consistent with the predicted local interaction
between these two positions during bridge helix kinking.
Each of the superactive point mutants is capable of causing
the phenotype to the fullest possible extent on its own, and
the absence of additive or synergistic effects is compatible
with the view that the mutants kink the bridge helix in a
similar manner. Structural evidence for bridge helix kinking
was previously observed only in bacterial RNAPs [10-12].
The data presented here reveal for the first time a common
link between the hitherto distinct bridge helix conforma-
tions in bacterial and archaeal RNAPs. Given that archaeal
bridge helices are more akin to their eukaryotic counterparts
than are the bacterial bridge helices, a plausible implication
of this argument is that localized bridge helix kinking forms
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part of the normal RNAP nucleotide addition cycle across
the entire evolutionary range.
The trigger loop base helices are structurally delicately
balanced
The residues that can be mutated to superactivity are
predominantly located at the ‘back’ of the bridge helix
(facing away from the catalytic site). Inspection of the
bacterial, archaeal and yeast elongating RNAP structures
shows that the bridge helix residues orthologous to mjA′
Q823 and S824 are close to the adjacent trigger loop [5-9].
Two short α helices form two pillar-like structures at the
bases of the trigger loop and are connected by a flexible ‘tip’
region (Figures 1a and 4a). This tip region tends to be
unstructured, but can also take up a variety of confor-
mations in the presence of substrates or inhibitors [7,8,13].
A network of contacts between the tip and various parts of
the rNTP is likely to promote catalysis in an as yet unknown
manner, most likely through the precise positioning of the
nucleotide substrate relative to the active site. In agreement
with this model, a variety of mutations in the trigger loop
has been shown to affect substrate usage and enzyme
fidelity [17,21,34].
The spatial vicinity between the bridge helix residues and
trigger loop base helix residues prompted us to investigate
the possible significance of these contacts in more detail.
Residues orthologous to mjA′ Q823 touch a specific residue
in the carboxy-terminal trigger loop base helix (abbreviated
as TLC from here on) that corresponds to residue I98 of the
RNAP mjA′′ subunit. Conversely, residues orthologous to
S824 touch another residue in the amino-terminal trigger
loop base helix (TLN), which corresponds to mjA′′ G72
(Figure 4c). Given the geometry of α helices (which imposes
an angle of about 100° between adjacent amino acids), the
bridge helix is thus capable of contacting both trigger loop
base helices using only two successive residues. The contacts
of Q823 and S824 with TLC and TLN, respectively, could
constitute an important functional interface between the
bridge helix and trigger loop. We therefore created two
more libraries containing all possible substitutions in mjA′′
G72 and mjA′′ I98, respectively, to study the phenotypic
effects.
The results reveal a highly unusual pattern. Essentially none
of the 19 alternative substitutions in either trigger loop base
helix residue causes any substantial reduction in
transcriptional activity as measured by the high-throughput
transcription assays (Figure 5a). In fact, the majority of
substitutions cause superactivity that reaches (for example,
in the case of I98P) a level that is indistinguishable from the
effects seen with some of the substitutions in the
neighboring bridge helix. The results also reveal that, in the
G72 (TLN) position, only glycine or alanine, and in the I98
(TLC) position, only a very select number of other substitu-
tions (I, V, L, M or K), are capable of providing the relatively
low levels of activity (rather than high levels, as might be
expected) that are apparently required for wild-type
function. Side-chain identity therefore has only a minor role
for these positions (note, for example, that, in the case of
mjA′′ I98, very similar activities were observed using A, G, S,
T, C, F, Y and R substitutions, residues with radically differ-
ent chemical properties), suggesting that one of the major
factors influencing the function of the trigger loop base
helices TLN and TLC may be local stability, rather than
specific side-chain chemistry. This interpretation is sup-
ported by a good match of our experimental data with
results from a bioinformatic analysis aimed at detecting
intrinsically unfolded sequences from local hydrophobicity
and net charge densities [35,36] (Additional data file 21).
This investigation reveals that the mjA′′ I98 (TLC) position
is intrinsically weakly stable and becomes easily disordered
when substituted by almost all residues identified in the
trigger loop mutagenesis screen that convert the RNAP to
superactivity (Figure 5b). The presence of a highly con-
served G-X-P hinge motif [37] nearby may be important in
this conformational switch. A similar study classifies the
region surrounding G72 as unstable (Additional data file
21). We therefore propose that the trigger loop base helices
TLN and TLC are finely poised at the edge of structural
stability. Even minor variations (such as the replacement of
either mjA′′ G72 or mjA′′ I98 with other residues by site-
directed mutagenesis) cause a substantial loss of local
stability by altering the local net charge/hydrophobicity
ratio. In bacterial RNAPs, TLN and TLC are capable of
adopting alternative conformations, possibly in response to
structural changes in the hinge region of the bridge helix
[12]. Similarly, in yeast RNAPII the scRpb1 E1103G
substitution (corresponding to mjA′′ E99, that is,
immediately carboxy-terminal to the mjA′′ I98 in TLC;
Figure 4) shows increased catalytic activity [21,34,38].
These results provide a plausible explanation for the
superactive phenotypes observed with certain substitutions
in bridge helix residues. Some of the mutations in Q823
and S824 destabilize TLN and TLC by kinking this part of
the bridge helix away from the trigger loop base helices,
thus causing conformational changes in the trigger loop
that increase the catalytic activity (Figure 4b). We also
imagine that similar events are likely to occur in the
superactive mutations located in more amino-terminal
regions of the bridge helix, such as D816, Q817 and V819.
The precise contact points between the bridge helix and
trigger loop in these regions are, however, not as clearly
definable because different trigger loop orientations have
been observed in RNAP crystal structures [7,8,12].
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Finally we created various recombinant RNAPs containing
combinations of superactive bridge helix and superactive
trigger loop mutants, such as mjA′ S824P/mjA′′ I98P. Just as
previously observed with the bridge helix double mutants,
no further increase in superactivity was detected (data not
shown). Single point mutants in either the bridge helix or
the trigger loop are therefore sufficient to induce the full
superactivity phenotype. The lack of additivity or synergism
suggests that each mutant affects the same process in a
functionally overlapping and mutually independent manner.
Discussion
Although the chemical aspects of the catalytic functions of
nucleic acid polymerases are well established [39], there is
still a considerable amount of uncertainty concerning the
mechanical aspects that link these catalytic steps to move-
ment of the nucleic acid substrates through the active site.
RNAPs are powerful nanomechanical devices that carry out
transcription at considerable speed [40] and exert forces
that exceed cytoskeletal motors [15,41].
In this study we describe the most extensive example of a
high-throughput structure-function analysis so far that relies
on neither genetic screens to isolate mutants nor the use of
site-directed mutagenesis to test a preconceived model.
Instead, we implemented a new experimental approach that
is designed to sample systematically a substantial area of
protein structure-function space. The collection of such
large datasets is especially important for complex macro-
molecular machines that undergo substantial conforma-
tional changes at different stages of the reaction cycle that
might not be obvious from the small numbers of ‘canonical’
high-resolution structures available [42]. Many of the most
informative mutants discovered in the screen would not
have been designed using prior knowledge, either because
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Figure 4
Structure of the trigger loop and its interface to the bridge helix. (a) Overview of the spatial relationship between the trigger loop (blue ribbon
representation) and the bridge helix (green ribbon representation) based on a yeast RNAPII X-ray structure containing a folded trigger loop
structure [7] (PDB 2E2H). Bridge helix residues E833 and T834 (yellow) and trigger loop residues A1076 and K1102 (orange) are shown as space-
filling models. (b) Spatial relationship of the trigger loop base helices with the bridge helix in the kinked (PDB 1IW7) and straight (PDB 2O5J)
versions of T. thermophilus RNAP. Note how the flipping out of bridge helix residues D1090 and S1091 during kinking disrupts their proximity to
trigger loop residues I1260 and G1233, respectively. (c) Sequence alignments of trigger loop sequences using the same criteria as for the bridge helix
alignments shown in Figure 1b. TL-N and TL-C indicate the amino-terminal and carboxy-terminal trigger loop base helices, respectively.
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there would have been no rational reason to do so (for
example, V818K), or because the likelihood of obtaining
useful insights would have been regarded as too low to
justify the experimental effort (for example, S824P).
The results shed new light on the mutual relationship
between the bridge helix and trigger loop. Specifically, we
show that the molecular contacts made between the bridge
helix and trigger loop are influenced by the conformations
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Figure 5
Activity assays of trigger loop mutants. (a) Graphical overview (‘heat map’) of the mutant activities from high-throughput non-specific transcription
assays. The vertical axis shows the identity of the residues located along the M. jannaschii trigger loop. On the horizontal axis the amino acid
substitutions for each of these positions is marked. The transcriptional activities of the mutants are color-coded according to the scale shown in the
right relative to the wild-type activity (defined as 100%). The activity values for each substitution are based on a minimum of four independent
assemblies/transcription assays. (b) Prediction of local stabilities of substitutions in the mjA′′ I98 position. The ‘FoldIndex’ was calculated using a web-
based program, FoldIndex [48] (window size = 3; step = 1) with mjA′′ amino acid sequences containing substitutions with all 20 different amino acids
in the I98 position. Areas within the graph with positive FoldIndex values (stable folding) and negative values (unstable folding) are indicated by a light
green or magenta background, respectively. I98 seems to occupy a critical area between regions of low stability (R96) and high stability (E99 and
I100). The identity of residue 98 (highlighted between the dashed lines) critically determines the shape of this transition; a small number of
hydrophobic residues increases local stability (I>V>L>F>C>M>A; green symbols), whereas most other substitutions cause local destabilization (for
example P, D or E; magenta). Certain substitutions may cause additional structural changes that cannot be accounted for by this prediction. The
symbols for the various amino acids are shown on the right.
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of the two domains (localized kinking of the bridge helix
and stability of the trigger loop base helices). The
preponderance of the straight bridge helix conformation in
the majority of available structures has resulted in the
kinked versions often being dismissed as artifacts or ‘off-
pathway’ conformations. Results shown here prove that
kinked bridge helix conformations are indeed compatible
with catalytic function and even capable of supporting rates
that exceed wild-type activity by a considerable measure. We
suggest that bridge helix kinking is a normal (although
possibly short-lived) intermediate conformational state of
RNAP and that the enhanced catalytic rates observed in
some of the mutants are the result of a bias towards this
state. Such an interpretation is in general agreement with
the original models proposed for RNAP function [5,6,8,
14,17], rather than more recent trigger loop-centric hypo-
theses [3,18].
It is nevertheless clear that not all observed superactive
phenotypes are exclusively caused by conformational
changes in the bridge helix. Independent mutations in the
trigger loop base helices and other point mutants in the
bridge helix that are likely to affect the bridge helix/trigger
loop interface also cause similar increases in the catalytic
activity. We therefore propose a model that explains these
apparently separate phenotypic classes as the perturbation
of a common mechanism in which both domains partici-
pate (Figure 6). According to this scheme, the trigger loop
base helices are delicately balanced on the verge of in-
stability and require bridge helix residues nearby in order to
form a stable three-helix bundle (Figure 6a,b; Additional
data file 21). If these interactions are disrupted by mutations
(Figure 6c,d), or through preferential bridge helix kinking
towards the active site (Figure 6e,f), the trigger loop base
becomes more mobile. This increased mobility of the trigger
loop is, in turn, responsible for the superactive phenotype.
The more amino-terminal bridge helix mutants (for
example, V819K, Q817T and D816N) probably act in a
similar manner by weakening trigger loop contacts in the
region closer to the active site, but they may also exert their
effects more indirectly through as yet undefined local
changes in bridge helix folding and stability (Additional
data file 21). We therefore propose that the flexibility of the
trigger loop is directly influenced by the conformation of
the bridge helix. Any loss of this bridge-helix-induced
constraint on the trigger loop allows the trigger loop to
remain longer in a conformation favorable to catalysis and
thus give rise to the superactive phenotypes observed.
We further suggest that under normal conditions a periodic
transition between the straight and kinked version of the
bridge helix allows the trigger loop to take up temporarily a
conformation that is highly favorable for the execution of
the catalytic reaction before it becomes restrained again
through contacts along the bridge helix/trigger loop
interface. Normal wild-type activity may therefore be the
consequence of temporary bursts of catalytic activity, which
are more prolonged in the superactive mutants described
here. We currently do not understand how the trigger loop
interacts with the catalytic site to promote phosphodiester
bond formation, but it is feasible that a kinked bridge helix
conformation stabilizes the post-translocation state of the
DNA-RNA hybrid and thus provides the trigger loop tip
domain with an increased opportunity to sequester an
incoming rNTP in a steric manner most favorable for
phosphodiester bond formation [7,8,18,34]. A recent report
also suggests that bridge helix kinks could facilitate the
conformation of the pre-insertion position of the DNA
template strand; such a phenomenon could also explain, at
least in part, the increased level of activity in some of the
bridge helix mutants described above [13].
Conclusions
The high-throughput mutagenesis data show that the bridge
helix of M. jannaschii RNAP subunit mjA′, in combination
with the trigger loop, has a major impact on the catalytic
activity of RNAP. The extent of this effect is striking: single
point mutants in these domains cause functional effects that
range from complete abolition of enzyme function to a
near-doubling of the catalytic rate without any additional
changes anywhere else among the up to 3,500 other amino
acids that make up a complete multisubunit RNAP.
Although our results are currently restricted to an archaeal
in vitro system, it is very likely that many of the features
described here are universal, and we expect that it will be
possible to create bridge helix mutants with similar proper-
ties in other well-studied organisms, such as E. coli and
Saccharomyces cerevisiae. Furthermore, the variations displayed
by the superactive mutations in the bridge helix/trigger loop
domains prove that the catalytic rate of RNAPs is
intrinsically subject to variation and is, at least under in vitro
conditions, not programmed to its maximum level.
Interactions with regulatory proteins (especially elongation
and anti-termination factors) can modulate the active site
by stabilizing different conformational states (Figure 6),
and evolutionary changes in the bridge helix and trigger
loop sequences can ‘fine tune’ the catalytic capacity of
cellular enzymes for an optimum rate in the long term.
It has previously been suggested that in prokaryotes the
RNAP elongation rate may be optimized for allowing RNA
folding or co-translation and in eukaryotes for post-trans-
criptional processing of primary transcripts [43-45]. Inspec-
tion of the amino acids present in certain rate-determining
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bridge helix positions shows an intriguing degree of species-
dependent variation (Figures 1b and 4c; Additional data
files 1-17), which suggests that such adaptations are indeed
used during evolution to continuously coordinate the
functional properties of RNAPs with other processes
involved in gene expression.
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Figure 6
Models of bridge helix and trigger loop mutant effects. Summary of the predicted positions of the bridge helix (green) and trigger loop base helices
(dark blue). (a,c,e) The helices are shown as a schematic cross-section (top view, similar to Figure 1c) to indicate their locations relative to each
other. The DNA template strand is shown in light blue and the newly synthesized transcript in red. The amino acids specifically labeled refer to M.
jannaschii positions in the A′ (Q823, S824) and A′′ (I98 and G72) subunits, respectively. The position of the catalytic site is represented by the ‘Metal
A’ ion as a magenta dot. (b,d,f) Schematic side views of the bridge helix (similar to Figures 1a,d) to illustrate the proposed equilibrium distribution
between straight and kinked conformations in the wild-type and mutant enzymes. (a,b) In the wild-type, the bridge helix and trigger loop base helices
are typically in close contact (indicated by the gray dotted lines in (a)) and the bridge helix is predominantly found in the straight conformation (b).
The contacts between the bridge helix and trigger loop stabilize the conformation of the trigger loop base helices. (c,d) In some of the bridge helix
mutants, and nearly all the trigger loop mutants described here (TLN-X72 and TLC-X98), contacts between bridge helix and the trigger loop are
diminished, although the bridge helix conformation is unaffected. (e,f) In certain bridge helix mutants (especially Q823D and S824P), the kinked bridge
helix is mainly in the ‘forward’ position and is therefore not capable of maintaining effective contacts with the trigger loop base helices.
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Materials and methods
Mutagenesis
The generation of site-directed mutants using oligonucleo-
tides with randomized codon positions (mjA′ A818, V819,
R820, T821, A822, Q823, S824, G825, Y826, M827, Q828,
R829 and R830) was carried out as described in Nottebaum
et al. [25]. Briefly, the segment of bacterial expression
vectors encoding the bridge helix domain was replaced with
double-stranded oligonucleotides containing randomized
positions corresponding to the codon targeted for muta-
genesis. Constructs containing the desired amino acid sub-
stitutions were selected from a collection of randomly picked
clones after sequencing. For residues mjA′ L814, V815, D816,
Q817 and mjA′′ G72 and I98, sequential permutation
libraries were constructed from custom synthetic libraries
purchased from GeneArt (Regensburg, Germany). Each
mutant construct described in this study was validated at
least once by DNA sequencing to confirm the presence of
the expected point mutation and the integrity of the
restriction enzyme sites used for the subcloning procedures.
Large-scale archiving and growth of mutants
The expression plasmids were stored as arrayed frozen
bacterial expression strain stocks in two-dimensionally
barcoded tubes at -80°C in the presence of 5% dimethyl
sulfoxide as anti-freezing agent. For each mutagenized
amino acid position, all substitutions were arranged in a
standardized pattern with multiple wild-type and negative
controls. For recombinant protein production, four 24-
deepwell plates containing 1.5 ml per well of autoinduction
medium (Novagen) were robotically inoculated from these
frozen stocks and grown with shaking at 37°C for 16 h
before further processing.
High-throughput subunit purification
The purification of mutant and wild-type mjA′ subunits was
carried out robotically in sets of 96 as described previously
[25]. Briefly, aliquots of the induced cultures were lyzed in
deepwell plates using chemical and enzymatic agents
[FastBreak (Promega) and Lysonase (Novagen), respec-
tively]. The recombinant mjA′ subunits were then purified
from the lysates as inclusion bodies and solubilized in the
presence of near-saturating (8.3 M) urea. The protein
concentrations of the subunit preparations were auto-
matically monitored with the Bicinchonic Acid assay
(Sigma). A similar procedure was adapted for the purifica-
tion of recombinant mjA′′ subunits by including 10%
isopropanol in the wash buffer to reduce the solubility of
the recombinant proteins during the inclusion body purifi-
cation step. This procedure typically yielded about 250 µg of
purified recombinant subunits from 900 µl expression
culture with a standard deviation in the concentrations of
individual subunit preparations of less than ±10% (the
presence of the point mutations had no discernible effect on
the growth of expression cultures or on the yield and
solubility of the recombinant proteins).
High-throughput in vitro assembly of RNAPs
The assembly procedure was carried out robotically as
previously described [25]. Small-scale in vitro assembly
reactions (final volume 100 µl) were robotically prepared
by combining aliquots of the mjA′ mutant subunits with a
‘Master Mix (-A′)’ containing an empirically optimized
mixture of the other RNAP subunits in 6 M urea (the
subunits present in the Master Mix are rate-limiting in the
assembly reactions; variations in the mutant mjA′ subunit
concentrations thus do not influence the final yield of
assembled RNAP). The assembly mixtures were then
transferred to a 96-well microdialysis device (Spectrum
Laboratories). The RNAPs were automatically assembled by
gradually lowering the urea concentration in the dialysis
chamber from 6 M to urea-free over a period of 16 h using a
robotically controlled pump. For chromatographic analyses
(Additional data file 18), 350 µl assembly mixes were
separated on a Superose-12 10/300 High Performance
column (GE Healthcare) on a BioLogic Duoflow system
(Bio-Rad) at a flow rate of 0.25 ml/minute in urea-free
assembly buffer [25]. The eluate was monitored with a
Quad-Tech detector (Bio-Rad) and fractions collected
(350 µl each) were analyzed for RNAP activity using the
automated TCA precipitation assay described below.
Transcription assays
TCA precipitation assays measuring the incorporation of
[α-32P]rUTP into TCA-insoluble products were carried out
as previously described [22,23]. For the robotic implemen-
tation of this assay [25], aliquots of the assay mixtures were
incubated for 45 minutes at 70°C in thin-wall PCR plates.
The radiolabeled transcripts were then precipitated by the
addition of ice-cold TCA solution. After incubation for
30 minutes at 1°C, the mixture was robotically pipetted
onto a 96-GF/F glass fiber filter plate (Whatman) on a
robotic vacuum platform. Unincorporated [α-32P]rUTP was
filtered to waste and the labeled RNA retained on the filter
surface was washed seven times with further aliquots of ice-
cold TCA. After additional washes with 2-propanol and
vacuum drying, the amount of incorporated [α-32P]rUTP
was quantified with a microplate counter (TopCount NXT,
Packard) in the presence of scintillant (MicroScint-O;
Perkin-Elmer).
The dinucleotide extension (abortive) assays were performed
manually as previously described [23]. RNAPs were incu-
bated at 70°C for 30 minutes with activated DNA (Sigma
Type XV), CpG dinucleotide and [α-32P]rUTP. The extension
products were separated from unincorporated label on 20%
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acrylamide gels, visualized by phosphoimaging (Fuji) and
quantified (AIDA image analyzer; Raytest). The multiple-
round elongation assays used a promoter-independent
nucleic acid scaffold (EC3) that mimics an elongation trans-
cription complex [46]. This scaffold contains a nine-nucleo-
tide RNA pre-hybridized to the template strand, which is
extended into a 71-nucleotide run-off transcript by RNAP
(in the absence of basal transcription factors). Elongation
reactions were preincubated for 20 minutes at 60°C in 20 µl
TB (50 mM Tris-HCl, pH 7.5, 75 mM KCl, 2.5 mM MgCl2,
10 mM dithiothreitol, 8 pmol annealed ECR3 scaffold [46]
and about 100 ng RNAP) before transcription (20 minutes
at 60°C) was initiated by the addition of NTPs [500 µM
rATP, 500 µM rCTP, 500 µM rGTP, 10 µM rUTP and 0.15 MBq
[α-32P]rUTP (110 TBq/mmol)]. The analysis and quantifi-
cation of the extension products was carried out as
described above for the dinucleotide extension assay. For all
transcription assays the incubation periods were in the
linear response range.
Additional data files
The following additional data are available. Additional data
file 1 shows the structure, evolution and function of mjA′
L814. Additional data file 2 shows the structure, evolution
and function of mjA′ V815. Additional data file 3 shows the
structure, evolution and function of mjA′ D816. Additional
data file 4 shows the structure, evolution and function of
mjA′ Q817. Additional data file 5 shows the structure,
evolution and function of mjA′ A818. Additional data file 6
shows the structure, evolution and function of mjA′ V819.
Additional data file 7 shows the structure, evolution and
function of mjA′ R820. Additional data file 8 shows the
structure, evolution and function of mjA′ T821. Additional
data file 9 shows the structure, evolution and function of
mjA′ A822. Additional data file 10 shows the structure,
evolution and function of mjA′ Q823. Additional data file
11 shows the structure, evolution and function of mjA′
S824. Additional data file 12 shows the structure, evolution
and function of mjA′ G825. Additional data file 13 shows
the structure, evolution and function of mjA′ Y826.
Additional data file 14 shows the structure, evolution and
function of mjA′ M827. Additional data file 15 shows the
structure, evolution and function of mjA′ Q828. Additional
data file 16 shows the structure, evolution and function of
mjA′ R829. Additional data file 17 shows the structure,
evolution and function of mjA′ R830. Additional data file
18 shows the chromatographic elution profiles of wild-type
and mutant mjRNAPs. Additional data file 19 shows the
activities of wild-type and mutant mjRNAPs at limiting and
saturating template DNA concentrations. Additional data
file 20 shows the functional consequences of proline
substitutions in different bridge helix positions. Additional
data file 21 contains the bioinformatic analysis of intrinsic
folding properties of bridge helices and trigger loops.
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